Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 3
1 [ . . . . : . . . . 1 . . . . : . . . . 2 . . . . : . . . . 3 . . . . : . . . ] 387
batch____ bits E-value N 100.0% 1:387 MPESLMVIRSSSTLRKHWEWMTFSADSVSSVHTLTDDLPLESLADQPGAGNVHLLIPPEGLLYRSLTLPNAKYKLTAQTLQWLAEETLPDNTQDWHWTVVDKQNESVEVIGIQSEKLSRYLERLHTAGLNVTRVLPDGCYLPWEVDSWTLVNQQTSWLIRSAAHAFNELDEHWLQHLAAQFPPENMLCYGVVPHGVAAANPLIQHPEIPSLSLYSADIAFQRYDMLHGIFRKQKTVSKSGKWLARLAVSCLVLAILSFVGSRSIALWHTLKIEDQLQQQQQETWQRYFPQIKRTHNFRFYFKQQLAQQYPEAVPLLYHLQTLLLEHPELQLMEANYSQKQKSLTLKMSAKSEANIDRFCELTQSWLPMEKTEKDPVSGVWTVRNSGK
1 UniRef50_Q089T9 General secretion pathway p... 296 1e-78 1 22.3% 1:385 1:401 MSER-LFIRLGKSSEHPCSWLVWSEQeiIASGELSDAASLSTLAERAGNRPVDVLVPAANMTLTQIMLPEKGQRQALKALPYMLEESLATNVDNMHFVVGPREGEQLNVAAVAHEQMQIWLEWLHHAGLKVKRIVPDCLALPLEQCRWAAMSVGSEYLIRTSEGSGVSMPKAwlPKLLIAAKpeSISVASYSDDIVFEGVDINNKPLDLPMMVLAKGILNAPINLLSGIYKPKHEYSKQLLTWKNAAI-VVMIAIVLALANKGIAIHQLNNQTTELQAQSEMIFKQAVPGVNRIVNMRSQMGSELRSMQGqfFEMLDGLKPAFSKVPELKPNTLRYEANRNELRMQVTAKTYGQIDTFKELVSKDYLLEGGAMnsVTSTLTLRNK--
2 UniRef50_Q5E1Y5 General secretion pathway p... 275 2e-72 1 19.7% 1:380 1:408 MSEH-LIIRLNSQPSDPIQWIVWSPeeVIASGELDSSEALPSLSSYSEQRMVSVLLPSSDVLLREVVIPEGAARQFSSMLPFIIEDDLAQDVDDLHMVILKKDSKVAQVAIIEHSKMTMWLEQLSDAGIQTKRFMPDVLALPFHDDGASMVQLGQQWLIRHHEYQGAVAEPQWVSMLLtsPMPFILHSYSECEMEIAGAKVNLESPE-LVMQLLAEGLLSSKVNVLNGPYRPQSSWRKHWRVWQKV-ILSLGLVMVAFVAQHVSEVQKLEQHSLALHAESERIFRDIFPNKRKIPTakSQMKNEEARLQGGalAWMAEISPYLSKVPQVKLQSLKFDGKRNEIRLQASASDFPYFEKLTSELGTKFEVEQGQLNKNDGQV-------
3 UniRef50_A6FGY7 Hypothetical general secret... 273 6e-72 1 18.6% 1:387 1:404 MSEQ-LVVRLGSESRQAIHWLVWseREIIASGILTSAEDLIELKSRAGGRPIIALVPSCDITFKKVELPGRSNKQLLNALPYMLEQELSSDIDKLHFAVLDKAANTVSVAVIAHDKMQQWQTWLADAELVCEQYIPDALTLPYNEAHWSAIELDGQWLIRQTPTQGLCIESELLTFVLATTEYPEDEGVNNIpdALALDNWQQGQIE-LPMKLCAEGAIASRYNLLQGQYKVVREENVALKLWRGTAIAAS-LAMVMIFVNQFVTLNKLEQQQSALDNEIRQVYKTVFKPKKMRLnvKKQMQSRLNDLrsGFLVMLSQLTPAFKQLPGIKPISVRYDTKQATIRLQASAADFQVFDKLKSSLSTQFDVAQGTLSQRDGRvtLDIKGK
4 UniRef50_A1SR64 General secretion pathway p... 270 8e-71 1 20.3% 1:385 1:403 MNER-LIIRLASSASQKNYWLIWSDSeiIASGEVDNAEQLSLLTEKAFQRRVICLLPGVDICIKKVVIKGAFNRQMQQALPYLVEEELASDVEKLHFNVIAKETHLVHVAICDKQKMYDWIDWLEKAQINCKQFIPEGLTLPLPEDgwQAIKLGEQWLIRETANIAWSCDHSMLNTILESKLKNSarIESYSPVIEDSVAEWSSHDAMLPMELLAIGTKNNPVNFLTAEFKPVKEVSPYIKKWRIPAAAGVLLFIVSVLNIYS-HTLQVQAETELIQQQVETIYSQAFPRESKLRYAryKLDTMLKELQgdFLTVLDDLSPALMSLKEFEISSLKFDSKKQELQLALTAPSFQAFETFAAELPEHLSAQQgsKSGVSGVLTIRKK--
5 UniRef50_P45763 Probable general secretion ... 263 5e-69 1 100.0% 1:387 1:387 MPESLMVIRSSSTLRKHWEWMTFSADSVSSVHTLTDDLPLESLADQPGAGNVHLLIPPEGLLYRSLTLPNAKYKLTAQTLQWLAEETLPDNTQDWHWTVVDKQNESVEVIGIQSEKLSRYLERLHTAGLNVTRVLPDGCYLPWEVDSWTLVNQQTSWLIRSAAHAFNELDEHWLQHLAAQFPPENMLCYGVVPHGVAAANPLIQHPEIPSLSLYSADIAFQRYDMLHGIFRKQKTVSKSGKWLARLAVSCLVLAILSFVGSRSIALWHTLKIEDQLQQQQQETWQRYFPQIKRTHNFRFYFKQQLAQQYPEAVPLLYHLQTLLLEHPELQLMEANYSQKQKSLTLKMSAKSEANIDRFCELTQSWLPMEKTEKDPVSGVWTVRNSGK
6 UniRef50_P45789 General secretion pathway p... 262 1e-68 1 24.1% 6:379 11:388 -----LVIRLGTNAQQPVEWLVWseEEIIASGILASAHALGELRERAGGRPVVTLVPGSDLIFRRVSLPGKYSRQAAAALPYLLEEQIASDVDELHLVVLGHEGHEVDLMAVDKEKMQIWLGWLQQAGLKSQQLLPDVLALPPAADGWSALQLGKEWLLRQGPCQGIVADESLLAMLLAAEADPVTIHSHTPLPAIPAANWLAADPELPML-LLAKGALNCQANLLQGPYRPQTEYSRYWLQWRKVAVVAGL-LLLVALTQRGMHLYQLAEQDKALKAEIRQVYTRIFPGENRIVNVRSQMAQHlqTPQDGVLLLLTELAPTFAEVPGLKPQVLRFDAARGELRLQVTAPGFAEIERFRELAGKRFEVQQGEGAQHRGQ--------
7 UniRef50_P45782 General secretion pathway p... 256 9e-67 1 17.3% 5:385 8:407 ----FLTVRLSSQKEADIPWLVWSaqEVIASGQVAGWEALHEIESYADQRSVVVLLAASDLILTSVEIPPGASRQLENMLPYLLEDEIAQDVEDVHFCVLSKGRETADVVGVDRLWLRACLDHLKACGFDVKRVLPDVLAIPRPEHGLAALQLGDEWLVRKSTTQGMAVDAQWLSLLAASDWVQNEGEYLppELSLAETQEWRYEPSGLVMQLLTQEALTSKFNLLTGSFKLKSSWLRYWQIWRKVAI-AAGLFVAVSISYSLFQAHQYEAQADAYRAESERIFRSIFPDKQKIpyLKRQMSDEMARLSGGalKWLSPLPEALKGV-NLQLQSIKFDSNRSEIRLEATSRDFQSFEQARTQLEQYFAVEQGQLNKNggVFVVKPK--
8 UniRef50_Q47VE2 General secretion pathway p... 256 1e-66 1 17.8% 1:381 1:413 MTE-TLFIRLGSQAHDTVHWLVVAeqEIIASGELKGAQQLSELTSKADKRQVKILVPGCDVLLKSLKVPAKSSRAIRLATPYMLEDSLAEDVEQLFFAysDEQGNNCFTAIVAHSQMQQWLSWLADADIETDTILPDVLAMPIVAEGWSAIALGdqVIVRQKLWQGFNVDANAWQLQCQTSAKqsILIEAYSPLAHSEQCNVSTMPEELALALMATNYDssHFNLLQGQYKVKENRSHTGRQWLWVA-GVAMFAILLSLGHKSAQLWQLNAEQENIQQNIVASYKKAFPKTKRVrtIKSQLNRELagDRQGFLAMLAKLQPAFAKVPALKPESLKFDGKRQELRIQATAKDYQAFEQfvALATTNLIVKQGSQSNQGDQVT------
9 UniRef50_B4S158 General secretion pathway p... 255 2e-66 1 14.8% 6:383 4:396 -----LLVRLGANYTDPISWLVYseDEIIASGELPSAEDLSTLTERAGQRSVIALAPSSDILLKWVELPPKAGRKIISAIPFMLEDELATDISQQFFAIGPKRGDEQAVAIVSHEKMLQWQAWLSEAGLFCDTIIPDVLAVPATPNGWSVLTLGEQLLVRQDEFKGVQGEQAWLLPTlqQEAPVTITNYAGIDLSSLPNIEEAQAPLELPMQVLAKEAMQSSFNLCQGEYKLKRKRSGVLSQWRVAAVLAVL-ALCTSLIDKGVTLYQLKSENQALSSEINAAVKAGFPNIGTYRNVRLKLQSELAKLEQgmLIMLDQLAPAFTA-TDVKPQTLRFDASRTEIRIQAQGKNFEALEQfrSAENAGFLVEQGAINNRdgTVSVR----
10 UniRef50_C9P1R4 General secretion pathway p... 255 3e-66 1 17.6% 6:381 9:400 -----LIVRLSSQQNAIIPWLVWsqQQVIASGELSNGQQLEQLTPHAVQRSTIILLSTSDLLLTQVTIPAGGSRQFAAMLPYLLEEEIAQDVDELHFSVLGKQGDQAFVAGVDRAWLQAMLEQLQALGLDVKRVVPDVLALPVHEEGLSAGQMGDQWLVRKGEYSGLSVDKDWLTWFCASDWVkpLTAYTPLPELPLSEQQSWQSMACPslVLLTEQVLTHKINLLTGPFKPKSSWNKYWLIWRK-AVIAGLFLLVVLMTSYGLQVHKDTQLAQSYRDESERIFREIFPDKQRIpyLRRQMTDELTAlgEDVLSWFSRLPETIGSVTDMQVQSLRFDGNRSEVRLDVTSSDFQSFEQARVKLAEYFLVEQGQLSRNEQRVS------
11 UniRef50_Q5QY99 Type II secretory pathway, ... 254 4e-66 1 20.4% 1:387 1:402 MHETLILRLPAYGTEEPIPWLVwgQQELIASGELSSVAELVQLKDKANRCEVIVALPGQDVSMTRVTLPAGTKRHLQRIIPYALEEELATDIEQLHFAWPDLKNTELPVAVVAKERMNYWLQVLTEAGIDSAFWVPDCFLLPHQNDTWQAIELADSVIVRTGEWQGFTIEKEQFAQLAPAFapTEIIHYGALNWPQSPAPLIPADIEVPFTIAVQSIATGNRINLRQGAYRSQRAKRSVDLPWKGLATAASVLF-VLAVLLNGVRYWQLESQRGALKAQAEQLYRDAFPGQTRIVNLKVQLQRQLESLgaSVLAVLQQLAPAFKSQPELQLELLRF--QNNELRLQATASSFSQFEAFQQAAKagLTVEAGSMsqVSGSLTVQLDGQ
12 UniRef50_Q3ILN2 Putative general secretion ... 252 1e-65 1 17.1% 1:386 1:400 MTE-ILLIRTGQTEQELLNWLIYSPQeiIASGELVNASYLNELSEKSLGREVVVLLPCDQVQLKTVMLPTKWNRKLEQALPYMLEEDIACDIDELFIAVGEpeQHAVRVAMTDREWFEAWLALFAEHNLSVYKILPDALLLPPaeDTVTAIALNNQWLFKQGPWRISAVETSWLNGYLTAMGNPDVKHFSPATQFPETVNLQAQTSDYdpLALFAKQLEHTKFNLRQGMYQLKKKSTLWWGYWKSAAIITSV-ALVASITIKAIELHQLNTQLELAKAQVIERYQKAFPGTKVRPHlkNQIKGALAKIqaGFLELTTELVGVFSQVSNFTPETLRYDKKRNELRMRARAKDFQTFGKVKAIlqQGLTVDQGSLSNDGDFVviKLRG-
13 UniRef50_C4L990 General secretion pathway p... 252 1e-65 1 25.2% 1:381 1:386 MNEFLL-IRLGSRHQERVHWLVWsqQAVISSGQLDNAAQLSELTERAGHRPVYVLVPGCDVIFRELTLPGRLNAQTMRALPFMLEDEIASDVEQLHITVLAHQGQQVNIAAVEQTQMQQWLSWLADAGLTAQQLLPDVLALPQPEGewSLLQLGDQWLIRQSAWQGSVVDNDLFSAWMTCHQPYPALHSYTPPPAEPPAEWIVSLCE-LPMQLLAEQVPVQRIDLLQGAFRRVSTWKKQWLRWRLPAV-LTGLLLLLFMANQGMEYVQLRQQQQQLQQQMTALYRQLFPEEKRIVNPRAQLKQHLQGLQQafLSQLALLAPLLHKTPEIELQQLRFEADKQEFRLQISAKDFGMLDKFRNQANTTFATEMTNMQDQGGRVS------
14 UniRef50_C9NLJ3 General secretion pathway p... 250 7e-65 1 17.4% 1:384 1:403 MNE-FLIVRLSKSKTAAIQWLVWSEseVIASGELQDHQDLAELANYAEGRQVIVLVSAANLVLTQLEVPAGANRQFDSMLPFMLEDDVAQDVDELHFTVLAKEANQAYVCGIDYSWLESILADMRQLGFAVRKVLPDALALPVAEegLSAVELDGQWLVKKGQFSAVSIELAWLPLLAQSDWVKqlQAYSHLPELTLADEqwHNEQPQLVMQLLSEQAVKSKLNLLSGEFKPKSSFGRHLKVWRKAAIAAGVLVAILSV-DNWLQIQSAETQANAYRQESERIFRQVtnKIPTVTYLKREMEREESRLSGgvLEWMVKMPQVMKQVPGLRLTSFKYDSTRGEVRLQAQSNDFQTFEKARELMSGQFTVEQGQLSkvNGTFVLKR---
15 UniRef50_D0Z0Q1 General secretion pathway p... 249 1e-64 1 18.8% 5:386 8:437 ----FLTIRLSSQSTSPVQWLVWSPTEriASGQLPDSSHLGDLTEYAAQRPVYVVVPTSEMLLTQVTIPAGSSRQLSAVLPYLLEEELAQDVESLHVQLLKREKDIASVAVVEHSKMAYWLEQFKQHHFEVRKLLPDSLCLPLFNDGYSAAQLEQQWLIRQSETLGINVEISWLDAWLseDLSQVIIHHYTPAPEVQLGRWRAETPE-LVMQLLAQGAESSKLNLLSGAYKPQAAWRKHLLPWRKVAI-AAGLVLTALVAEHVIAVNQMENQAQAYRTESERIFRQVLPQFKRIpyLRNQMKRAVaeQQQGLLTWLLELQPMLKQVSQMQFTNFKYDQKRGELRIQANSTDFQHFEKLRTLLAKDFTVEQGQLSKEDGRvvLRRHG-
16 UniRef50_D0I3A2 General secretion pathway p... 249 1e-64 1 18.9% 5:385 4:399 ----ILTVRLNRDPHEPIPWLVWSpqEVIASGE---AEHLSQLTDYATDREVIALADSAAMTLTSAVIPAGSERQLGTVLPFLLEDDLAQDVDQAHITLLDKHGESAQVAVIEHKIMQRWMDALSDANLTVRRLVPDCLCLPLHEDSCSAVSLNHRWLLRFGETEGGSVEDAWLPVWLQSLglPTVFSYSPLPEGMGGN--WQAEPCELVMLLLTQEAVKSRYNLLTGRYKPQSQIYKYLKPWRGAAIAAGLLVAVLGI-EQVVNIYQMDAQAAQYRTQSEARVRALLPQNQRIpyMRRIVEAEVNRlqSGIMVWMAEIGPLLDAAPSIELDALRFDQNRDELRLNARGKDFGDFEKLREALSTTYNTELGQLSRDggAFVLRRK--
17 UniRef50_P31708 General secretion pathway p... 247 5e-64 1 17.6% 4:384 25:419 ---PCLIVRLPVEEQGEIEWQVRSSNglLSQGRGSIEQVRPALAAYPSVTFTRVLVPATDVTFYALTLPRQARRHVTQVVPFMLEDQLATEIEKLHFAVLEIHGDDGTVAVVEKNRMQRWLAQCDALGLSVDTLLPDARVLPKHQDGWSALQHDDMWLFRQPTGHAMAAESSWCGDLlaSMPLPAIYSYSAASVGGELAqeWKAQPETDLFTLAATAHLPASVDLRQGDYAPDKAWQNTLLPWRGVGI-AFACYLLLVVADAGWAHYQLYQQAEHWRQESVRVYRQIFPSETNVVNPRAQMQQHLQraGKALLDQLTPLQQLMTQNSAIKIQSLSYDGAAGEFRLALQGTSYQELEQFQQQAAAYYQVQAGEMRQENDRVEGRL---
18 UniRef50_C4K3G0 Putative uncharacterized pr... 243 1e-62 1 18.5% 3:385 2:407 --TDILVIRLPEKADQSVHWIHYseDLIKDYGKLNQVSELTELSALSLRSDIQVLLPGQQVSIQSCLLPKRAEKKIDQALPALLEDSVADNIERLHFVALEVVKERVTVAVIAHSYIQTCLDWLAHAGLQATRMIPDWLALPYQEGEITAVKLGNDWLFREGTYQGFTLEQECLPILYLVKAGQDQTRDSTLNQNIRSFSswQAGAVIPALTVLARGCLSPNITLLSGPYRQNRTIRMPLLKGAAAVCMAILCFVILSVIEKGLIFHRLTQEIKKTQIKAEQAYQALFLKPQKVVNLKAQFNALTNQmqPKVPHLMDFLAQIAIGIANMRIqaLRYAREHHSLYLQIGVNHFSEFEQLRNGLSEKFTVEQgeKKRVNSTFTLKNK--
19 UniRef50_UPI0000E10DE5 general secretion pathway p... 234 3e-60 1 16.7% 6:383 4:410 -----LILRLGADAQTPIDWAIWQTTErlASGVLPDADALASLQERAAGRPVTVLVPSTEVLLKRVDLPPGASRKVIQSIGFMLEDDVATDIDEQFIALGPKQGDQQAVAIVAHHTMRQWLDWLTTANLHCDIMLPDVLALPlpAATASIITIRDQVLLRDSAWSGFCGESDWvsYFNAQSGPISLTQYTTDDAFSSHQKVQTVTAeeLPMHVLADGIATHsfNLCQGQYQQRKRSSGQWQYWRSVAAVAVIALTLGLI-DKGLTISQLAAQNETLSNQIKADIQSGFPNIGTYRDARRAITQYVKrsGSSAVDMLANLTSAFAN-SEIKAQSLKFNDDRSELRIQAQAKAFSDLETFKQQAqaGYTVEDGAINnvIGTLTIK----
20 UniRef50_P15751 General secretion pathway p... 225 2e-57 1 17.8% 2:382 8:393 -SAAVLIIRLNPDAATAI-WRLAAPGDTAQTGEWHPDAGDPTLSLLAQRHPAWVLVPASDCAFHRVALPAGARRRPQQALAFLLEEQLATEVEESHFALLHQHKTDCAVAVVGRGKMRAWQAWCDSLGLSVLALTPDVLALPHSPTGWSAVRCGEQWLFRCDTWGGMAVETVWLDQLLTHWQdaPIACYSPPPDIAAP---WQPLPAQDLLQLAAANPDARRICLRQGDFAAKRRRQPTPRRWR-PVIVAALALLLLWSSNCLHDHLMLGQQADAAVQASRDFYRQWFQTEKNVVNPRLQMQQHLRqaRPALISRLGALQQIIDDTPGIRLRTLSFDAARNALQLEISAVSSQALEQFSQRARARFRVQTGeaDGIEGRLTL-----
21 UniRef50_A8AIN0 Putative uncharacterized pr... 223 8e-57 1 26.7% 3:377 2:370 --KQVLFIRPDANVDGKIEWCVSGSQQVA---TLESRDALRTLAVHPLATRVCLLLPASEMVFRHFTLPKKGLSTASTPFSWLAEETLIGDVDSLHWTVLRKQGREVDAVAIDATCFERWLALCEEAGLKVIQVLPDAILLPVNEGGSTLVSCDESWWLRFPPFGACEADATLLPLLLAQGGDGEVCCYGEAPAGIDVVEQLPWQ---HPLVLIQPQWKACRANMLHGAFAACGKEVGRFRHLRTAMAVSALLSMGLLIGPRVAMAWMLVQQENQVQAEIAQVAQHYFPSLRQKTNIKYHFGQNIKKQSKGIFLQLEALEQVKQSVPAIEINEVEYDNAQNVLTLNAASPNAQALQDFVTQASPHFDFALQPVSNQS----------
22 UniRef50_Q8GBD8 Yts1L protein n=5 Tax=Yersi... 218 4e-55 1 19.9% 2:383 12:391 -SSDELFISLAESAGQPVHWYHQPSHGDTQQGELVDETVLHELLPLATTSQITLLIPTKNVLLKTVTFSGKYRHQNLAVLAWQLESFCPGDVEQLHLTVLKRQGTQFSVAAIDKNQLEQWLGWLRSAGLSASRALPDVLALPVPTGGWTAARFNDVWLMRQSVDQGFSADDEELGFILGRYplPAILSYSQRPENEPTWL---QKNVQPIWPLLAQGAQKNSINLLHGDFTPPRTAKVRGN---KLLVALAAVYLLTFVTEPTLSGYYAQQHAEQIQQKTQQLYLKNFPGATPPKQWIQGIAQQIHQLepGLLSQLRAAMPILQSLTGVKTQAMEWQSETLALTFNLAEPEL--LARIPRQNANKLNITTHPMDQQHTLLTVK----
23 UniRef50_B1JQA6 General secretion pathway p... 218 4e-55 1 13.0% 2:387 10:395 -STFTLLIRLGETEFEPIYWYVESQGKKLVrgKINGVAELKNIILYAK-DIVKILVPANQIIFRSLSIKKNEVKNNIKSIAFSIEQSISSDVDNFHIVILDQDKNFCHVAAIEHELINRWLFWLNINGISACCIMPDAFALPFFNSEWSVIKIESNWLVRNNEMSGFLVNSSVLENIL-MLAEPTIKVNAFSPTDIKWGNWQSLDYSDPVL-IMAKTVSGNHVNLLSGKYKYAERIIVNNSVFLRVASWFFLLFLVMSL-NGWYQGYKIVRDTGALSKVAQDFYADFLPPAYHGGDVNTSFNKylKKNNVSFIKLLNAVS-YYTADENVDVRSFNFNYSDGEISFDIEGDD-DLINEMLNDKTNLFNARVEVIRSGEDKYNIKLSSQ
24 UniRef50_A0YG41 General secretion pathway p... 214 5e-54 1 15.3% 8:385 21:420 -------ILARQCGNGNFEWyqPDPTGDDASFFTGDGEYLRE--KIADGVRLVMLLAAEDVVVKTVVFDNHERKLLHQTIPYSLEDDSVDDVDGLHFSLGSAEANTVPLAIVSKKILERIIFELKSDGIEADQLESELHAIPIDAGSWSIVVEDRRWLVRSGNHEGFS----LQPTIAGQALEILLESNDELPQHLTIYCQPEQQSEVLswQVMSKGHTNhaINLLQGQFAAKLPWKKWWQSWRTVAVLL-IAVVIIQMGVRYTQLVVLDDRNIALRAAIEKQYRQAVPK-GALMDPERQLRRKVNAlsSNLMSMLVQIGPVLKATDGISLQSLNYNEKQSEFRITILASGFDDVETVRANLEngLTAELTGSNADGNSTRARLR--
25 UniRef50_A3WP17 Type II secretory pathway, ... 213 9e-54 1 18.4% 1:386 1:402 MQERLLIRLPASDAEPRISWLIWQPSgvIASGELNDPAELTQLTEQAKRCQVTLLCPGQAISMRKVTIPNSGKRHLDKLIPYALEDELADDIDSLHFAWAENgeGQIPVAVVRHSEMQQWQQWLAAAHLEADEWAVDYLMLPEPESewTGVQIADDVLIRMARWDGLAVEQTLADAVVGLKQSehVVAYSDIALNDSTLALEFANSELPMVAFANQRV---SLDIRGQRYAPKRAKRTLEIRWQPLAWAAGIALAVT-LASSWVKTAYLNHQAEQLQQQAEALYKETFPNQTRIVNLRAQMRQQLQSLgpSALAMLDQLAPAFQQQPQLSLELLRY--QDGALRMQAVAQNFSQFEAFQNQAQqgFEVQQgrGDGVAGTLTIAYQG-
26 UniRef50_B8KIY8 General secretion pathway p... 204 5e-51 1 19.5% 1:385 1:394 MSDNLSVICLR---DDALYWLDAGQACDLGADASDKRDPLREVLAQREHG-VVFAVPGGDVRLLELSVSPEERKHLGASLPFMLEESLTDTIEDVHFARTPLDRDRYAVAMVDRASMLRWAEELGELA-SLVPWVPEPLLLPWSPGEWTLVLDSDSALLRYGRCLGTRIENALLPTLlqESSPERVIVYGEDETADLARLGpqWRKGGLAAALLLHDPATPAVNLLQGDFAPQLPYRRWWGQWRRIAALLLVALSIHLVGG-WLDLQRLERENRVLRTEIQSVYREVNPR-GAVVDAQKQLLRQLDGLrtTFTGLLSPLAELFSPPGSLVLASLSYSQRNAELRVNLLAANFADVESLraLEAAGYAASLESSSRSGDRVRARLR--
27 UniRef50_A0YBF0 Type II secretory pathway, ... 201 3e-50 1 18.0% 1:384 1:445 MNNQ-LVIRLRetLSSEVDWSLFDGDG---QHLCSSSSPLAQLRLNANNvsIVVIVPGEAINLLSPSFPSRQLKQIKQALPFMVEEMIADEIENVHIALPDqaDGVVNLAVVSHAVLINWLDILHSVKLSPTRIISDVLCIPFHAGQLSLLLDDKRVMMRSGQHSGLVLPIEDFGFLFASWIGQHSKQDavEPEVVAFVRQNHHDCeeILVSSYSNERLDRQLNLLQGGYAVSAAGKNDWSNWRSV-ISVVAIGLLSYLLLMAGSGWYFNGKGNSLDAEAVLLYQQLFPNERRIVSPKKQMQNHIrgKNSDFLPILASLASTLAADSdlIVDQLRFDGGSGELQIQLRSSSIEKLDQlrNLEGIGLEVDINSAAEQdgRLVVRR---
28 UniRef50_D2TMH0 Putative T2SS protein L n=1... 201 3e-50 1 29.9% 1:384 1:373 MAFSTLVIRLTS---DELEWAIHDETGCGEIHRLPAGQPLTALPRPPEVQLVHLLIPVALATFRRLEIPTAGYTLTPQKIQWLADETLDESSPPLHWTIVWQTEGVVWVAGVEPAVMQTLMLPLTAGGIRPDHVTLDALCLPITTDGWTVLKDEEGWLLKPHEGRASRLSEEWLDHLLTHYRPQQITSYGELPEAHTADTSCSPRP------LLSLYSPTESVNLLHGRLRPSAPATAGIRRLKRLALIAVLMLLLCPLLSRAIVGFQLHRLEQQLTSTLEQRWRSYIPQNRHRGNLQAYLPKQLQQRFPAPSILLQRLGQGMAAFPALALEGIRYDQQRQSLQLFIYASDEDQIKQFITADAVGLPLKIEKHDQ--GLWTLRN---
29 UniRef50_C8R0C2 General secretion pathway p... 199 1e-49 1 18.5% 3:385 1:406 --MKKIIVRLDERAPAECVWRKFEADG----AEVAGWGSLADLAALAAGYRLWVLIPGTEVLLTRVNLPPGNRKQLLAAIPYALEEFLADEVEDQHFAVgpDENGALAVAVIARERLDYWLELCRQHGLAPAGMVPEMLAVPLAGPDAAGREPGAaaLVRTGPQDGFVLDRDSLAIMPGMPgeFYHEEEAPELPEELAVLLAGSHRVGDVFALLAETLkkEALNLLQGDYRPQAHWEKHWRRWR-LPGVLVLVLLLFYAGLGLLENQRLSRYHEQLHDEIIEVYRTTFPGAQRIVNPRAQMEHQLQTLRggFLPLLADSGPVLSGAAGMQLRGLRYRA--GELDLELTISDLQALDELKAALEegLEVDIRTATTRDERVLARLQ--
30 UniRef50_Q21EQ2 General secretion pathway L... 198 2e-49 1 16.2% 1:377 1:397 MNEKIFARQLDN---GLWQWRLADEQGNWLNEDcgDNEALAESLGDRASPVVHLILPGTNVVATSETVEPSIKRHLAKLLPFEMEEQIIDPVDDIHFVFGPVEGDRVEMLYAHADCVAGAIASLEEVNCDIQRILPDYLHLVREPVGAILVLDEGVLYCRTSDNDGFAIDESAAPIVVSQLKHEyvAETEELAEAMKSWLPAKWLDENGPEIRLREghLCPTFNMRRGRFARQLPIMRWVKDW-KVPGYVAAAAFVLAMAAVSLEYFQAKAQFDRVRSEIFAVYKQVAPN-GRSSDPVRAMESMVKGQGgnVMMLIDSTAKALKNTPEVNLTSMRYSGDQKELRVNLETKNFSDLETLRTAIAkgLAAELLRVSAQG----------
31 UniRef50_B7RST7 General secretion pathway p... 198 4e-49 1 15.6% 15:385 11:394 --------------EGRLAWYPpsSDGPQWLDQESGQASLRGIIAQRKLMPV-FAVPGEDTRLLRLQIAAEERRHLATSLPFMLEEELSQDIDEVHFATCALDRLDFAVAVCSKENMNAYQSSLASYP-GVTQWLPEPLLLPWQGGEWCLVLEGDRAIVRTGACEGFSVEREMLSLMLHaaAPTAIIVYGQDQETDAarDRVQWRQGDLYAAMLIAESPDPALNLRQGEWAVRLPLARWWQHWRVAAVLFGVAVLVHLFA-TGLDYRHLKQENLALRGAVQSSYRQAFPK-GAVVDAEKQLRRQLQTMtsGFVSLMARVGEVVATADG-SIVSINYNDKSGEMRLNLLAADYEAVERIRtiAESGLQATLENSSAQGERVRARMR--
32 UniRef50_C5BM28 General secretion pathway p... 196 2e-48 1 15.6% 8:385 5:403 -------IFARQTIDGLWQWRRANADGQWYSdhTGDDEALAESLA-GKSVPVTLLIPGQDVVVCELEVDAQEKRHLAKLLPFELEEQVIENIDDIHLAFGTLTENRVPVCYASTRLIAEALEELTAQGLDVRTVAADYLCLRRLNNGVTIIREANRVVVRTGEYTGFAVETFLAPQVLAEQQTalVAEDETALAELRSWLPEVWTQENGpfWDWLDLAQAPSINMRSGAFSRQLPFKRWIELWKIPMIAVAAAYLIA-VAITFAQYQVAKQEQRVLVDQMNDVYLQAVPNGRR-GDPEGALRALVKNLKGGamALINGVASTMKSVAGITVSSFRYNSDQRELTLNIEAGSFEDLERLrtVTEKGFVAELLRVEARGDKQSARMK--
33 UniRef50_Q1N4H6 Type II secretory pathway, ... 194 3e-48 1 13.5% 54:380 25:356 -----------------------------------------------------IWISDAQCQIYNVDMPIKQARQIVKALPFALEEQIAEDVDNLHIVYLGKEDGKASALVVNKQYM----DGLFEHQIQHAYYLP--LALPFDKNSASLAVLNDQVLLRLSEFKAYSIQKEAVGLFLQRFKneSIQVFGDLDELIKLEMESEneIHQKTLDDLNQLIQSSRPnlMSGPYKVTIKKKNPKLDLLKTPLTLAAALFICAISINWIQAFQLDGKSEAVKNASKNYYEQLFPGESAGYGMKRMFRQKLeqNGETFTRLLSGIGNPISSMSSLELLGLRYNQSKATLEIELNAPSIAELDKlkSLEQQSYTVEIAAANNQGGKI-------
34 UniRef50_C6XJ55 General secretion pathway L... 193 7e-48 1 14.1% 4:379 3:378 ---NCLVAFAKKDPGQSCDWRVVSETGTIHARGESAFEDLSSV----KHDKFILVLKGQEIASFRTPLSAKSNAQLRSIAPFAIEDDVSAEIEDQhiAYGDTGTKRYTLSVITNEKMVYWSDTVKRAGLVATKIVPDYFCLPIEDARISCANLVDRSVFRYGHWGAcgFDSKLLDKIIASGVSQNDNIAELDQLSYRDFSEG----GVDPLDVLAVQAVKEKFSLQQGQFEARNLGGKLDLKEWRLPVGLAAAAILAMAAFNFVEGIAFNREAKALQATIEADVKRVFPDVKRIVNPKAQLKTLTSGNgsAFLQLSGLISTGINDVDGISLDALRYDARRREIQASIVYEDYEQLTQFREIIEngGTFREGGSRQIGNR--------
35 UniRef50_C7R8F2 General secretion pathway p... 193 8e-48 1 19.1% 3:385 2:406 --KDRLFIRLKSDEES-LEWGLLTYEekLKEQGELLLDDMIALAEQANQQEVILLLPASRVRCFNVKAPTRSRKQLEKAVPYILEEQVLDNVEHQMFALGGvsNGMLAVNVIDKAYLSSVLERLKEAAIEPDFAVSDAACLPLFEDAWTLLEHDDSVLVRQSANEYWSTEVDMLEDLvnQTVSQAARIYSPDEQSElaGLAIQKMSVDNSLEWLCSQFDNSSINLLQQEFSSQKKSQMNLGQWKLPTIAASVLIGVG-IIYMISQMIVLGQQRANLKQQMLVSVQEVFPNINDVNTGLIQVSNRFSTLGGDAAslLFDRSLAAINPKEIKVSQLEYLSSQAQLSFDVEAASYTTLTGAQnlESSGMQVEMRNASENGGVWSARIS--
36 UniRef50_C4T0X3 General secretion pathway p... 193 1e-47 1 13.9% 25:384 5:367 ------------------------DGQKNKYGKLNSYAEIKNI-KLQSGCRVKVLVSASCIIFRRINLKNLMINKNMKAISFLLERTIVGDIDKFHTINLKWDNDFCYVAAVEHKLMNQWLGWLKEANISAKIIMPDVLALPFSLGKFSAVKLSNEWLIRNSQLSGFSISSEILAKIL--DSKFSSAHINTFSSSGNKAINWQSTQYCDVLRIMAENIDYCNANFLCGKYNHFPGIEMNGLTIFRTVLLCLILSAVVCL-NYWFDRYKIARDIDVLNTVSQEFYANIFPVDNENRNNTGHFNDYIeeSNANFIDLFYMTSPVIDSIDS-NVNSVSFNKDAGVMSYNISADESNTVekLKEINNkgVVLNQVSNDSDSHDIIFKY---
37 UniRef50_Q2SFC4 Type II secretory pathway, ... 192 2e-47 1 15.7% 1:383 1:427 MTIKLFVRPIpqAAATALEWALYSygERIGSGRADDAEELMQLVAQHDLQDVWvvLPASHFTFTVAHVAAKQARYVQQALPFAIEEAIAEDVESMHLVTGErgKEEYPVLVIRRERMDRWFDAANALEFPLHGMYVDAQMCPGEEGALTVLFDGDEVLlqPGLVCMRTHHENLLPYLEICARSRASSEEGEApeHVDGAIVQIESFSVPSFDLLCESftSHAANLCQGPYAIKESSGSSGIGKWWPVAAVAAGWFAIQVGLDLTQGFMYQKQADEYEQQMVKLYRSLYPNEKNVSSPKRQMEGKLRNASNTGGGGFLQLlsVQPGKQNMGFNNLQFSNQRGELAVEVKAPSLDQLDRYKQAlqSGYQVDIGSasGVRGKITIK----
38 UniRef50_C4U9B7 General secretion pathway p... 191 5e-47 1 13.4% 5:384 1:372 ----MLTIRLGNTEYDPVYWRVDanDDEIKYGILSSISEINKLNIYLKN-SVKVLVSSRKIIFRKLTITNVKVIRSIRSISFAIEKSIADDIDKFHVSILKYDEEFLYVAIVEHELMELWLYLLRTNGVIIESLIPDVLILPFINGEWSAVKLDEEWIVRNNEVSGFLVSDELFEKIYS-------FWYSSTLVNIMNDCdwRVIRNKDPLHFMAKDIQSCNSSLLTGKYKFHDGAGITHRYISRVTGWGVLLSLIICL-NTWHDGYKIAQATDMLDVYSNFYYSQ-FP----IVNESGDLSR--NESSVDFINLLSYLLGYFDD-KDLDIVSFHFSKEDKAIFFDVDRIDPsdFPEWAGNENEKIKISQSYNESGKDRVIFKY---
39 UniRef50_A1JPG7 General secretion pathway p... 187 6e-46 1 14.5% 1:379 9:389 LSSKTLIIRLGSHATDPIYWYtvVDGGHRKSGQLCDHTKLDNIPFLLNY-NVKILVSSSYVIFRKIDIIDKEILKSEQSLAFSIEKTIVSNIENFHTVILKSDSNFCYVVAVEHELMSRWLGWLTNVGVSPTVMIPDVLALPFNDGRCFPVKLDDEWLIRNSEVSGFSVNDDIFKKLCLSTLIFCPENRFSRVYNQTSG--LHATDYCDVLRIMANNIENNHVNLLTGRYYRHRKKTISSASFFRSVYLFFLLSIVMCL-----NSWCYKNDILR-DIHMLDVTLQGF----HIKYPLVQ--QYADEDspDLIFLLHGLVENFDRL-DITIKSIIFTNEKNKSSFNVRVINVDGIDqlNKIYQKNNRLTITKINNKNGT--------
40 UniRef50_C6P583 General secretion pathway L... 187 7e-46 1 18.4% 1:385 1:395 MNLRIHLTAHWQDAASPCDWSVLDDTGNVRE------SGNGNLAAMPQCDDATVIVAADRVLATAAALPRIKRSKLETALPFALEDILIDDASEAHVTPGTKLPDGRSvyAVNKDWLSRFLAASTAARIRVRRIVPEFCLLPTRTNEWSLAWDGAQGFLATADHLGGMLdpAALQLRLQQGAPAALRLFALGSEIRQPdiKVPVIYEKQSFDWRKADIPADAPNLLWGKFAPPPRISELW-PWLRPALMAALLLFGVEVAVSNVEWAMLAHEKRQLMNGMTETFRETFGADAVIVDAPLQMRRNVARLraDFSPLLEKLSGVLDAVPGSTLRTLRY--GEGKLDIEMALASASALDtlQRIAATGLTAQVLDKRDSGGVLNIQLR--
41 UniRef50_C4RZJ2 General secretion pathway p... 184 3e-45 1 15.2% 21:349 1:329 --------------------MEIQGSEGITHGKLDNHCELIKIAAY-DYTRVKVIVSSNRVVFRKVDVKNIKIRNIIKAIAFTIEQSIVGNIDDFHIIILKRDDDFCYVAAVEHSLIKVWLGWLQNAGIYTEIIMPDVLILPFNPGEWYAVNLGNEWLIRDHEFSGFSIQEAVLKKLVLS----RFISISKDLFSTSNDKPIDHhsYCDVLRIMSENIENCSANFLRGKYAFCHNQGSKSNYNFKFIWLLFLLSTLIC-SDYLIENYKIGKSIDALTFMSDDFHNDFFWNNKviIDFSYYTYSYNRrmNFNLISLLHDSSHIINDL-DLSINSIYLDNERQTISFNVTT--------------------------------------
42 UniRef50_A1U0C5 General secretion pathway p... 183 1e-44 1 16.6% 3:382 2:432 --SYRLFVRPVPPYADpfSWVLQDASGdqARGTADTREHIEQTLAQNALEKVLllIPGDEAVFCLADIPAKQTRFIQQALPYAVEEQIAQDIDSVHLALGPHTPEGYRVAAIDREQMARWRQLFSGwhARLEAVYPDASLLPAAESGWVICLDAESALLQSQRGEWLRMQADNLPLLAVTLAAppVQLYGTEADLDASQALVSELSgtEFLAWSYHHHLSQPINLCQGAFAFKAEGSSPLKPWKPLIAVASLWFVIQMGLEIGMGIYQ-QQQAEQLESQAMAVYRNAFPSDRraGNVRRVIEGQLRVAGsdFITLMKYTGDqlQNPGAVTFNSINYSRSRGELVVDIRADSYDRLSRLRnlASEGLQAQIGssSGARGRLTV-----
43 UniRef50_Q31J19 Type II secretion pathway p... 182 2e-44 1 13.3% 32:384 21:363 -------------------------------GAWFDLSGKLVLLDSQKDRLvvVWVPTQQVFLTQVVVPGKRKTDWMKALPYALEEEISQPIEDVFIAVLHRdaGLTQVAIVSNERMTQWVDALTSAGLANAQLVPDCFQCPIPEEHnhYIETDTHRLARTGKWTGMAIPHDWLT--------------------LAPFKHMTWQQEAPSFQVMEH---FKPFGLRQGKYQPFSKSTAWAKNWAKV-IGVFGALLVLLVTQNWMEAHQKTIEKQQLTEATERLFKQMFPEVKRIVNLTAQAKTALDqaGVGPAQLAKAVEPAFKQVPKVEIKAFKWQNKR--LSLSLESPDNDSLQALAGALKNKVTLTLKINSMQPNQIQAEM---
44 UniRef50_A4A5K5 General secretion pathway L... 181 3e-44 1 17.4% 1:385 1:392 MNKNLSVICLREDQ------LFWLDAGVLHALDEDGARERLSLCLGERDHGIVFAAPGGDVRLQALTVSPEEKKHLEASLPFMLEESLTDNIEDVHFARRAVDKTRYGVGMVDKQLMHHWETQLDVFARQVP-WIPEPLLLPWSAGEWTLVIEAETTLLRYGLQEGTRVENSLLPALLGaaPPERVLVYGEQDaaALEDLDLQWRRGGLEEALLLSEDGRSQLNLLQGEFAPQLPYGRWWREWRAIAALLLLALSVHLASG-WLDLKRLQRENLVLRQEIETVYRGINPR-GAIVDAEKQLRRQLDGLrgTFTGLLAPLGAALSPQEDTVLASLSYSQRNAELRVNLLTANFAEVESLrsLEAAGLSASLESSSRSGDRVRARLR--
45 UniRef50_B3PF10 General secretion pathway p... 177 6e-43 1 16.8% 18:385 22:420 -----------------FRWCWLGADGQANADSGDRDALRTAILQDANPKSAWLIVPGSRVATRALEYSDKEKKHLRNLLPYQLEDTVIGDVEDFHFALSTPRDGHVTLAYTDKNWLHMVFAELASLGLEITRCWSAPMTLPLvaEHWTLGLYQGQLLLRHNAYQGFSASSSYAPLALQLLLNQRESSDLPALHLRAASEaqGQIASQQIADEWALDFGTNTIDLCQADFSQRLPVERWWKLWKSVAIFAGVCLLV-YFSTALFEIRKLGKENLAIRQDIEAAARLAIPQ-GRIVDAEKQLTGLLRQMEPavMTLLAKTLPQIAALSSVQIKGVAYSSETGELNINIQADSFSTFETlsNIQAQGLAAELLSANVQGNVQTARLK--
46 UniRef50_A0Z782 Type II secretory pathway, ... 176 1e-42 1 15.3% 13:385 2:383 ------------TASENLGVLRLDAQGLRLWRAGQEAVSLDTSAENIAAD-CAFAVPADRARLTEISVRSDEHRHLKQALPFILEDEVIDPIELMHFAFTPIDGDRYLVALASQADMGSWLESLGDD--FEGAFVHEALFLPWQPGEVCLVVETRSVLLRWGQHQGARVEHDlaADAVIVYGRDQVQNLALLPDVLRELAQWRQGHFGTALMLVDRG--QKFIDMRQGAFAPSLPFKRWWQSWKPLAIALIIGA-VLQVASDLAQYWRLKDDNIALRAAIEESYRQANPR-GSLVDAEKQLDRQIAEYAVgfTEILDRVGRVIAVSSELTLSSINYSDSAGEVRLDLLAPNYDEIEALRERftSGLNATLETSSQRDTQVRARLK--
47 UniRef50_Q5ZUD0 General secretion pathway p... 176 2e-42 1 13.1% 41:384 37:376 ----------------------------------------SQIKDLQKESSTIIVETCTRAILLGLAIPWLPERKARIAIPYALEDKVTQPVEELHFAFDkyQNNQYLVVVIDKQRMKKLIQVFDEHGIEFDAVTLDWFALASQE----LIISESELLINNEDFKG-VLSGDLAQTYLKNHppAHLFQDSKIPVASPA-----SQNEEHSYTWISKRLIKspLNLCQGEIQHGKTTDWVKKGYLLVGGLC-GFWLISILFVNWLSLHWLNRQIDEIDRQTAVIYREFFPDAKQVISPKFRISQLlaENQTRFWFILNQLSKAIKD-SGITVEQLRY--QNKTISITLVSSDFESLQKIEnlKQSQLKVKQTQASTKDQQVVATL---
48 UniRef50_C4UYF5 General secretion pathway p... 175 2e-42 1 15.1% 15:385 2:370 --------------TDIIYWHLTSNDGKNEqgRLNNPSELIDIPMLFNSD-VKILVCTSQIIYRRIKLQGNKKINNLKSLRFSFEKTIVSNIDYFHTIILKTDSDCCYVAAVEHKFMQLWLGWLKDAGISTTVIIPDVLTLPFSNGQWTSVKLNNEYLIRNNYFSGFLVKDTIVEKLLLtlSEDVFICTNSQPENL------QRGQSCDALRIMANNVNDSDVNLLCGryRYRKRVADNYFSFTRISIL--LLLFVVVFINSLFNKYEIENDINILNELSRGFYAK-FPSVEQYDSYSQNDNGYPLTDRYNFIMYLHDSNTAMVNI-NSAINSIRFDNKNRTlnLDITNSNVTdfDQI-DLKMAGLSMTKSYHDDDTYNIVFQHQ--
49 UniRef50_A8GJP7 General secretion pathway L... 174 5e-42 1 14.1% 2:383 4:361 -SKPLLVLALGE-AGAPILWCQGDPSESQWRHAGADTLP-ATLPIKASRCRVVVCVPGQSVTLQRVTFSGPSRAATPLALAYQCEDSLLEEVEQLYWVILGRQDDHYALAGYRHVDMQRWLSQLERWGIVPDSLLPDTLCGPVNDRHF--YRWRGRLLRRTSPWSGYSLPSQWL-------------------LAPSDVVDAVPLSPCDVLWDRVRGEAETAVSLLQGKYKAPPRWQRNPFWRHWPSIAGAALTLCAL----AIGGAHYHHQAKQANQQRDALYQRLFVGQPIPAEPVSESARYIRALQEafFELAAQAQRALQGIPKHRVIGLTFDADRSMLAIRLQAPELQPFTQI-NDEGNTLELQVNPAKQQ-GTLTLK----
50 UniRef50_B8KQM0 General secretion pathway p... 172 2e-41 1 14.2% 28:385 43:409 ---------------------------RLWRAGSKTPDTLTEDSAIPENA--VFAIAGDAVRLFVRELAPEEARHIAKSLPYLVEEDIADDVDALHFAYQACSDHRYAVACCAESVIDSVQQVFPHCS-RLRRWLPEPLLLPWQAGEWTLLFEEDSVLLRIAEYQGTRIEYELLPAllIAYGNDRQRALQAIPDELRAMVQWRQGGFGD--ALLVADIGPATLNLRQGRYAPRLPLQRWWGEWRWVAMAAGAALLLQLGSDLVI-GQRLKHENQALRAAIESSYRQANPR-GAMVDAEKQLDRQLAEFQsaFTPTLAAITSVLAQETGITLANLSFSGRQGQVRVNLLAPDFSAVERLRSAmqRGYQTTLESSSAAETRVRARLR--
51 UniRef50_O32574 W0030 n=15 Tax=Escherichia ... 170 9e-41 1 19.8% 117:384 1:273 --------------------------------------------------------------------------------------------------------------------MHRWLAYCGQLGVREVRLLPDVLMLPLATEGWSAVKLAGQWLFRRDRYAGMTVELSWLTHFLSLTAPPVIESYSVPPVPCPGptEWRNQPGRDLLQLVAEGDGYDGADLRQGEFARQGTWYARFRPWRYVAGALLACVFLAG-SNAGLAHYRLWQQAQFWRYESVRVYQQLFPSEKAVKDPRRQMLRHLQQSTGnlGSVMRQLQQLLSETSTIRLQALAWDSSSQTLKIDLQAASFQALEHFQQIAGEKYLIQPGEIRQQPQGVESRL---
52 UniRef50_B8GU52 General secretion pathway p... 170 9e-41 1 14.8% 1:385 1:406 MNQQTLLLRLPEGEGDAQFVLRDAAGAIREAGQ----DSLAALAERARGQAVVALTPGPEVLLTRARVPARNPRALARALPYALEDQLAGDVDSLHCVPGARldDNISVAVVSRAQMDQWREQLREAGLDPRSLVPETALLPTHGEGWLLWLEHDSAWLSTGPGEGMALDRDNAALLVRLRLEepARDTDQGLEALDGQTLKWRDSEATLLEEIAQQLPAkpFNLLTGPYSRREQLGRLWRPWRAAAAVLAAWALI-QVALVVVDIQRLERERAALDAQMREIYETAVPGSRAGGDPRRQMESAlaAGAGDLGEALAHTATVLTRLSGLSIQSLRYRPGQMELDLQL--DSLQSLDRLKQELEAdwAVEIQSASARDDGVESRIQ--
53 UniRef50_Q0A612 General secretion pathway p... 166 2e-39 1 17.5% 1:383 1:416 MSQYCLLLPTAPTADDPVEWCLLDADGRVGDHGEAPAGDLAT--RLPRGARVWLLLPPGEVSVLRATLPTRNRQRARQALPWALEDQLAADPDRLHFALgpEADGRHSAAVIDRERMATWLHWAAEQGLELHTITPLELAIGAGDDDWRLILGDQAGWLSTGPRAGLALEADAWPLILPRLLAQAQAAGEAGDEGAPAGLALHPAGAAPGQVEALRAapHQAINLLQGPFSGREQWLRRLRPWRAVAALALAWVGLQFVMLYA-EVRNLERTEQALRAETVEIFRDTFPD-SRVVNPRVQMERALarRSDPFIAVLNAVAPALTGDDAPRLRSLAFRQQRLELDLD--AASVQALERLREAVEadWQVQIHSAASRGERIAGR----
54 UniRef50_Q1YQU7 General secretion pathway p... 161 4e-38 1 16.0% 37:387 10:367 ------------------------------------HLDRHQLGSGDANRAMALWVPSQRICLHVIEAPTAPQRKWAELIPWILEDRILQPVDEMHFAIGdeGKKQLRVSVISKQDMREWLRIADNAGVTATAMVPDYLALPFESGRISMAWCEGQFLVRSDTDSGFSAAPdlVRRLLERADIAPRLSISILDAALMPEDLREAADVNDAEIDWQFSDMPMSANLLTDEFKPQTTEVSASSWLSTAALL--VLAIVLGFGYLQLSNVRFEERIAELETQASAGFSNLFLGKRAKPdgELLMADMFKQRESLQAPVMKAlsDPIMTNCNCELETLVASDSGVSLGLKNVASG-----KIKATTVPGFKVDQKVADGVT-TLTLRKVGQ
55 UniRef50_A3UEX0 Hypothetical general secret... 160 7e-38 1 14.9% 3:384 2:427 --TDVLILQPPSSaeQTARWSVIRAGAVIAEG-VTGPGATVEPPAGTVIVRAVVVLPSEDVFIRRLPVPGQSERDARRAAPFLIEDQIAQPLDDVEVSLGPvaDGARWLAAVDRDQLKTWREMLASLDAPQHHTVPDGMVLTGHGGDLTVMGYGDRVVfrSGDLGAlaIEPHLLTPVLalSPKRVLISTALDPSALAPEGKPIarIDAPDLRIAAASLPPEALDALpdAFATKLDWAALLKPWRAAAVLGLTAVLAAS-GLMVGQAAYLQDRASRYQAAQEAEFRMLFP-EARIVNVSAQMRQAlaVSGAGFLPLATVLSETLSDVDGVRVDSLRYDASRGELSVTALYSGFGDFERLRMAAEARGAvaRQSAAGVAGEFIVRL---
56 UniRef50_A1WZN9 General secretion pathway p... 160 1e-37 1 14.1% 1:384 1:402 MPEYLLIQLPRCDDGRYRFAVVAEGGAILDQGLLRP----EVVAPHRAGRRCVGVVPGAQVLVTRVWLPTRRRPRVLQALPYALEEQLTSDLEALHFAIRRIddGGVHAAVVEHAAMQAWLDEFASLGLEVDALVPENGLLPADSGHWRVEADRNQVVLALGAD-GFALEPASAPVTlaERPPQRLTLQAPAALQTRLelESRAVDADLLPRLAAWYHPRTAVDLRQGPYARRERWGWLWRPLR-PAAALLAVWLLGQGALQWLEVQRLEREAEQLTAEIEQVYRETFP-EGRVVNPRVQMEHHLRtgGEGGGHLARLLGKAAPALAGDGLRVRTLRLRDGSLEVELDTVDIETLEGLRRALeaGLAVEIRSASAREGRVDGRL---
57 UniRef50_A3VSK9 Putative uncharacterized pr... 159 1e-37 1 15.9% 7:365 5:362 ------IILLPSAPEGGGLWAIGDREGVTQSGDWQGGDAL--PIELVVADDLTVILPGLKVATRRLALPVTGDKALESAARLAFEDILAEPVDRFHFAFgtGHDGRRTVSAIPIDLIEGSLAYLRELELGPTAITVDHLAIAGEDARDHLLFSETAT-VAYLSDGAFTVPAEMGADLLALMPLAANADVTAapPKGGGADRSLPDRDALAAYWFGKVMAHRPPNALRGRFRRRTDWRGVGKRVR-MPVALSLGVIALWLGGVAIEGMKYQRVADQLYDEAAARFSEAFPATP-IRDLSRQASRLGGGATTdfLPLSSRLAAALESHDEVQLEGLRY-GQDGELVADLRFPNTAALEQVREDLRTG----------------------
58 UniRef50_P25060 General secretion pathway p... 156 1e-36 1 16.4% 6:384 7:378 -----LFLPPASTAGADGELAVWWVQ-DGECRRAPFAQALAEI-----RAPWRLYLPVEAVTACAVNLPTQKARWLRQSLPFAVEEQLADDVEQMHLALGPaaDGRHRVFAVQRTWLAAWLALAEGAGKAPASLHVDADCLP--GEGSCLFWLEERWLLGGSGAVRLACGSEDWP-VLRDSCPPPQRAFAAQEVAPLEGVEVQALAGNPHVWLSEQPLGT---DLAQAEFAARQQSSQWRRW--RPLLGLVGLWLVLQWGFTLVQAWQLQREGDRYAAQSAELYRQLFPEDRKLINLRAQFDQHLADSASslLGLLGQAATVIGGEPTVSVEQLDFSAARGDVALQVRAPGFDVLERLRSRleSGLAVQLGSASRDGSTVSARL---
59 UniRef50_A7BVH2 General secretion pathway p... 154 6e-36 1 15.4% 3:261 2:273 --RTSLLIHLHNDPTHPISWATYDSAGKI----LDSAEQVSFDTIPRQHSKPIILLPGTDIVLTHVDIPSKQWKRIVQAVPYALEEQLAEDVENLHFALGKResGDIAVAVIAHAKMDAALQQLSAVGITPTILLPDILAVPKPEEGWGLLYLNDIVLVRTGLQAGFAIESDCLSLALqeMPPLEMVVYQDKEQIIPLAELqeQIHEQGTLAWLAQGVTEnpLNLIQNDYLPQDKILTHLRPWRLTIGLLIFWVDCSLLNN------------------------------------------------------------------------------------------------------------------------------
60 UniRef50_B2VI00 General secretion pathway p... 152 1e-35 1 18.9% 2:345 8:321 -NSGILCFYFSGQPRNTLCWEYRSASGEFRSGTEDDPIP------GAKKDRVWLAIPAEQCLFYCVT----GGKMSAEALKWQLEGTALGDVDTLHLTVLARTAQENHLVAVDPPRLQAALDAVKQRGFTPDYALPDVLMLPHGQ----AFRLDEQWLARTEPFSGVSVAVADLPLLAAQDS------------ALCERVKEHETCG----RLTAEAEKISLPSLLHGGFSPAVNWRNGLRSLT----AALFLSGCCLSAIPLYHGWQLNLAADRFREQTLQHYQHYFPQERPAKPAQALlqKETHKPTAGLLVLLTECSALLSNIKEIPLQTLEWDAKRQQLSL------------------------------------------
61 UniRef50_Q2Y7T3 General secretion pathway L... 151 4e-35 1 14.7% 18:378 3:393 -----------------CQWIWTGDDGLPLTGEGQIAD------LPKNASSVQLIIPAAQVLLTRARLPDAARRQPGSVLAFAVEEEMLREPEANQVSWIGSAGGEDILAAVDKKRLTQCLDALQAAAIQVDEIYCETLLLPWTPGEWSFAWEGREGFVRTGEFEGGATdgDASPPLSLHLMLEDAERHGARPASIaaWQRVLGIPVYIAGTWDWRGAQQSSISLLQKHRRWPP--FRGLLSRLRPAVWIGAAALVLHSLAVAADWALLANEERALHQQMETRFRALFPAAVAVVDPALQMRRKLIEAraDFLPMIKTVGPALSELASGSLHAISYDSGRIALELAAEEGLANRIAA--RLRENDLSVDINPAPTDGG---------
62 UniRef50_A5GC15 General secretion pathway p... 151 5e-35 1 17.6% 29:386 30:438 ----------------------------AARHPLGQEESLPQLLeaPAERRVILAIPSNQLFMRELELPLSDRRKIRELLPLELKGETAVDTDQLMFEAVPLEEGKVLAVWAKRHALEDKIRLMTGKGLEPEIVTAsqCLIPTEVESATVAITDGESlfRNgpMTSGEPDAEVTKTLAALEIGKGLTVdqAASSNASADQETSPFPPLpaYAVARAIATGDPVNFRSGELAYTAGQAKTRKKLR-LSMILAVSFVILLFAEVGLRYYLVKKDVDSLNNSIKTIYREVFPTRKKAVDEVAELRSEIKRLSSGKTslLPILTKLAEAKGDDVFEVFEAEISGNQVHLKGDARSIQAVNDFKTRTADALsvEVGEisRPDGSVSFVLRG-
63 UniRef50_B5JVC6 General secretion pathway p... 145 3e-33 1 16.6% 36:385 29:394 -----------------------------------GRGSLADAAQALGSRRVVVLLPGNECLHTRIALPVKQLSKARQAAPNVLEDNLSQDIDLLHFA-LAKSGDSYEVVVCERRLMDAVVASLIEANLPVDALRTDVQALPMPQEawSVMLREDDVCL-HGAHGSVHCTRAELPIFLQQLYREQSDDEDKLHLSvpVFVEIDQQETVEELELLSRGAA-SGVNLLQGEFVIKSQSSGSLQRWQVPAVLAVV-VLLVWLGSMFYQAYQYKQENQRLRDDIIAMYQSVAPGAQvvMTVKRQMQNRLDRLEQgtDASLKRLNRLASALQDQDLTqsRVSLNRDALDFELVAENLESIETLRQAlqAGAQADILSAPSQDGEVRAELR--
64 UniRef50_D0XKE4 General secretion pathway L... 143 1e-32 1 13.2% 22:377 4:357 ---------------------RPVRSNLPSRGLWRIVDDRILAVDRTYSGPTTVLVPSEDVLTVAVDLPFATRAQRLSALPFALEDAVAEPLATLHFALGTEVAPRRHIavVRHARIQGWIALLTEADLDPAILMPDALTLPMPPQgwVVRVEGGRCLVRTDTGAGFALPLSALDGAWTAAGRPRLI---PLGDALPATFAEAVGSETLHLGTMGEPVVvpPLDLRQGPYAATRATSASAL---RTLALVAGVGVVAHIALLGLDTFLLDRMADRKEAEARTVLQAVAPATTPDEDIVAAADRIVPGAGSgfTRLLAQTSGALPGAGAVAFNSATYAP--GSLDMGVVVSDAATLDRAVQALTASGLTASGAPSGVD----------
65 UniRef50_A3YCA7 General secretion pathway p... 141 6e-32 1 14.3% 15:385 24:425 --------------ADEFEWMLLSpsDVLHSGKGKSADQLQTYLKEQnyGDLVFLPPEHRVQVRRITLAQGQHRHADQVIPFLLEESLGQSPDELHYTVLNKSNKEwwVSIVDKQVMASWLDDLKMMGWLQVIVLPVNSlwPEQDTEADFLFTSDLNLLYKDQDSVSCLPKQGANYlnLCCDQAEVDGFGALAASFEILSPWSNQSVniVATRVQSNSKCLLANLCHGEFGRQTQFFSQLKPW--------LWVGVFAVFSLAVELYLTHQQTQALNAKADDIYQKtaPDEGRISYLDRQIKGRIQRAKQgvYEVMALVDQVREQVSG-EHRITKFDFANKEYRLDWQAGQRDTLDSIQTALEKkfQVVFEQVAKRGEVYVASIK--
66 UniRef50_A4VFT8 General secretion pathway p... 140 9e-32 1 16.9% 76:383 1:305 ---------------------------------------------------------------------------MQQALAYAAEELLAENVDELHLAVGETldGRQRVVAIRRQLLAGWLEQLRELGLLIVAIHVDADLLPREATQLLFIGERGLLGGEGETRLAFavDWPQLATLCPAPWHAQGNVAEPPLALDDYRQLDDPYAFLAAQRSAA-------LNLAQGDFAV--EVGNTGLGYWKPLFAVAGLILLVQLGFNLGQAWYFQRQGDAYAEASLALYRELFPEDIRIVNMRAQFDDHLArgQAGFLRLLDHAAAALEDGIPVTIGQLDYNQDRGDLALQVQAMDFATLETLRRRLgaRQSVQLGSASREGDGVSAR----
67 UniRef50_B7RHZ6 Putative uncharacterized pr... 139 1e-31 1 15.3% 54:379 66:388 -----------------------------------------------------VVLPGEQVSLMAAVLPVRGTRAKRAALPFALEDRISAPLEDIHIAFCRTLDgqVLAAVVDRNVMQA----AAVAGDTP--VLPEIFALPTPATawAVWISDGRALVRVSDGTGFVVSVAMLPLIWAQAAKPQIQSYGEALPDTMDARAYDARPPKP-------DPKDLGVDLRQGAFAPKAT--DWTRHIKRAAIIAMIGVI-GHLGLIVVDTVALTRIAERERAAAQAAIDTVLPGLIVTADVEPILRraPAPKGSAFLTILGNVSAALLEADniSFRRLAFADNPARLTMSVEVPGLDDLQQAERLlaSGFVVTSGAATASGGV--------
68 UniRef50_Q0VPY1 General secretion pathway p... 137 7e-31 1 13.0% 39:385 37:374 --------------------------------------SLREALEQSAGQTLHVIVSVAFARLTHVSLSRKQARHMQRILPYLLEEQMLDNPESLWFVSRKGSGDDYEVTAIARQFIEQLKRWAAEQDVLITSLQVDAERL-QGQAPLIAELDENQTLLMADRDRCLVVDAQQRDGV----------------QALFGDSLNEPMVLSGPTAFVDALRNGSGQELLTGPYAPKQKKGSnfAPWKPLGILAASVFVLALVAI-WVQQWRYNQAAEATFADAQTLFENLFPGDKASAALSRQFEGRLARLGGgfFPLLRPVAQVLKEI-NVDPKRLQYDQRENTLLLDVGAKDYAQLEQLQNAlkQGARASIANYRNSAQGVSARIK--
69 UniRef50_B7GZW5 General secretion pathway p... 137 8e-31 1 15.1% 21:377 8:364 --------------------WHWSNGENWL--QAASLDQLIQDLQIHQGKEATVFFPSRHAQMLQQTMAKSHYKQLGagVKYLLEEFVTLPIDHMKVVH-HFHADQLTVLGVAQGMVETWQHSLALLPTKLVALLPDFLVLPEPQaqVILCNIDHQLLVRENKWLGNSIDDLglEFQSAETHYQYSGLTAEQLESLEAASSAEQRSEFVYQFQPLDKTKQHPFNVLPKSKGQERTFSNYW----KACAAVVLAIIVVQFSYDLLRWVKLKKVADQTAEQAIEQYKYWFGPSSRVtnIKGQFESHLRMSQQgaLSLLSRVGPILMQR-QILAQQLNYDAS--ILTMALKAKSADDLQAlqQLNQQGFKAELGNVQADG----------
70 UniRef50_Q0C119 General secretion pathway p... 136 1e-30 1 12.2% 3:372 2:349 --KSVLYVALPSDADGLIQIAQ----------ERGDRLEIVNHRGPFGAASCVAFAPATSVGHFRAIVPGRNETEATRAALYAIEDELAQPVEDVHIVLGPRLKeeRDIYVVDRSLMKSWIDLLTKAGLAPEKILSEQCL---FTDIDHPVNLGDRIIQREG-NRIVGIDAAL--------------PQQARDALSAPTLEPSLEDGLHLIRLAERSTTRPAVNLRTGPFTLTKSAKQGVSAWRKAAGIAIAAASV-WTGTLILEARNYNHAKEVTEKRAAERYTALFPVAAIPTNMDQATREMLAVAAtdFRTSVAALYEAVAQSTNTQITALKFEGTDNRLTVDLSSPSPEALGAIISFLQsgFQVTSPE---------------
71 UniRef50_B3E7L3 General secretion pathway p... 136 1e-30 1 12.9% 31:386 38:430 ------------------------------REELVSKIAESLASVTKGETRTILSIPPGLLNLRELQLPITERAKIRAVLPFELAGETAQDDATIVCDAVALAGGGQLAGWAAQGQIADLITTLTEAGAEPEIVTASclLLPPDSSevTVCRQGQLLFCRTLNNNSDDLERTLATLELTRDlsERVIELFPLPDALKTPASQDGLAPLALAAPFAAALAFcpFNLRSGPLAWKQKNRRLLRAFRLPLILACIAA-VLLLAEAGTRWYLLSRDITSLNSSIGKIYRESFPNRKKAVDEAAELKAEIRRLEGTSlpTILPFLRLLTEHKGVEISGfeIDYDGTRFKVKGDGRTSAAISTLRqlLTAGWQVEQPEisRPDGTILFQLKG-
72 UniRef50_C4SKM6 General secretion pathway p... 134 5e-30 1 19.2% 49:256 11:214 ------------------------------------------------HCDVTILVSTSFIIYRKVELHKKKIIRNLKYLKFSFEKTIIGNIDNFHTVILKYDKNFCYVAAVEHELMSCWLKWLDNAGISISLMIPDVLTLPFSEDKCSLLKLDSQWLIRNGEYSGFSIKESIFDKI--HLVKDKNLSTNRVNYISEQQKKAHLINFCDALSIMAENINKDGVNFLSGKYSRYRERKSGFFP--PLGLLALVFYYL-----------------------------------------------------------------------------------------------------------------------------------
73 UniRef50_B8GXS1 Type II secretion pathway p... 133 1e-29 1 15.0% 1:381 6:359 MTLLSLLI-LPAAPDEPAQ-LLQDYGLSVTRRTLAPDERLDEVGA------VILVAPGEEVVARWMDLPMGSAAQARSAAAFRLEDEVALGAEDLHIAVGEADagRTLVVWTARDKLQAWLDMAQTHGLAPQAVIPDYLLLPEAEDGVLTVGR-------------------LGARLALREPSKALSADADLAALLFENREHRYLAGKELDAQLITGARAPVINLLQGRFAVRTTGGRGGLRRLAILTAAAVLSPLLLMI---AQIAHDQWTARALERQATKLAVSLAPQASRYEDAVGYALSRLaqSGQGFGDLSASYLSMVESTPGVTLDTLVY-GEEGAIRSTIVYNNYSDMDQLrgAKRLGLELTEQSTASEGGRIS------
74 UniRef50_Q4KD22 General secretion pathway p... 133 1e-29 1 12.7% 12:374 19:381 -----------QPQQCRVDFARLDRGGRVTDTGCCALGQLGLPGKGDKPPAVECFLHPLDSLLTQIPLPQLPAARIKAAVACAAQALILGPSEQMHVAHGPRdeGQVALSWLPRERLQALGRLLEQAGLKLalYPAPYALPAPPPGQVNLCLLDEQLLVRQSATQG-SVQPLVAETLEQLRASASELCWIGEVPALPGQPLPAPQPLAAQLRW---SGTPPSWGLHSGALAGTRAPQGWGRALGCCALAVAVWVLGL-----NLYAAREAEQGQRLKAQMSQRVKQVFPELPVVLNPLQQARQQLAARqqGFAHLLAQAGLAMPFMVG-SVQSLEFSGQRLQLQLLPDTPKTADSAWQGALIQAGYSVQAQGNG-------------
75 UniRef50_Q0ASQ5 General secretion pathway L... 131 5e-29 1 11.5% 1:384 1:405 MSQDLI---LKPMREGAIAWSVVDRRgrLHEGRLASGESFP-VGVADAVDRTLILLPGEHLHVTRLAIPAKSEHQARQAAPFLLEDELASRLSGTTILPGPrdDGSRWVVAVETGLLDEWREALAPLIVRPAFIVPDSLVAAEPGAALTLYDRGDAILFAHDPDaaGVMDTALFGSVVQALVKAAGSGEIAVSRSLGLTGANFRAIGQGGIDLRASALDAERlrLFGDSFASTMDWSSLVRPLRRPLLLAAGLLLAFCLLIGGETIY-YRLQAERFETATLAEFDHAMPDFGRAVIprARVERLSGDGQSAFLQLITALDELVDGNDSVRIDHVRYDPARAALSVGATYSDFSDFDDLNARaqLGLRLDDgsTAGIEGEFVMRL---
76 UniRef50_Q46833 Putative general secretion ... 130 1e-28 1 17.5% 111:385 1:286 --------------------------------------------------------------------------------------------------------------MIHQQHMRNIAQWLQENGITRATVAPDWMSIP---CGFMAC-DAQRVICRIDECRGWSAGLALApqLNEQDLPLSLTVVGIAPEKLSAWAGADAERLTVTALPAITTYGEPEGNLLTGPWQPRVSYRKQWARWR-VMILPILLILVALAVERGVTLWSVSEQVAQSRTQAEEQFLTLFPEQKRIVNLRSQVTMALKKYRPQADdlLAELSAIAssLSDIEMRGFTFDQKRQILHLQLRAANFASFDKLRSVLATDYVVQQdeGDAVSGGVTLRRK--
77 UniRef50_C0QLU1 Putative general secretion ... 128 3e-28 1 13.0% 38:383 61:472 -------------------------------------STLVEKIDPRDIATVAIALPSSSVSFRNITLPFRSKKKIRQVLEFELAANLPL-ADKRYVsaEKTDENTLLTASIPDNILNAYFTPLGEKGLKPALiiAAEYILAVEDKewIDCSDDHTTLCLssLGKALGHDGFVRAIVQTMEGETqiTSQGEPSKALFVYLEKALDFPVHLAEllAQNTSQPVLNFCRERYAEDSILKRHARNIAILLVFTTMAFSAFMFKLHD-DIHGLEKKGALLDGASVALFKRNFPQKGRIVDPLMQMKIELEQLKQAplSCIETLAEISNRIPaiDVETTRFILNPGRILLSGSTANFNDIDKIKGLLekQVEIQSAAADKTGNRVRFK----
78 UniRef50_Q5P1A1 General secretion pathway p... 127 8e-28 1 14.6% 3:385 2:404 --TRRLIIYIDepAIPSAPWMLLDERNRIVQ------EGQSEPAHWPVVPHCELVLGGPQCSMFETRIPKAARREQERLLRYALETQLLKDVDAQHLAVTHRHADGAmvLVISRARLRTVLAGLAEVGCPPLRAVAELQAVPDAGSRWTLALgtGGCILRLDATHAFVADAGALADILAHALLQACASGAGPEALEVRRAPTAPGSIEPaaAYRWWETPAASADLLHGEFAPSHRGSAGRQALRRPLILAAVAVGVFAAVNLASVLWQ-RHELDGIEERMRRLFVTAVPDTPAIA-PALQLRRHLDEARsdLLALLSAYTEIGGSAAPASVRTLDYEAGQLKLTLdaSASGIGVLE--KRFASLGYVVRSTGGAAPSLTLSRKNQ--
79 UniRef50_D0KWL6 Type II secretory pathway c... 126 2e-27 1 15.0% 3:375 2:400 --SDRLFLFVTNREATELHWWQPEHSAQSASPALGDWDAFADWQAKANLRRPvvLLPDSVCSRLIVPIPGTRREKALQALPFALEDLVADDLSQLylAERPLSPGRWPVLLVDADVRTRVLDALKDQGLVPQHLVAMADTLPQPEMGEFCVWVdeHISVLTGPHEGMALApqLAEWLPRMTPAPNRVAFHVPLDQPAHWPEGIEFTAQAAPDwwQAGLEQNRALSAITSAKAVNDQQWQRRWWQVAAAAGV--VLVLLLVAQGIKTAQMNHQAERLQTQITQDFHAALPQITRMVNVRVQLQQALDQreDTFMPALAAFGSAypQDAQLVIKSIRF--GEQQLTVELTAQKYAVLQQLLEHLKKNAPAEVKQIDA------------
80 UniRef50_Q3KBD9 Putative general secretion ... 126 2e-27 1 13.9% 15:387 17:365 --------------DSEVDAAWLDRQGQVTRQERVRLGAL-------PKQPLVCFLHPSDSLLASIDLPPLPANKTAAAVQCAAQALMLGDSAEMHIAHSTreSGQVQIAWVARKDLQH----LGQFGLNLKGLYPAAYSLPVMSGGVG-CLHDDHLLLRHGQSSAQVQPMIDEAWLLETGLPAHWIGDGAPEAVQSTLADTQRCSGPL-----------PNWGLHGGIQQPGTEHRGWGRALGCCALALAVWVIGL-----NLYAAREAGQGQQLKAQMAQRVKQAFPELPVILNPLQQARQQIAARQQgfTRLVSQAGSGMPSMAG-TVQRLEFVDGALQLSLLPEARRSGNDKGWqtLAQAGI-----SISPNDDGWVLRPAGE
81 UniRef50_C6CIM8 Type II secretory pathway c... 125 2e-27 1 16.2% 3:384 8:389 --TARLSILLPSSPRGRVRWWwaDSGELIHRGEAGSLAELTLPAAVRREDDAILWIPAEQSVLETVSV-TGNVALSAAQLALLIEDKLGQPAADFHWWLIERS--SRLIFGCSCAWLSAVWDEVQAAGLNVKQILPEWLSLP--DAPIVLAWAEPRWLLRFSKGAGYWLPAVSVQTLLPHIAAPESVSLYGPPPVEAVC--WAAQHPALSDAQRLAPPERVEVNLLRGLPGSLhhIRSWHRYIAAASLGLLAAAILALASGLGMVGYQIQRDTAFLQaqSIGDAGASLPVLERLIHDRQQ--QLVVSGESNFFDRLADYLPLSQRFHDPVITRLQFDASQRQLRIDVLLPETEVRNLIHTaaNVSVAVHEAQAEKIHVTLVIRR---
82 UniRef50_B3R7W9 GENERAL SECRETORY PATHWAY L... 124 4e-27 1 16.1% 1:378 1:462 MSTTLYVRLPHRPHDQPQPwlVRTAAGDAARRGLPRAAPeaRIADLPAAERLVLILAASDVLLTTASVPPLPPARLKQALPNLVEDALATDAQPCHIGIGPALEgrRLLMVADRAWVRAVLDAFAEHRHRRRHILPAQLCVPLaeAAASALAQGgqLTVRTGAHAGYGLLLGDDALAAWQALAPEGNWYADADATALAPVPALRQAGRAGWPLWIDGAQapGLDLAQFEFAQGRADRWNLVAWRLPLALAAGLVLVQLIG-MNTHWLLLRNEQQRLEAAQAQTLRGAFPQTPTVIDAPLQMRRQVEQLrdDFLPLADRFAQAARRLPPDALQALEYRGRMLVVTLKPGTDTAGLRSAAR---QAGLQMEEDKAGNAAG---------
83 UniRef50_Q1NDR4 General secretion pathway L... 123 1e-26 1 12.2% 2:379 3:363 -SRDALILFLPEAAELPVRWMRVIDGALVQSGEGANWLAACGIAALPEQARVLLVPPAALVTLHWMAYPDLPPRQGRAAARLAVLASGLLPADQLFAAVDENDDPshLIALASRSDMQHWMLWAQNHGLDPDIIVPAPLLIEAPEQGLGRAMIGGAAVLR-GENMALPEDMA-LPELIADAPMIDVTTGMVEGRAIAA-------------------LDRPPLDMRQGDFAKRVRPALDHRALQRIAVWTGMILFLL-LATALIWLARQHSEANRLDRESLALAQEVLPNASDAAQAQIEMEGRLAARGAgfTAPVAALLSAMQDAPGVALTTLSRDAD-GMVRATLASAKAEDInvLLALQAAGFTITATSSQDPGGR--------
84 UniRef50_A4BDW8 Putative uncharacterized pr... 123 1e-26 1 15.3% 13:385 10:411 ------------RAVDQLEWY-WAGDSDRYSGTLEDLSDQKQERNL-DVCLTRLFLPPQWFSTVDVSLPAKSRRVSLTMLRFAAEEYLAQDIDTVHLVlqKPVQGKATIEATDLNRLSLILGTLKSAQFQveAYNAQSFIVPDDQTDDLLLLVHNETVTVSARNTVFDVhaQWFELWAEQQQLPdlISESAEGSAKALATewQVQPTRHLVDWHDQAEQRQPinLMTGPFSQNQGRPNYQQWL--PALVASVAVIALWTTLTVFENQRTAEKIDQTWQASEDVFLQVFGQNKRIQRPlrEMRTRVATAGSGASETDANALTILRDISNVplEDFRYNADRSEAFFTLAKpaYSQFEALKnlAQQGYQVEY-SANQESDRFRAQFK--
85 UniRef50_Q48JN5 General secretion pathway p... 123 1e-26 1 13.4% 13:371 12:361 ------------NPETPLLFVRLDRQGKTVESGLSN---LLELKQGGALQPVEAFLHPLDSLLARIETPPLTASRVRSAALLAAQGLILGGSELMHIASSPrsDGAVYLGWLPATALERLSRLLSQSRLSLRGLYPAPYGLPVppGQVSVVLRDEHWLLRHSAGQGGVHPR------LTETPDAHLANGSELHRLDDKGTAGLETSAGLLL-----SGPSPGWSLHAGIGAAKVRTSGWTAAWVCCGLAVGVWALGL-----NLYAAREAARGQQLRAGMVQRVSQAFPHLPVILNPLQQARQQVAALesGFEQLVKSAAGALPFLVG-SVQRLTYSDGRLQLQLLPDNAQPAVDDTlrSLAQVGLTASRD----------------
86 UniRef50_C7HZE9 General secretion pathway L... 123 1e-26 1 15.9% 3:348 1:367 --MQTLVLRLPphPLPELEYVLLSANGKLQS------AGREQVALLPRGARVVAVVDALDASVMAATLPAMAPSRLQAALNGALEDRLLQDAGQLHLSVGPLAEDgtLACAVQKAALQQAIADLAQAGQEPEKIVPEAALLAPGDALLQTSGQGPRLLWRDLQGEAAWLpaAPQALPLPVTPEHLWVQDQAQPQLSWLDLPPGLTPATLSDAGWMARAAQSPWNLRQFDLAPKHALSRGWaaWRRVGALLGLLAVVQLVGMNAA-AFKLSRQESQLRQKLDTTAAEALPGVPAILDARLQVQRALnrPGDGDLDVLMGRASVVVP-PGIVPTVLKFSPGQLQLSLPGD---------------------------------------
87 UniRef50_Q39Q90 General secretion pathway p... 122 2e-26 1 15.8% 19:386 24:420 ------------------ELLFQGADSRPAATEAELADALRELPPAGNDSRIALSLPLARLFMREMGLPIRDRKKLREVLPLELRGETALETDELAFAGLPLAGGAVLALWGRKRELAACISATAAAGVEPEVLSAAPllLPSQDHGTVALTDGSAllFRDRefRALTEGEDCARTLALLEISKGITVDRTCRLGAPATAEGTPLPVEgaWALATAMAQGDAVDFRAGDLAWTKGKEKALRR-LRLPLALAALLLFLLGADASIRYLLVKRDLASLDASIGTIYREVFPGRKKGVDEAAEMRAELRKLGsgKSQVLETLNRLAMAKGDDILGLYEVEIDSGQVRLKGDARSTQAVNDFKNRLAAMLsaEVGQisKPDGTVTFTLRG-
88 UniRef50_Q1QBS4 Putative uncharacterized pr... 122 2e-26 1 13.7% 5:377 1:409 ----MLHVWLRAQHSPLAVWHEDSQHWQLVEG-WQQLQDIYSRYKANSQKAICLYFPSNHMLQVDTELNSTQLKQLGSskQYLFEETSLTPVEQLAIRQMS-HNNTHHLYALAQTDIELWQQSAKLAGMNIVALLPDFLLLPLPEEGatLYQDKETVLLRQSLYQGMAVspHLSEVLIVPAIDDPVYDTGYVSDIITTDNELANRTEIEN-SIAAGSFTAITADmrHALNFFVKSMDSQLSPYLRVAMMVALSALVLQMATDAVQWYQYNEATTATKTEIATQYQSWFPNEptRTKLQVQLEPKLRSDSQAPASHMAVLSRISPLIKQSSLKAQALVMQPSALSFTLIAPDRGSLDQfaTLVAQGLTAKLEQVNGNE----------
89 UniRef50_C5CPK6 General secretion pathway L... 122 3e-26 1 17.1% 13:351 14:372 ------------DAAGEYDWAQAGDDGIALRNH-----GRALLALLPASAEVTLGIPAAALSWHRVTLPKGsaSKLRAVLDGLLEEHLLDDPEALHFALEpkAGAPVWVAACNRIWLRTLVQGLESAGRRVVRIVPEFAPQPADGpqVTGEAEAPQLTVCDADGVVSLPLAGAGLALAAGLPLDTAVISAEPAVAQAAEHLLERRVPIVQAPQRWLQAARSPWELAQFDLAVTGRARAGKkpEWRAARWGIVALLLTQLIGLNAWAWKERNALEAKRQAVKTMLTRTFPSVKLVVDAPLQMAREVAALQQAVGDVasDLEPMIGAlpGRTPSAIDYSAGQLRLRGLGLQPS------------------------------------
90 UniRef50_Q7NRH5 Probable general secretion ... 121 5e-26 1 13.6% 12:379 6:381 -----------PDSEPGLPWALLGARGEL------SAQGDSAPGGWPKAEQCELVLPAGRTLFTDVKLPDAVKQPTPAVIGFALEEGLANDPGANLYALGEAlgGRRAVAATEAAGLRRAVAMLKSLGRLCDRIVPEECLlpPPAGGWSVTRLSDRWLVRAapRGGGQQEQALFASLLSTAMPARLqgVDSAEEVLARLPGWQGETARGEACDWRSARRHGGYDFAQGDLAANRYWRDWAPSLKKTGWLLGGLliLLTLGQSGWYAWQKHSLSQQIRAAATpiGGQAQPGSSALAMTRAVDRLRLSHGLPA-RDDLVELMGALAAVSGRELQVRTLEYEAGRLKLQVAEVPAESLARWRKQLAARQIMLDATSSQPGSK--------
91 UniRef50_B8FE40 Fimbrial assembly family pr... 120 1e-25 1 12.7% 27:387 35:476 --------------------------EVNGQGGLALAlaLEDLGGQTDVDRIPCSVsdANTSFKNVVIPFSEAKKIRQVLPFELESLIPYKVedYHV-IRKGDHTECLAAVTTAFEVGGALEIMANAGLNADILAPsaWAQPKEDGVFLDVERddLILLRNLrcAGAGMNWENLQDAVQEQTGLPlrDLQLPMEGRVAGNWDSSAMDGALALALYHPTETTGFNMRQGPFAVRRRWEQYKGWVIHVSILLAILLAAFGVRYFANKSVQ-EAKIASLKSQIEEVYQSAMEGRASSGDPLAAMMSEMEALSQAPidVLKAISDGIPPALNVKITSFSVNPER--VEINGETDAYESATEIKTGLeeDVSLQSVTAGKDPGVWKFRIKAQ
92 UniRef50_B4WDQ9 General secretion pathway p... 119 2e-25 1 13.9% 1:381 1:363 MSQTRIVIIPPAASMPAPFLTFDAGGRVLQRGSLLLEDSAATL-----DVRTVAVAPGADVLVRWLDLPVGGTAQVRAAARWALKDDLAGDPERTVVALGpaGEGPRLVAAVGAGLLEAWIDYLAALGVTPVAVVPDCLILPAPADDALSAAVFGTDMGLRGAHFAATVQSDLVEAVAGGRPLIRM------------------DDPETLERLLAAAAAAPAVDLLSGLERKREVRAGGWRLAAGLAAALVVSPLILTLAV----GARDQVAADRAERRTLALITETMPDAARASDPMEAARRQIAVAPpgLASVSAALFAAVEQVEGAELDSLSADPGQG-VRATVSYPAFSDLETLRTALAagLSMSDASTVEDGGRVV------
93 UniRef50_A9BXP6 General secretion pathway L... 119 2e-25 1 16.1% 2:374 16:421 -PMSTLILHLPAGPAGEYAYALSSDGLRADRH---GHAAAGLLPDPGRTGQTVAVVPHQALSWHLVSLprRGHVRLRAVLDGLLEERLLDEPSQLHLALQprAGEPCWVAACNKAWLHAHLQALESAGRPVGRIVPECPPQATPQ-LWAVGSPESAWLLATGLSTA-AQGMDSLACLPLRTDSADPAMLAALLQALPPDTPIQADPALARAAEALqaARAQSWDLAQFDLDLGGGSRTRRRMlwKAARWGAVLALLAQVVGINAWAWTENRAIAAKQVQVRSTLATSFPRVPVIVDAPVQMQREVATLRQTAGALTQglAAASRALPAGQLPQ-AMDYQDRQLRLKGVSLEAEALEQAQqlAGSGLRLQRDGAD-------------
94 UniRef50_B1Y326 General secretion pathway L... 118 3e-25 1 12.4% 28:373 33:410 ---------------------------LSADGQSVDGEGRCAAALLPRATSLSVVMAGADVSFHRLLYPKAPASRLRAALRGVLEERLLDDPDLVHVALAphAGTECWVAVTDRAWLAIQIELIERTGRAVDRVI----CAASPAAEGSVGELDVQTlvACWPWDTQTRPGGLATALLPSPLPAELRCSASPAFVLATEAWLGRPVAVRSQAQRLLAAAHGGWNLRQFDLAPRHRGATLLrpAWRPARWGLVGLLAAQLIGLNAWAWMQRSELQERRTAMTNLMRSTHPQVRAILDAPLQMQRENEALRAAAGRAGddLEPMLQAAASAWPDNLalRYENAQLSLGATQLGAEQIERLRSSLqaGWRVEGGAG--------------
95 UniRef50_C4UIB0 General secretion pathway p... 117 5e-25 1 16.4% 19:177 2:166 ------------------DWlqYQRQELAEYKNGTIHSQLELLELIRDLrrIIILISSRKILFHTFEFNFKKIINSTDVIKYALEDYTATDIDDMEVSVINYDDGLYSIAAINKDVIKYWLRWFYELDINPDFVIPDVLCLPYLKDQWSAIELEGNLLVRTGKCSGFSIDKEDLGKI------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
96 UniRef50_A8ZWZ1 Fimbrial assembly family pr... 115 2e-24 1 11.5% 38:385 52:481 -------------------------------------DALGHRADWSGAA-CVATFPDRQVSYRRIHMPFADPRKIEKVIAYELEPLLPFAPADLFIDFvnEAGVEVLAAAVHKEKVKEWIDGFAGAGLQPEMIVPRGWAapDQEAGRSALRDgrQTLLAYEYETGVAAgkTVADCLGIDARPFNMADGSSLVTGGRPdtWEPGLLDMALCPALLKKSRKPCINFRKGEFSLAARWLQY-RYLFGGTAALAALVLVLGLMGFFYDLYSLNRSIATVDARRQAIFRECFPESAAAPSAEM-MRYEIDRLRESSgdILNDISRLVPQETDVVITRL--DAGLNDVSVTGNTDAFQSVDTMKNRLEetVVISSATMDKADKRVHFKLQ--
97 UniRef50_B4RFJ5 Type II secretion system pr... 115 3e-24 1 11.8% 1:381 6:368 MRRTRLVFAPSDPQAPPAYLLLDAFGEVVGRGEQPLRAE-----APAAPTTVVLVVPGVEATARWLRLPARGEAQARAAAALLLEGEQALEDEPVHLALGPLEADGCRLAvvARSRMQGWLDLARLHGISPDVVAPDCLLLPEPEGERPVAARIGGALAVRGRRLAFACDPDLAPVLLQDRDPE------------------LASDAEAVERLLAQGAGRPAINLLQGEFAPADGRRIAPRDLRRAGVLAALLLASPMALE-GAEALRLSFAADRAEAAARQDAAAVLPKGTVVRDPAAQVAARLERLegGPAGLAARLFAALSGIEGAQVESLIVSPD-GALRASITHANYSDMELLGGALRGDGIaeEGTRDEAGGIVS------
98 UniRef50_A1WNN8 General secretion pathway L... 114 4e-24 1 15.2% 1:374 1:407 MSTLILFLPPGRPGPATEYSYTLTADGHHATGHASAPAALLPEPARP-GAEVVAVVPARALSWQRLLLPPgqTPRLRSALEGLLEDRVLDDVGQLHFAIEPGagQALWVAVCDRDWLRENLQALEAAGRRVARVVPEFAPGPTASAGPELCALGtlVLSGQGADQGVAVLpaLALAQTGSAADQTPVLRAEPAVAALAERTLGQSAGLYTASQRALDAARSHWDLAQFDLASSGSRrwLYAPRWRAARWGAGLLALTQLAGLNVWAWHERQTLAAKQAAVHAVLTQTFAQVQVVANAPVQMENELARLRQAAGSVSASDLEPmaLPAGRLPTAIEYSPGALRLRGLALVPDEASALSGR-LQAAGYQASVEDGN-------------
99 UniRef50_Q221L3 Putative uncharacterized pr... 114 6e-24 1 12.3% 2:382 10:418 -PMTTLIVTLPAEPLDAAALYDYVLTRDGSTVAEQSRAPLALLPLVGKAdeVVALVSAQRLSWHQVQLPKggALRVRAVLDGLLEDRLLDDTEQLHFAlqPPTDAPVWVAVCERAWLRAALQVLEQSGRAVSRIVPEFTPQALTNTLYVTGEADAAYLVGAAEGSVAVLPLS-REAMALLAGSEEKNVVAEPAVVASAEALFQRPVTLQQSALRQLQAAQSAWDLAQFDLVTSQSARTWKRWAGAARGLLSaaLLIINLAGLNAWAWKEKSLLNSQRQAIQAVLTTTFPQVRVVVDAPTQMAREVATLQQASGAplESMLGAFGAVAPVNAVPEAIEYVAGEARLKGLKLTAEQLTAIASQLkqGYAVNVEADNVVIKQVAA-----
100 UniRef50_B4SL36 General secretion pathway L... 113 1e-23 1 16.8% 14:387 17:387 -------------ADSAVEWAQLHKGGVLAKGR----DALAVLGQRHPQAGVLACLDPQDLILLELQLPPLSGRRLQAALQGEVEAMLLDDLQEVALAHGTQadGSVPVAWLGQQAIMQAQQLLASCALQLQALYPTPLLLPWQNGQATLQADGEHLLVRCGRDRGVVQWCGGRDVGAVLQSLAARLQQSGVQAVQWIDSVPSVWPESLPATVVAHELQACGP-----LPAWSLPLPGRSRQAPRLAVGLAVAALVLAALGLQLQVSRWRSEGEALQQDMARQFSARFPEITDVVDPVLQARRALAVPLPAPPLPprQVATTLQAVPElqVRGLHYTPGQLELELdiLADDAQRLEQWQQAVQAQG---LQLVRDAGGRLRVSGGGQ
101 UniRef50_A6V157 General secretion pathway p... 112 2e-23 1 17.2% 8:385 5:356 -------LYLTSTADdpLCWWRADHDVR--------HGDLGQAAADLAGAELTLLLPAEATSHHEIEVPARSGRWLRQALDSALEERLLEDLEELHLARGgrDARFCRLFAVRRDWLRERLARLAARHLRPKHIHVDVDCLPGDPP--LALRCAGRWLVSAGSAQRLALDDAGLEDLGPVLPP------------------GLRRSEAPPWPLLAEGARL-AIDLRQGEFAAHTAKRIRWPLLALLAVLAG----AAQMGQDIGHRLLLEQRSAELRQDNLALWQQRFPSEGRVVDLTRQVQARLRQDGQSPVDLARRLDRLADTWSaaTVRRLDYQAGEG-WSLEVGAPAFADLERLRelARQGLDVQADSAVRGHDGVSARLQ--
102 UniRef50_C6BGG8 General secretion pathway L... 112 3e-23 1 13.9% 1:360 1:449 MTTSLYVRLPHRPIQSPERWSalVREEGAQGPQRVQREGTSRTDELPAADRLILLLPAADVLLVPANVPPLALPKLRLALPNLVEERLVQDAQQCHIALGPRLGdsRALMIADRAWVRFILDTFAGHKHRTCHLLPAQLCVPFETpdASVAAEPAVELPAAEAVAGVTPATIALDAAPSSDPDAPVAVdsPALRELAPGLSADPATATLDWSTWAAGARDaeADLCQFDFARGGVAGMDWSLWR-LPIALAVLIVVVQLIGMNARWLTLRAEQKRLDTAMRAQLQTAFPNTPVILDPPAQMRRQVEQLreDFLPLADRFAQAATGLAPDALLALDYHGRALTVTLKDGTDTASLRTAARN---------------------------
103 UniRef50_Q2G4Y8 General secretion pathway L... 111 5e-23 1 13.9% 6:379 11:360 -----LIVLLPASPDEAWRWWRVEADGIGAEQFLDGPLG---NAPWGETGSVTVLVPAADAPV--IDKPMSAMPVAQALAAERLALAQAGLAVDHHVAV-AEHRGRLLSATVSAADMDRWIADLSGLGLDPESIIPAGLVLPRDDDRLVLGTLGGQLLART-PGVAFAGEEALVMTL-------------------GAGLEQVLTEEERIAQSLAAIHAAPPLNLRQGAYAAKRVSVFRTADWLGLARMAAIAALLGLLLMLVW-IVKWNIDSSALESRALEMAQARFPAATDIDTAERLLNAELARRGQgfAAPAAALLEAMRAVPAVRLRDLGYAPD-GTLRFTAAAPRADDVNalIALQNEGWKVTVPPALAPDPT--------
104 UniRef50_Q1JVU7 Fimbrial assembly n=1 Tax=D... 111 5e-23 1 11.3% 49:385 58:451 ------------------------------------------------GDRFCTVLPGDDSFVRRLNFPFNDPRKIDAAAGMELASQLPVDISDHLVaaRGEDGQFTTTAAtpQQKIAEFLDPFDSGKIPIHVL----GLTPFTEISGLSPWLTNGVLVRAHAGesLVVDAEMvpQRLasQQPLCLIGSDVTPTLISAIKEMDwdPAFLPVCAMALATDQPLINFRRGPFTLKSEWAALKKHFY--IGGGLLLASLAILAATALHSYQFKTEVAqyRKQLNQVFRETLPGQTAIVDPVQQLTVELNRLREtaLAVLRDFSTHTPKDITVDIKTFNYEPEN--LNVEGVTDSFDSVNRLAGELRKsvRIADAKMGIQGKQVSFRLQ--
105 UniRef50_A3ERG6 Putative uncharacterized pr... 110 6e-23 1 13.7% 43:386 58:449 ------------------------------------------LPERPQPTQTVLLWPTHLSIAGPTKLPLLPRGEIPGAVAGELETLLPWNIEDCQTAIHAVRQDqvYGWVSPRRWLENALSVLAVYGLEPKYILPESfaLPRTNEFLSAPS-GDRTLVMtgENTDASVCMDLLVASVLMDSTEEAFFWTHPEAARPPGAPVIKSPDPEKQEEERYAAALGRWSARAGdlAFRKDRDDLVRHIRTLGGVAFL-LLLLSLSDAWIHVRALEARVEKTQAILTDLASQIL-RPAPVVEPLSQlqEEILSRGTDIIAILKDIAG--GPDPGIPFSMVSLSIGKKSLTLSGKTASFQDVEKIRTALLKtlVVQSARLDIDRKTVAFRLGG-
106 UniRef50_C0QPK9 Putative uncharacterized pr... 109 1e-22 1 11.5% 56:386 41:371 -------------------------------------------------------FPSSKSTFRKYSFPFKDRSKIEKAVRTQLQMDLPFPVDQIEYSYFEreKNRTEivIVRKEDLqaLLRLAKYNGLNNCEILH------FSEGYSVYLKIKDQFI---DQVRVFSQKPEIDDNFYLSGNIPEDISSNRILKNPTDDPSL-----NVAFGLLLRGVDDTGIDLLH------RSEELYTEKILKGAVYLTLAVVLFNLAL-IFRLELLERQLRSIKEKEKELFVKGFNYTGEVFDPLEQAKGKIASlkEDAVDILDFIGRSKRSAGISRIYRISITSER--FVIQGIAYSIKDVERFKNGLNSKYEANIDEtsTPEGMVRFSISG-
107 UniRef50_A5V9H8 General secretion pathway L... 108 3e-22 1 14.6% 10:364 5:344 ---------LQSPSIAPIAARLKNMLGPRAEAGVWRLDAGVVKAVAGAAARPVLLVPAEHVLTMSVALPLPSHARRLAALPFAIEDRIADRPDVPHLALGAQQAGGGWLaaVDRDLMAAWVAHVAEAGIADAAIMPDALALPVPEAGRWNVRrdGRILVRTPDGAGFAAREALFVALWTAAGKPACDEVEAGGEALPIA-----------------------LDLRQGDYapRQGLSRTGRRVAIVAVAGLVAHGAIavALRSVAAKRGAELTQLLATAAPGRYAGADPREAALVAAEL-LPAGGNAPPGTLLPLLSRASSALAPFGgvTIRSMQFDEAGRSLRLDVDLADPAARGNIVNALRS-----------------------
108 UniRef50_A6GLQ1 Putative uncharacterized pr... 107 5e-22 1 12.0% 2:369 4:397 -NQPLLVIwlDQTRAEEEGRMIRLRYEVLARSGDKLHGGEEALNKLPKDLPCLVLVNPTEVGLFAVVPPKLTGNKLKEALPFLVEPYLLNEPEENhwANLPHHTGGAKLAAvaRNIVSScqQGLKLAGLScdFILVDGIDTPLLTPTAQAAVLKVMLQRRLQQAGAPVIELNNTDYTWLSSQVDGAMGEHKIRA--------SARAPIEPLPRLLNKSLLNADELRKMGMRPMANQAG----LRKLLAPAVALLTVAVVGLNVL-AFKIESANASIEAQINESYAQALPNTPMVADPLLLIEREKRNLnqGASALLHEVGLAMEQAPFNSMVDFAWAENTLSVRFNANVSEDQQGAALQKLKARRLDAK------------------
109 UniRef50_C9YDY6 Putative uncharacterized pr... 107 6e-22 1 15.3% 54:314 1:287 -----------------------------------------------------MIVPAAALSWHRVSLPprNPAKLRAVLEGLLEDQLLDEPAQLHLAVQANAggALWVAACQRVWLKNTLSALTGAGHTVRRIAPEWAP--------STLSDSPTTLWLTGEAEGAELVWADHAGVYRRIVPPSNTSSGTAPAALPTDAAVYAEPACAALaqRLQSCTDTDWNLAQGEFATRNAALrwQAPAWRPARWAFALLCAVQVAGLNAQAWQARQALSSQRSAIQNVLLTTFPNTTVVVDAPLQMQRAVDALGQSSGP-------------------------------------------------------------------------
110 UniRef50_C0GQN7 Fimbrial assembly family pr... 105 2e-21 1 16.3% 1:355 19:392 LPDRVLVRRAGRGLPGRIAGVFEQEYDLGPEGDLSTVLSLARTSMPSGSAGLCMllPLRHFSLASFTLPAAAARNLDEAVRYALMRHLPYDPEAARITYQSREDGERltLAIPDKALSAFLKAAASAGMTVQEVFPSLLYWARKKGevSLSAGYSEILVHSGARGfwAEDEDlaEKLLSSMppADLYLWGARDDAGAILDRMGLKPGKAVALNLAHVRDDHGDKFLQGIsvLPLKIRRQQKMATYLAVIGLAFFLLAVAFWPLGGYLGHKRYLAGLEQKIAETAHMA-QEQRELAEKNLELKEKiqKAYPQALEILAEVTRVVPDTAWLS----SFACFETQVDIQGEADSATAV--------------------------------
111 UniRef50_C8PZS0 Putative uncharacterized pr... 102 2e-20 1 13.7% 5:376 1:397 ----MIHIWLPTQHAA----LRLWQQTTQTWQTADDWQTLATLANLQTTqqACLYFPSVSLLTIQPTLTASQLNAldTGRRYLFEDISIGSVEDLQVKIQPAVSNSEllFGLHAADIHSWINAASLAGIEIVALLPDFLLLPtpTTSAVYYQDADTQLLKLHTYHGMAV---SFLPLVLTKLPMLETLYLTGFHDETVAQQLASMpsSELLPTPIKDPVRHFFNFAT------IKGKTTLAPYAKVIALITVCALLTAFVVDALRWYYYNQAQKQAATLLAQQYAQWFPNEpsKLTLQRQLSGKLTTQQSATPSVLQTLSSIQPVLQQYQLTAKQLNFQNNHLQLQLLSSSADSLNKAVnmVNKGIKAKLGSVDAA-----------
112 UniRef50_A5F8T1 MSHA biogenesis protein Msh... 101 5e-20 1 11.9% 51:385 66:474 --------------------------------------------------QIHLVLHSQLYQTYQIEQPSIPREEWSAALPFLLKDMLSEKvdVVADAHPLPGSGKVQAYVISKRTILELQSMAVSAGLTLGRVIPEQAIwpVTDNAASALQLDSLAlqRSIDYLSAQLKGGSLQQldGEDQQALITGLNERLSVRASGLDGEATICGEQLARYARNIPQETINFYQDHLKPKREKFTLTNLL--LAWLALSVVLLLGYAGVGYQNwsLTEQAAHLRQqaIGRIKQEISSKQQALDAIGQFDVAQQTGYSGVLNSLAQLARSDISLSSITLDS-------SQLNVQGLARDPAAIPNWISQFKQElqLKIGRNDQDMITFELNTQ--
113 UniRef50_A6D021 MSHA biogenesis protein Msh... 101 6e-20 1 10.3% 28:367 43:400 ---------------------------DITANNWQKALEQLLQPKATKGQGVNVVIGSDLYHTYQIDTPRIPKSEWPQALPFLLKDVISERveIVADGLELPSLNKTTAYVIQKSWLLQLRGVLENLGLELSQVIPEELFWARAQKESHSAVLLQRSRFHHYRVSAFVEQLPIFHRTIRSVSGPVIQGETIGLDVDSLALELQRSLDYLSSQLKTGGVHALQvnQLAEALTARLNVKVKPLVSERTGWSGALLAQIaqLEGPAVNLykPKQEHFTLTRVASVMALTAIAAVAVYGYIsaQLESELAQSESRADSLHDELSQQKAALESHRPSPVKVAaeRLKQEIAAKKDALDAVDDYDKEQQVGYS--------------------
114 UniRef50_Q3BXL8 Type II secretion system pr... 100 6e-20 1 12.9% 42:381 33:353 -----------------------------------------AATPPGPSTRNLLVVPGVDVHLRWLSLPGRSIAQSRAAARLQLAEHLAVDAQALhiAAGAEADGTRLVAAVDSVVMQHWLARATQLGFVPDAVVPDCLLlpGADATVAVMHWDGRWLIR-GAQLACSLEPEAARLLL----------------GDRVPAVPPVPDPTQSIACFARNAAHVPIDLLQHPFANKAAAEQRRAPRRLAVLAALLLLSPGVLLLAQTLRYEIGARVLQACAATQLGVRDA-----AAVPAALQARRQAGTATDRLAVQLSTLFGAVDTLPAAELDQLDYNAAQ-PLRATLLHTDDASLQQLSARLaaGWHVDPGSSQVEDGRMR------
115 UniRef50_A3SDU1 Putative uncharacterized pr... 100 1e-19 1 10.9% 56:368 20:324 -------------------------------------------------------VSAEHVSSFIVHVPRSNARQRQALITFAVEERIAAPLQSVQIIQGPLAdgDHLAFVLSNDVMTQVTQEDAPH-------LPEYLLIPRPPsaWAVWKEGNRAVVRCSDGTGFAANVNMLPLLWQRAGRPSLRALGEPLGADLPAENLSATPPPPDPIDVA------------FSFAQPRKAAARGLAAWKWAAVAVGSALALHMTIAALNLRALSQIAQTERRAAELAISDILPGMALTREVGPVLArqAVVKESSFLPLLSDISRVLTDAP-VGFRRMAWGASENTLVVLMQSPGLDDLQGiqTLEASGFAV-------------------
116 UniRef50_A7K2X0 MSHA biogenesis protein Msh... 99 2e-19 1 9.2% 26:385 42:476 -------------------------QFDISESNWEKAVEQALSVAASAYDSLTVVLSHNYYQMYQIDKPVMPRQEWPAALPFLLKELISErvDIIADAVELPNSTKVQAYVLSRKMLDKIVLLASRAQLPLEAILPEDDIWGETAGELGNFLLLQRSVRGHFRISAFvvPSSELQMDSLSLELQRSIDYLslSTKVSPLLLPEHELSGHVLADAAAASNTRRVNLYPDYLKPKKELLTLKN--IALSWGVAAAAILLSYGYVTWQSSGLEDEIAIVKSkeLERYqrKHQPDNNKLAAKARLEREVKAKRDSLKAvySGVMQSLAKLGNQEISLSEIRINNHTLDLKGLAKKPSSVPSWVNQFKNEIsvKIGRNDKDIVTFELKTR--
117 UniRef50_C4K9R3 General secretion pathway p... 98 4e-19 1 17.5% 1:361 1:374 MTTTLMLLAGERWPQDPvdWVLLDAARRPLDHGRSDP------RHWPAADRHELVLAGSLVIRLELELPPAPKREQPQLIRYALESHLARDPDLQHLTVSGRdsARVGVLVVARSELATLVATCKALGRPLDAVRSALQLAPPASGEWTLALlgATAVLRTGLQAGMALDADSTDTLAEWLALQLDATPAEARPTRLEVRSTTGTPIPETPALAArrLANDAANLLHGEFAPAHGGDGWWRQLRRPALLAAGAAGAWLLVQAALVAI-DGGEERALRERGERLAAEALPGQP-LLEPRMQLrrALQVHGQLAAGDLLALLDAALEAGAPQPQALRYEDGRLTLEL-ASAPPADLLVRLDAR--------------------------
118 UniRef50_A6VAT3 Probable type II secretion ... 98 6e-19 1 16.1% 38:372 38:371 -------------------------------------LSLGELAQRRQGLPVELYLHPRDCRLAALELPALPAAKLAAAVNCAAEALVLGDPAQLRLAHGPraDGGLTLGWLEASALAPLEQALQRLRLDVRQVQAAPFLLPLREDGWVAGEWDGHLLLRRSLTDAAVHP---LPEQGLDELPEDLRLYW-LGERPTWNCATLARTEALDEALRWSGPACPW------GLALKQPMAGAGRGTWKLPLTCAALALLVWVAGLNLYAGRLAGQGQALQRQGIQRVQQAFPELPVVLDPLRQARERRDaaAPGLAALLHGTGEAMPFLAG-RLQRLDYRDGELDLALLPGPAITDAATWQGELGKHGLQADASD---------------
119 UniRef50_C3K8J6 Putative type II secretion ... 96 3e-18 1 13.6% 29:374 25:335 ----------------------------LERGVVVEEGYEHLAQLGKSRQAVDCFLHPQDSLLTRLDLPPLPAAKTAAAVACAAQALILGPVDQMQVAHGPRddGGVQVAWVPKAGLTR----LAQLPLKLRGLYPAPYALPVGA----AALDEGYLLTRDSLQQGAVHPLGLQAL--------------DVPLVEATQRWGGPVPAWG----------------LHGRLNQPSTGGWGR------ALACVALATAIWTVGLNLYAARQVEEGQRLKASMSQQVRQAFPELPVVLNPLQQARQQLAARQTGAAADPGQRFASLVQLAGnsVDNLSFEQGRLHVELLADSRNpaEGEWQAALAQAGFTASRDEHG-------------
120 UniRef50_C6HW28 Putative uncharacterized pr... 96 3e-18 1 16.1% 10:387 39:466 ---------PSGRHGTSAEAVLPLSGEDWEEALL----GLGLPREERPRIPFLLFWPDERTLTATAGLPPTVTSAEREAVAgeVESLLPWPLEETLFSLLPQKGnrLLLWAASQEEVARLLTRIEESGLSPRWILPESLRLEISAPLPVGPERQTAGMIHVEESRAVCqdRRILDLLllSLPPRFAIDSPVLPESPLAPLVAQVPPVTRPLGEAasGEELASLTFRKGPLAWQGDRAEIRKGIRSLALLSLVLAGVL-VADGSAHLSRMNHRVERAREALDREARMALPGHA-IVMPVEQlqRHLLSRGADIIGLMKAITAA--PPPGVKVELVSLSISRRFVTLSGKTGSFRNVDAFKSSLAadISIQSAGLDIDRKTVTFRMRGR
121 UniRef50_C9Q260 MSHA biogenesis protein Msh... 93 1e-17 1 12.5% 51:385 66:475 --------------------------------------------------QIHLVLHSQLYQAYQIDQPSVPREEWSAALPFLLKDMLSEKvdVVADAHPLPGSGKVQAYVISKRTILELQSMALAAGLTLGRIIPEQAIwpVTDNAVSVLQLDSLalQRSIDYLSAQLKGGSLQQLKVCCDGEDREALIEGLNARLSVRaeAAISCGEQLARYARNVSQDTINFYPDHLKPKQEKFTLTNLLlwLALSAVLLLGYAGVGYQNmeNQTLTAQATSLRQQAaeRLKKEIVAKQEAKQAIGQFDAAQQTGYSGVLNSLAQLARSDISLSSITLDAL-------QLNVQGLARDPAAIPNWINQFKQElqLKIGRNDQDMITFELNTQ--
122 UniRef50_Q2LVK0 General secretory pathway p... 93 1e-17 1 10.2% 200:385 308:504 -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SWNAPLMNQALALALRGGNGSAGFNFNKTEKAVTNARNGMKSQLRWTALMAVILFFALG-SNLAAGYYADSRKLRHLKEETTKTFKNCCPEVTRIVDPVRQLQQKiaEQGSLFLDSWKKAMDTLPEASGIVIRELSYN--QIVLEISGEASDFQAVTRWKGELEknIQMQFGSGTNKDAKKTFKLR--
123 UniRef50_Q88P00 Type II secretion pathway p... 92 2e-17 1 15.4% 9:372 18:353 --------WLLLRPGAVWHWALVQDGILQSEGQGEPPA--------NPQAHVALVLPAEACSHFRVPAPPGLKRE---EWPLLLEDRLLQAPHEVACACLAREPGYLRLLVVARQQLDDWRGQCPEWGLQTVRCWAELQLLPSPEPGC-----AWQWQRTPGMSLYKGLAEDGQEHWLA--WPDALGGVPQPPWAVLHRTSLSGNWPTVFAPLDTLPGLFDRA-------RKVRSLPAASRQQQRLLAACLVLATvgLWLSQQWRQAQLWRSQVIAVTGEQASPRHAAQALKRLR--ESVLQQQLRTRQ--LDDLQARLQTWLRDNPGLRLQAVRFDGQRWHLRLEGEG-SAPPWPDMAAAAGATVQVQDGQ---------------
124 UniRef50_Q1GWC6 General secretion pathway L... 92 3e-17 1 11.4% 20:379 21:366 -------------------WLRIDDGVVVDSGQDDGwaDWEKQGDDGPDDRLIALAPAADVPLRWFHYPDAAPAQAAAAARIDALKASLGDAAGLHVVAGQPtgQAVPVAVTTHAAMTGWTGWLAARGLtaIIPAAAALPPPEADSLWSAELGGERII--RSADRAWASDPELDPLIAGNHDVAPLDAEAMREALLLTLAAPPL-------------------DLLSGAWKPKRRWAVDPAMLR-LAKRLAIALVAVSVAIPIVYALRLTADTSRADDAVVAMATRAGVTASDASAAETEIDRRLATAGGGPLAfaSALYDAMRDAPGVSLKNLSHRTD-GTLTTTLAAPRVDDINqlLALQARGYRITAQPMAGAGGQ--------
125 UniRef50_Q1LHW5 General secretion pathway L... 90 1e-16 1 10.9% 1:340 1:337 MSTTLYVRLPHRPHDQPQPwlVRTPVGDKNRRQAAEQAPeaVPSEMPPADRLVLIVAASDVLLTAAMVPPLPPVRMRLALPNLVEDVLATDAAPCHIALGPAFDgrRLLMVTDRAWMRAALDQFAEHKHRRRHVVAAQLCLPLAA-----------------PVTAPEPAPEPEPALATADGppARAAAQSAPTEVGTVDTSPEQPATLVVEAATSTLAQSALLLDTAAPAPGELSRLWQLTVRTGPYEGYGLLL----DDRALSTWQLLAPAGQWHGDNAALANAPVPALQGKRPPM-----HASRASETWRIWLAGIEECLQQ-PQLDLAQFEFAQGR-----------------------------------------------
126 UniRef50_C1TK51 Putative uncharacterized pr... 90 1e-16 1 14.2% 54:378 33:373 -----------------------------------------------------VLVPYRTLSVRTFDFPFGSVSAIREALKIQY-SSISGNREVEIFPVVHRREDRrsALILPSEERAAVEDGISGLGRSTIWPLPFAMAAELGGNGAVLCLDEEgvLYRWQSRSRRSVDQELRWLL----------DYGGKFDFDPSDSVVVDVSegERLAVKARETLTAFPSL--GSYSLSRKVLDSAIVLETLAKAVglLAGCVFLGAGFLGGLVERKKVDTIRARAEAVYTDAF-GPGKVRDPLSQARGKLAElsPDTRSLEDGLRLIVRSWTdiSVDTLRYTSDGMELI--GTAEEVSSVQAFQKNlnNDGTVKLGDIQQVPG---------
127 UniRef50_B2T7P7 General secretion pathway p... 90 2e-16 1 15.1% 1:258 1:263 MSTLIVLLPPRDPAVPSQEWQLPELPFVLLDKSgaQRTGRSALALLPRASTTVLMVAARDLLMMPATLPPLRGPRLRQALPNIVEDQLIQDPQTCHIAVDPkaGGRQLLAIIDRGWFRYICESFTNAGHRSLRAVPVTRCLPQAadADVPAEVAETVNAGEPAMAGAADVATSLPGVAPVLTPGVVAAVPMVAAVLGAVVQTAPALLLEGVTNSAGERGVPRVELAIARGVQGEGLAVPASAVNATLSALAGAAPVSL---------------------------------------------------------------------------------------------------------------------------------
128 UniRef50_B4D867 Putative uncharacterized pr... 89 2e-16 1 15.2% 20:387 18:399 -------------------WAVWRDAQRQHVAPTLS----EALALLPGASAFEFAMPCYPLIIERLRLPATEREDLAGMMQLQWEKSLPFSPEEifMVLGSTDGDsvWSVAAALDSLAEFDETWSKANRWPQRVAptVLVLYVEQRHWVVAVVEDrqVMSASDAAGFATepSLMLTLGMDDVPSEFARVLVAPEIVGCEDTLRSVTQAPIEAllITPAAQVDIDLLPPHWQVSAQQHQQGKAWRKRALAVAAVCLVFVVAglLVLQYQSSRLESELKAqlLQTRQARFNSLAPAVDPHHY-----------AIELLFLLNRCL---PGESVRLTEFDQMPQEWRVVGEAASASQAIDYLSRLKHDPDLGAGDISADPPRLLANEKAQ
129 UniRef50_C9QN52 MSHA biogenesis protein Msh... 89 3e-16 1 11.4% 54:387 70:477 -----------------------------------------------------VVLHSNLYQTYQIEKPNVPDEEISSALPFLLKEIISERieIVADSAPLPLSTKRQVYVVSRALIVGLYESLTKLGIELGRVLVEDEIwpLTGVASSVLQLDGIAlyLSSQLRGASL-HQMQVCCDEEEQQEIVLALSDRLNVKVAALSDSEQESGPILAAMLSDIHHAEVNLFPAELKPKKDYLTLKNV--AVGWGAVAAVLLLSASYFQFQKSQLEQELQLFRAQEAEFKQQVtpTAAKvlDAVGEFDDSQQQGYSGVMRSLSELGR-----DDISLSSIFIDAT--TLDLQGLAREAKSIPNWVNQFKSEikLKIGRNEHDIITFELKTKQE
130 UniRef50_B9NIA3 Predicted protein n=3 Tax=c... 87 1e-15 1 14.0% 139:373 639:889 ------------------------------------------------------------------------------------------------------------------------------------------LLLDTAAPAPGELSRLWQLTVRTGPYEGYGltWQLLAPAGQWHGDNAALANAPVPALQGKRPPMHASRASETWRIWLAGiqQPQLDLAQFEFAQGRMDRWNVRAWRWPALLVVALLLVQIVGM-NVQWLTLRKEAKRLEAAQVDLLHTAFPNVPPVAEPILLMRRQVEQLRtdFLPLADGFARAARDLPPDALLQLEYRAATLYVTLKPGTNTSALQNAVR---QAGLQMDEDRS--------------
131 UniRef50_A3W190 Putative uncharacterized pr... 86 2e-15 1 13.5% 46:363 26:366 ---------------------------------------------PPPRAPFVASVPGAAAPLVPLNLPAALKGQArrVARRQLRDAYGGTEAGLDiaRLGSAPDLWtlLITDAGDRRDWLRALGVFAPQCRAVLPDFLCLPAAPDLWVIETTATGVIARLGPEDGFAAEPdlLQEAARTGMPRAILRNGPARAEIDTFLTAQNLPIcdPADLTTHGVTApsLDLARDPGAERAEMRGILSRL-GLPFALAVLGLAGWIAAAMIETGTLTAQGLAYRQNAERILRQVMIPTGPILDIRSQVAQTMDRAraRPLDVLRRAGAVLGNH-ETTITRVRYQPGAG-LVIDLQITDFAALDALVADLR------------------------
132 UniRef50_A1HQ14 Type IV pilus assembly prot... 82 2e-14 1 9.2% 21:325 71:379 --------------------MVDLPDGIMENGYINDSAMLTQTLRqaRGRDAVFAVGGKSIYVREMLFPTMTEEELREAIKWDIEKYVPYEPDSYyfAVVGPGKNevLLVAVPRPIVDSITAVAKELGLRPVAIDIEPLALYRTLAevSVFQQGSLAVTRAIAVGGRRFTEVVASTLDLEIGEAELFKRRQKALLQRPDQEGEQSHLHRQLELVVNDLIREV--LRTAEYYQMQNKEARLDKVLLCGGGA-----------------KLDNLSYHLAAQL------GLPVSPQTFMPQLQVAEAIDqlQENFAQLAVAVGLAMRG--------------------------------------------------------------
133 UniRef50_Q01NT7 Fimbrial assembly family pr... 81 8e-14 1 13.1% 7:358 33:405 ------VTRVRPAGIRVLGRLTLENYAQRPAAEWGAEYTRFLKASGSERISATVLLPRREVIVRQVALPGVASKDIEGAIRFQLDSLHPYGDEDVVWGWSPLAYGSVLVGITRRVVVDRYVSLFEEAGIAVSSFtaAAVHAAIRLNGIAELSAGFVALSRTAAGgvFSAEFDLAPQRAAALALSELRL--APDTASRTLEEILPKPDVNPVANDLSRNALPYATALAGavLPPEHRRFNSRAVFVPTMVLAALLLLVAGSMAVYASWSEKQYLKQINAEIAKL--EPLRKRADVLdaRAQLLDQFRKQTRTDLDALNEITRLLE--PPAWTNSIALD--RDSIRITGDAPQTAPLTKL-----------------------------
134 UniRef50_D1N170 Putative uncharacterized pr... 81 8e-14 1 11.8% 18:382 35:397 -----------------IRALEVPPDERSAADRLAD---LCRKLDRRRDMTLVIGAAFPGAVFFRSRMPEMSPRELASALQFEVPQQVllPPeaLQFTADPADEEgvGVQVTPREELNRFCDLLAELRLQVDDCISPFLALPELPAgvFLPLFEPDFYWADGSFHPAAAGIHCNDEAVELLKKEFDFSDGYREENFRKFL-----PELLIARFVAAphRKAGLELLPKQLRPQRLRSQLRLAVILLVLLLGMWlaGGNILSFHSEYSLITSRTAGYKSRTTEI-------QRRMRSCDKELKEMNRVLEQNFGdmPVTLARIANVIpaVLVSSFRITDTGIDLTLHTTQENLDIGPALRKV--PGFKVATLQSRKVNDTLSM-----
135 UniRef50_B3E9T0 Type IV pilus assembly prot... 77 9e-13 1 17.9% 48:164 73:196 -----------------------------------------------KSKDVACSISGNAVIIRKIILPVMTSEELEDQISWEAEQYIPFDIKDVHIDFQILGQdqVLLVASKKDIINDYVALFNDAGLSLNVMDVDSFAVQNAFELNTEVSDEVRALVNVGAG-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
136 UniRef50_Q1Q6D7 Putative uncharacterized pr... 76 3e-12 1 21.9% 25:152 39:173 ------------------------ETFVVKDFLIKDSQQLKPILVQQkaGEIILSVPRELCIIREIEFPYANIKELREALSYQLDSFIPFNNEDVYFDirNRHNSKVLIVAVKKEALDDILLRLKALEIMPSRVIITPFaiPLIADKRGAVA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
137 UniRef50_B5YDZ3 Putative uncharacterized pr... 75 5e-12 1 16.5% 25:139 43:171 ------------------------PPEVIQGGQLNNPDYLLEVLkkVKSGKTLISIPAQNVVVRFFNFPYMPENELRESIKWELERYIPLSPEDVNYDigDTKESRIMLVAVSKEILNPYLDVIKKLNLEPELVDVSVF--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
138 UniRef50_Q1NMN0 Type IV pilus assembly prot... 74 7e-12 1 16.0% 24:254 72:328 -----------------------DDGALVEPEAVAGVISGLLTNLKSKNRRVAISVSGYSVIVKRVTLPVMEPAELENYIHDEAEQYIPFDIDDVYLDCHDLQTNsvMLVAAKKELVDGYLEMLDSLGLTTVVVDVDAFSLENAFEAAaiLAGGASALTRDVTLGGWQLTEQIQRALDISFDEAEEIKLGRQEPADDGARERVAAIVLDTCRQWNTEISRALDKYQSGNPEYPVSRIVLSGGGARLAGLADFLA-------------------------------------------------------------------------------------------------------------------------------------
139 UniRef50_Q1IB26 Putative type II secretion ... 74 1e-11 1 10.8% 1:231 1:228 MNTLLDVQLPPLAELAPASSLDYRLSDRQGHTLATGNAERAQLLREAKGAGWRLHLHEDDSLALAVALPPLTGKRLSAAVRCAVQGLVLGDIGQVHVAHGPRQggQVAVAWLGLAQLVHLQDWLQAGRIRPQGV----FTQPAEDRPVVDLGGGLQGPAHSLDVGRVVAVWSVAVLVWCLGLNLHAMQLASEGEQLRARMVTQVRTAFPHLPVVLNPLQQTRQQLQSGQGA------------------------------------------------------------------------------------------------------------------------------------------------------------
140 UniRef50_C8WIS0 Tfp pilus assembly protein ... 72 3e-11 1 13.8% 25:140 34:165 ------------------------PEGLVADGRIVSHDAMADFIkgGVSKDVAFVVPSSDSLFRRLSLPAMTEKELRLNLPYEFRDYISQGKDRYVyaDGQPEGMDLLAVAAPKQAIADYTEMFRRAGLKLKVALPEQAA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
141 UniRef50_B8D2D5 Tfp pilus assembly protein,... 70 1e-10 1 13.8% 26:141 47:166 -------------------------QGEIQDYAVVSRILKDVLEEINGSKYIITAVPGKNLIIRNMEMPLISEEELTEAIKWEADDYLPFPVEQAMFDYidEENMSVLLVAAERKTINGLVKIFDNIGLKPAVINAQPMAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
142 UniRef50_C0QLC5 PilM n=1 Tax=Desulfobacteri... 70 1e-10 1 15.4% 25:141 42:171 ------------------------DPGAIVEGVIHDVEGVAEatHRIKEKNIAISTGGYSVVIKTISLPTVSEKVLQDSIRFEAEQYIPYDIEDVNIDFqsPDQMNVLLVAVKKDLVASYMELTRRAGLNPCIIDVDTFAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
143 UniRef50_A9GGQ6 Tfp pilus assembly protein,... 68 5e-10 1 15.8% 7:139 31:166 ------LVRLGYAPLAPQA---IVDGHVMNAQAIVEALGRAFSEAKIRQREIALSISGQAVIIRKITVPLMTAAELDEQIQWEAEQHIPFDIKDVHVDypEAGQMDLLLVAAKRDEINDYTQIARTAKLKPMVVDIDAF--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
144 UniRef50_B0T7N5 Fimbrial assembly family pr... 68 7e-10 1 14.0% 21:220 47:251 --------------------WSVRAGQDGVLGLWRDGLPVGAMVGPPANARADLVLPPEAVLVRDLDIPRLSRADLNRLLTANMDRFTPFSADQVYfaESGDGKQRLRLAVIIRERARLILHQARSLGVEIARMGPEARDAAPPIDFLPAIMAAEGGGDRRRLTAWWTVCATLVALNILTAVMLDMRDVSRLRDVVEAEQPRVEAAGRMRQAVQAEQDTR-----------------------------------------------------------------------------------------------------------------------------------------------------------------------
145 UniRef50_B1J7E7 Fimbrial assembly family pr... 67 8e-10 1 16.3% 9:223 31:258 --------WLSAWQAELLGMLPQAIAARLANGNTPQLLPWPLPADCEHGRPAVLLLPASHVLTQHIELPVAATRNLMQVLAYEIDRYTPYTADQVHfaQRRAAQAQVELVAIARSALDTLLAACGEHGVHleRLMIDLLPAESARTRSRPGKLG-RWLWLGCAACCVMLGAAWLERRQGEVQAMQREVAAQREAAQQVQLLRQALDTTLGASSYLASLKAQRP--------------------------------------------------------------------------------------------------------------------------------------------------------------------
146 UniRef50_C9KPR6 Putative general secretion ... 67 9e-10 1 14.2% 28:182 77:237 ---------------------------RTAVERLDGGLTLAEAAAMRAQrdFAVCLPAEQVCFYETELPpmEAAEWREAAHWELDARLTDeaDAYAMACQREGAGRVVLAAAERDLLARLAEDFREQGLSLRGIT----ALPPGTAAAMTASWDGQGLVLTEAQRAFMPAIAAAKSVLQEDG-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
147 UniRef50_Q72IW8 Pilus-associated protein pi... 67 1e-09 1 13.3% 2:159 23:195 -SALKLVEVSGNPPALKALASRPTPPGLLMEGMVAEPAALAqlEARTRKRYVVTALSNLAVILRPIQVPKMPLKEMEEAVRWEAERYIPFPIDEVVLDFAPleQVQVMVAAARQEAVAGVLEALRGAGLVPVVLDVKPFAGLYPLEARLAEEPDRVFLV------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
148 UniRef50_B0TEF6 Type iv pilus assembly prot... 64 7e-09 1 21.1% 33:141 57:173 --------------------------------ALEAAIEKCLAGLRKKAKRAVLAFPSRHLISRQIRMPHMPDDEMRASLRWELEKYVPLSADdlHQGVIDVEGDrlLLVALPKEEVLRHHACLKRVGLTVTAVEISSFAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
149 UniRef50_Q2KZM9 Putative general secretion ... 64 8e-09 1 10.3% 3:225 2:222 --KNMLRVALPPLAALRADTLLPYAWHDRRGGLRQGESTAQALATAFRRAPAELVMHPDDIITTVIGVPPLGRARQAAVVRGALEPLVLGDLNEVAIGYADtaDGQVEVAWTPRPALEQACALLAGQGMRLRAIIP---PSALGEGQALQARGDPRW-RAPSPGWSLELPRQAGNTVSQWRSPLQWAAAAALLWLIGLNLYASheAEARALRARMTQRVQQSFNL------------------------------------------------------------------------------------------------------------------------------------------------------------------
150 UniRef50_A5D357 Tfp pilus assembly protein,... 64 1e-08 1 13.4% 45:193 68:224 --------------------------------------------ARIGSRDVIVGVSNQVVLMRIARLPKVPANKLEKVVRFQAGDYFPIPLEQlfFLIGEVEGgeVLLVAARRENLGGLLDALSAASLRPLAIDASSLALLRTLPGERQAGAVAMLDLSTGRNCSFMIAENGVPRLARSILQFQPAAAQKNP--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
151 UniRef50_C9R931 Type IV pilus assembly prot... 64 1e-08 1 14.3% 7:153 38:186 ------VLALRRLPSPPGVWGDVFDEEKL-------IGVLREL--EPGTREVISCLPGDKVVSRILRLPPMSDREREQAVRLEVERFLPTPVDELIIRSvgGEGRRCLILAVPAALVYRYHALFSRAGLVLGVLDLPAFAlpQLQEGSVALVD------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
152 UniRef50_D2QWD9 Tfp pilus assembly protein ... 63 2e-08 1 20.2% 48:141 82:185 -----------------------------------------------KGAKVVIAVPGHRVLGRFFELPPLPAKKVAGAVQYETKHQIPINLEElhYILDERDAkrIMVVAAREVHVQERLAIFKTAGINVDIVQSECIAI------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
153 UniRef50_A6BC52 General secretion pathway p... 63 2e-08 1 27.6% 101:176 2:77 ----------------------------------------------------------------------------------------------------GKQADKAQVCAVERAWVQTVLQRFASQGLTIKRILPDVLALPVSDDNSSAALIGEQWLIRHSETEGAVVDSAWLEL-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
154 UniRef50_A8MGF3 Type IV pilus assembly prot... 62 3e-08 1 14.4% 46:135 140:237 ---------------------------------------------RFSTDSTHVIINSSQIITREIIIPKVNENEIAAIISFQIEDFLPIDPEEyhLLIGNRVDdeILLIAVPKKIVVAHLELIKDLGLSPLVLD------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
155 UniRef50_Q1AW01 Type IV pilus assembly prot... 62 4e-08 1 14.4% 21:159 44:195 --------------------YRRLPEGVISGGEVSDPELLAAELraFRGRSVLLGVANEQVVVRFVSFPRMEPGELAGALAFQAQDYIPVPLEEahAVLGppGEDRVLLVAARKEMVRRLTAAVRSGGFRPVGVDVKALCLLRSALPATFFEDEGDVVL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
156 UniRef50_A6C2R8 Type IV pilus assembly prot... 61 5e-08 1 19.4% 48:140 72:172 -----------------------------------------------KGRRAISCLGSQELFIQNIRLPQLPTEELTKVVAWEAEERLPYPVVDAEIRHLPAgkQEVILLACHKGILERHLNLLEQSGLNAVAIDVEPSA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
157 UniRef50_C8W5I8 Type IV pilus assembly prot... 61 8e-08 1 24.1% 37:144 59:176 ------------------------------------AGALEElkSQVGSREVTLGIFNQGVLFRRAVFPKLEQKKLAQVVRYQSDDYFPVPVSELvfAVVGELEGevLLVAVQREILEKSLHVLTAAGLRPLVIDASPLALART---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
158 UniRef50_A9IRQ2 GspL protein n=1 Tax=Bordet... 60 1e-07 1 12.6% 15:188 24:191 --------------STPLAYAWLDRQGRAARG---GSLPAAALAAAFAQARVQAILHPDDVIIAPIAVPAVPANRVAAAVRGTLEGLVLGDLEALAVGHGPraDGTVLAAWMARDALRAAWRRLSSAGLAVQAFYPLQVWSETPEQARPAALDD----IRDPRWRAPGPGWSLALPQLAPRQPSRWRG-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
159 UniRef50_A5KSX7 Type IV pilus assembly prot... 59 2e-07 1 20.4% 48:155 73:193 -----------------------------------------------KTKDVVLGIPSSKSFTTVVEVPNMSEQELRGTIKYQADQYIPMSPDevDWALLGqqKMEVLLASVANNYIESRLDLVEGLGLNVIAAEPDSIalPAgtDAWLLIDVGD----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
160 UniRef50_UPI000169929E General secretion pathway p... 59 3e-07 1 17.9% 32:137 41:152 -------------------------------GLIDPSGLGRERLLLQDARRVELILPPEGYLKKRLILPRVAESNLREVLTFQLEQETPFRLSQVYFDSLCVARNriDLYVAPRGRVDLLLEQLSKHAIRLDAVTVD----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
161 UniRef50_Q48HA0 General secretion pathway p... 59 4e-07 1 19.0% 11:136 25:165 ----------GSPAQHGWQWWVAepRVRRWLGRETLEQavEPLPDASPQARRVLLLPASAVLVQPLQLPAAAARNLSTVVGYELDRFTPFDAGQLYFVARQDSRsqVTLVAILRERLDAILSECAERGLRPDAVDV-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
162 UniRef50_C1ZJR3 Tfp pilus assembly protein,... 58 4e-07 1 19.8% 51:141 72:170 --------------------------------------------------QVVLGIPSHELWIHNARLPQVPSEELPQVARFEAEERLPYAVDEAELRLigVSKHEVILLACRKTAIQQQIQICEHAGLVPQAIDTESHAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
163 UniRef50_Q3JD25 General secretion pathway p... 58 6e-07 1 25.6% 52:137 100:191 ---------------------------------------------------LVFRLPPRQVLSKSLVLPSAAEENLRQVLAFEMERHTPFTANQVYYDFAIRERntVSLIVVPRRILDEWLERLSHWGLQPAVVDVA----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
164 UniRef50_Q609V6 General secretion pathway p... 58 6e-07 1 19.8% 40:140 81:186 ---------------------------------------LEAEPELAESRTVLRLLP-DQCMTRVVKLPLATEENLLQVIAFELDRLTPFKPDQVYFGAraAGQIRVSLAVVPREKLDLMLESMIAAGWRPDYVDVSEDP-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
165 UniRef50_B8JD40 Fimbrial assembly family pr... 57 1e-06 1 14.7% 13:223 32:247 ------------TASAPVPAAEGDDAPPLLARQAAAVHQLLGERGWRVDESV-VAFPGSSVSSNVVTLPFTDARRIEQTIGFEVEGQIPFDLATVAWDWQPlgKSDLLVGVVRREELGALLAALGHGGLDPRAVIPAGPAYAALLAGGAvlAAPPEGPAPAEGVLDVGAERTSLCVTAAGACEAARTFAFGGAHLVRALARALGVPEADAGALLAGELGGPPP--------------------------------------------------------------------------------------------------------------------------------------------------------------------
166 UniRef50_C6IYF3 Predicted protein n=1 Tax=P... 55 5e-06 1 19.1% 48:141 76:175 -----------------------------------------------AGKKVRLAAPTSQSFIRLLQVPKVSKRQQRRVTELEIEGSieDPVIDYHWIEEREEGEALlvAAVPRPIIQEMVSSLEQAGLRLEAVDLAAIAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
167 UniRef50_A6FZH9 Fimbrial assembly protein n... 55 5e-06 1 17.0% 54:153 71:174 -----------------------------------------------------VCLPGGSGSYRVLTFPFEDPRQIAQAVTFEADGQFPLPIEELAVDHlgDGQGRALVVAAKRTTIQHVTARFELAKLNLKLVTTSALALAQALSTLPAPEL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
168 UniRef50_UPI00016990A8 hypothetical protein Epers_... 53 2e-05 1 18.3% 219:300 1:81 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------PRSLLNLLQDEYRHVDAGVQLLKPWISAAVLLMVFLTL-QVTLSVLDFIKIDQENSQLSQQIRQLFHSTFPETKWLVDAKAQ---------------------------------------------------------------------------------------
169 UniRef50_Q1D0B0 Type IV pilus biogenesis pr... 63 1e-08 1 13.7% 25:228 85:317 ------------------------DGALMNSTAIVQAVQDLMSELKVKGKDVAIGVSGHSVIIKKIQMPRMSQDELEESIQWEAEQYIPFDVKDVNIDTQILDGgdVLLVAAKKDMINDYTTVVSEAGLAPVVvvPERETVVLINAGASVVNigATVFTRDVTIGGNQFTEEIQKQLNVSYEEAEALKIGGNGADADAVVPQDVERVLSSVAEQVAGEIQRSLDFYAG---------------------------------------------------------------------------------------------------------------------------------------------------------------
170 UniRef50_Q2LWT8 Pili assembly protein n=1 T... 61 6e-08 1 11.5% 25:155 55:199 ------------------------PRGIIVDGILHETSLLTEktSGNRRKGIVTSLSGHSVIIKKVDFPTMEEEEMRDMIRDDAAQYLPFdmDEVNFDFQILGEneVLLVAARKDIINSYTDALKAAGLTVVIMDVDSFALETVYEENYDFEEED----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
171 UniRef50_A8ZSX9 Type IV pilus assembly prot... 60 1e-07 1 14.9% 48:141 71:171 -----------------------------------------------KEDRVAISIGGYSVIVKKINVQSMSEEQLQEVIAVEAEQYIPFDINNVNLDFQILGDndVMLVAAKKETVNDYLNVIDIAGLTPVIIDVDAFAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
172 UniRef50_Q3A2N0 Tfp pilus assembly protein,... 60 2e-07 1 18.1% 48:141 74:174 -----------------------------------------------QTKNVATSVSGHSVIIRNIFLPTMSDDEVEVSIEWEAEQYIPFELSDVNLDFQILGPdkVLLVAAKKDFIDEFLSVFNECGLNPVVMDIDCFAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
173 UniRef50_B2A7F8 Type IV pilus assembly prot... 60 2e-07 1 16.1% 24:141 49:170 -----------------------DDEGDNQGEQIGQYLRECLDKYKIKNKNAYLAIKNDDVVIRTISFPPMPQSELAQAVDYEADNYIMMPKndWHILKQDEHGITVLLLAARKDLINKYHEVCETAGIKLKALDVEVFSL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
174 UniRef50_Q0EXA2 Type IV pilus biogenesis pr... 60 2e-07 1 16.8% 28:146 43:168 ---------------------------IIDSTAVTQALVDAVEQARPASKNVALAVSGNAVIIKTIAVPVATEFELEPQIEFEADQHVPYDIDDVFLDFhdPEQMDVVLVACKREVVEDYQLVLGNAGLDVKCMDCAVFALENAAE-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
175 UniRef50_C1ABF4 Putative type IV pilus asse... 57 1e-06 1 13.7% 25:141 106:228 ------------------------EGEVMDHGIVADAIRQTLSATGIKTKHIVTAVGGRDVIVKKITMERVKEAQARELMRWEAEQHVPFDMDSVELDFQVLDPdsVLLVAAKRELVESKQSLLQEAGATASVIDVDAFAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
176 UniRef50_Q6AS38 Related to fimbrial assembl... 56 2e-06 1 13.5% 25:165 47:199 ------------------------PEGAVDDGILNEPSLVGEIVkrIRNKKIGFSISGYSVIVKKIVLDAMEDALLEEHILAEAEQYIPFDQDDVYLDFqpQDRTDIMLVAAKKEVVQDYLFMFEEQGLTPVLVDVDGFAFENAFEHAHP-NEKDVALVNIGATT------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
177 UniRef50_A4J3B9 Type IV pilus assembly prot... 56 2e-06 1 14.5% 48:323 71:339 -----------------------------------------------KDREVVLGICNQGVFMRYTTFPKIPDKKLAQALRFQAGEYFPIDNSQLVfaVLGEDKkkVLLVAARKDLLDISLRTLEAAHLQPKVVDISYLALLRT---LTREQLSDSLVLVDLANGLTTI------QLVHEGIPRFSRVISHSLQSYAREVNVPLADENLTSLPLVAATEEVAARSYTG-FNTPEDWSTTLANEIRSSvlAQANAGSVEIVILSGRGARISGLAERLQEELGVRV--------EVLYPLKNLQESLQSNGLGFADIGTDFTSCI----------------------------------------------------------------
178 UniRef50_Q6M9N6 Putative uncharacterized pr... 56 2e-06 1 17.9% 56:328 62:406 -------------------------------------------------------LDGMQVLLRSLTIPLTKTKDIEATLHFQAEPLLPYPIDqsQVIKQENDETKLLLFATKKDLLQTHLEQWLSFGIESEKVSCTQAALgfEEKIVTAVLISESLILSsdLDQFFGQLKKLVTKITLSFAKEnvIFTGEIAKWPSIYEQLSQSIQLPLLPLVSTEdaTPSIDFRQGKMSYPHPWRRLKLPI----ALYFGLMFCLSFLFYFFGQSYLSHQESLLKQemNKSYEQ-FENSYLTKNLSAREKSqtQLNRQDLLDRLTFLQKDLQATPD-----------------------------------------------------------
179 UniRef50_A0LFN4 Type IV pilus assembly prot... 56 3e-06 1 13.8% 48:141 70:170 -----------------------------------------------KERTVATAVSGYEVMIKKIELPTMTEEELDSRMHAELGQYIPYNIEEVDVdvLDVAKDrvLLVAAKKESIGDCVGIVRAAGLDTDVVDVDFFAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
180 UniRef50_B4D6S1 Type IV pilus assembly prot... 56 4e-06 1 14.7% 2:144 4:169 -STRILSLSLGTQTIGLAEFKTGQNGGLitRELLADPAADATRLAQTkgGKVNYAVSSQSVFTRFVKLPSVGEEQVDQIVGFEAQQNVPYPIDEVVWDYQLVDSgeVVIVAVKADLLDDINDSVEQTGLKTTLVDVAPMALYNA---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
181 UniRef50_B4AXY5 WD-40 repeat protein n=2 Ta... 55 5e-06 1 14.4% 74:288 384:592 -------------------------------------------------------------------------RRADKAiqDEIEKEVLYQLIDNRLLVSRGDDGKATVEVAHEELIRSW-EVLQELIRENEQIIILRNRLYADAKEWDELRKQDAVKARGDLWSGSKLARIVELRREHSLPNLDDLANEFIDASVKEREEQQQRELKAAQELAKANKKA-----LQESQKREEEQRKANKRLRQVSVILGVLLIA--VGGFGWAAWNQKNQAEYNQAESLGRYASSL---------------------------------------------------------------------------------------------------
182 UniRef50_B1I3E2 Type IV pilus assembly prot... 55 5e-06 1 14.4% 31:141 59:177 ------------------------------EGARLSRLAEAVDAAGIKGQHVFAALGADKVITRLVRVPRMPEKELASAVSFEAEKSIPIPLSDLIVRYVKLGeqQLLLAAVPAQVVHDFYELFVQAGVTISALDLQPLAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
183 UniRef50_C6BTF6 Putative uncharacterized pr... 55 6e-06 1 9.6% 1:387 1:367 MAFKKLVYILSFKGNEH-QWMMFDGRDLIESEG----------PADKNKHPVVALLPDPLFFFFK---PRGAIKSRHAKSATMMQMNYSFPMQEGEFKVLRPSGDAV-LGYTGHDLLDRFLD-------RHREVLAKATVLTTAFTVCWRAAVAEGLSVWAWKGQGVRILACADELTYFRGNDEE---FQNRFERLGLDGEPEFMDLGKACDVFAKKKVraRLNLVSGKRSGSDKSITIDYKPYAVAAVLVSLIGVLFIAGQYHRWQQSQVHANEWRNKLKETYVSALGPNpkILYKLDQLKSGGDGGGIDVLGLLAVLSNSAPV--GIEIEGFSLGADSGNIR--GKVSSYEELDAmkLAANSQFNFVLEQANNIEGGISISLRAE
184 UniRef50_B8FH96 Type IV pilus assembly prot... 54 9e-06 1 13.8% 26:163 44:194 -------------------------EGAIEDGVIKDHEKVAETIKdiKQLNAAISIAGYSVIIKNITVKTMTEEEMQESISVEAEQYLPFDIQDVYLDfsERDGhdVVLVAAKKDLVDEYVSVVEMAGLHPVVMDVDAFAVQNIYELLSDVDDEIVALVDVGA--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
185 UniRef50_Q1IXL4 Type IV pilus assembly prot... 54 9e-06 1 16.4% 8:135 30:172 -------LRPGTPPVLQHAVMVPTPIGSMRDGLVIEPQAVANELkrITARHAVTAVPNQSAVTRNIMVPRMERKDLQEAIKWEAERYLPYPIDEVNLDFDLLDdmEAVIAAAPSEAVARQVEVLRLAGLEPIIVD------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
186 UniRef50_Q2BKX0 Tfp pilus assembly protein ... 53 2e-05 1 11.9% 48:148 63:171 -----------------------------------------------AGSQAVIVLPEGSYQVLLVEKPDVPNEELAEALRWRIKDMVSFDIETAVIDFVELPDDavYAVVAQQDNVDELTDWCEEIGLEPAIvvPEFALLNLTEDLA-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
187 UniRef50_C1SLD1 Type IV pilus assembly prot... 53 2e-05 1 15.8% 22:141 35:166 ---------------------LPTPAGAFSGGTVADTDVLAKSLsrGAEKDIALSLKGADVVVKRIALPWNGKGHFTEQFLWSAEQYisFDAQLLHYDRETQTADAV-LAAASKVKVADMLDLASQSGLNPVVLDIESLAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
188 UniRef50_B2UR42 Cell division protein FtsA ... 53 2e-05 1 11.6% 2:251 8:279 -SKDALIL---DRYATRLVVLDPSAEGLRLTKIGEAIADLVQELNV-KGSVVNYSVSGQSVFIRFVKLPALDDTDVEQLIRFEAQQHVPFPLDEvhLLPAKGLEREAILVAIKAEDLDSLNDEIVSHGLSTGKVDCALTSlpDEKEPVMLIDIggRFFTRSISAGGIFVTSAIAREFNIPFLEAERLKTTSGLVSMSNGQTEGLDPATANLATVIRTAMTRLASEIqnHYRAQMSGSAPVKAYLCGGGASL----------------------------------------------------------------------------------------------------------------------------------------
189 UniRef50_UPI00016C5933 probable fimbrial assembly ... 53 2e-05 1 17.0% 48:141 68:171 -----------------------------------------------KTDEVAIGIAGQSGLARFVKLPPVEEKKIAEIVKFEAKQQIPFPLDEVEWDFQKIGGgeIGLFAMKRDVISRYMGYFAGSKIEVHLIQMSPLAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
190 UniRef50_A0LUH5 Type IV pilus assembly prot... 53 2e-05 1 16.0% 23:141 43:170 ----------------------VRDGEVADVDLVAAALRRLWSEVGFKSRKVALGVSNQRVVVRQVDLPWMELAELRKSLGYQVADFLPMPVEQAILDFYPVEelRVLIVAGAREMITNAVEAVRRAGLKPASVDLTPFAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
191 UniRef50_B1I3B3 Type IV pilus assembly prot... 52 3e-05 1 15.6% 52:141 84:181 ---------------------------------------------------LVTAIGGGRVIARNILLPVMPEREFEAAVRWEAERHIPVPPDElhVRLGEVVTdhVLLVGAPRKLVQDYDTLFRETGRVLNAVDLQSLAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
192 UniRef50_A4J3B1 Type IV pilus assembly prot... 52 3e-05 1 15.0% 23:135 49:167 ----------------------PSREGKLAEQETAQAIGRLVEIAGINDKKVITAIAGSKVITRQIKLPFMEDKALADTVEAEAAKYIPLPVEDLIIRylGREGGtiMLIAAPISLVEQYYYIFLMAGLTIKAID------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
193 UniRef50_UPI0001746041 type IV pilus assembly prot... 52 3e-05 1 12.0% 48:256 67:301 -----------------------------------------------KGKTVWYAIPGHSVFTRFVKLPPFDTEKADQIVEFEARQNVPFPINEVIWDyeGGSEREVALVAIKADALNDVNDQVESVGIKVAGVDLAPLAapDVEESalVFVEGSRVFTRNILVGGSTLTGNIGKELGMNFSEAEEQKRSRGYVAPGGAYEPNEDEVVDAMAKIMRNTMTR----LHGeyYRGQQGGSPPRRFFLCGGGAQAALAV-----------------------------------------------------------------------------------------------------------------------------------
194 UniRef50_A6GHB3 Type IV pilus biogenesis pr... 52 3e-05 1 14.9% 48:141 67:166 -----------------------------------------------KGKDIAMAVSGNSVIIRRLHIPAMEGAALAEQMEWEVRQNIPFARDEVIVDWepDEQMEVCLVAAKKEIVEQYVSVVSAAGFNPAVVDTDAFAM------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
195 UniRef50_A6C8P9 Probable fimbrial assembly ... 52 4e-05 1 11.5% 48:178 70:210 -----------------------------------------------NGDLIAISVPGQTSLARFIQLPPVQSNRVPEIVKYEAKQQIPFALEDVIWDYQPLGGgeVGIFAMKRDQVLHALQPFLKRKIEVELIQIAPLGLYNTLCYDSLGMRVGQDFEGNPEESAIVVDMGADSTTL-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
196 UniRef50_Q3JEG9 Type IV pilus assembly prot... 52 4e-05 1 9.6% 48:141 92:193 -----------------------------------------------RTKKVAAAVTGSAVITKTISVpaLSNRELESHIELEAGQYIPYPLEEVNlvLGPSEKDsvLLAACRSENIESRVASLELAGLTPAVIDVEAYAM------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
197 UniRef50_UPI0001743286 hypothetical protein cdivTM... 52 4e-05 1 15.7% 48:136 73:165 -----------------------------------------------PSPQVAVSIPTSKTYSRTFSVPASTKKNLREAIELEISQYIPIPVTSLYVDyeSEENINVLVSAAPRLLIDKIVDACSRVNLTVNLVEP-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
198 UniRef50_UPI00016B26A1 type IV pilus assembly prot... 52 4e-05 1 15.7% 48:136 73:165 -----------------------------------------------PSPQVAVSIPTSKTYSRTFSVPASTKKNLREAIELEISQYIPIPVTSLYVDyeSEENINVLVSAAPRLLIDKIVDACSRVNLTVNLVEP-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
199 UniRef50_Q6MPJ0 Fimbrial assembly membrane ... 52 4e-05 1 17.2% 58:144 80:172 ---------------------------------------------------------GTAVIVKKITIPKMDRKLIKDQIRFEAEQYIPFDINNISLAHhsPDAMDILLIAAQNELVTQYTQVIEVSGLTCGVLDVSGFALANA---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
200 UniRef50_UPI0001743B82 type IV pilus assembly prot... 52 5e-05 1 14.6% 7:136 21:167 ------VVQLTPQGDDSWSLLHAgdPKIIASDSDESRKKLGQAIKSasATNCVIGIESSRSFVTMIQLPKMTDSERSSILKYQADKYIPIPVDDAKIDWvnPQQDEVMLASVTQDYIEGLVDMIDSLGFNVIAVEP-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
201 UniRef50_A5FPX8 Tfp pilus assembly protein ... 52 5e-05 1 11.7% 14:141 28:159 -------------ASSPLETGLVIDGLIQDETKVSEAIKTLFSREKIPAGRVVAAMSGLKSIFRIVTLPAVPKNILDEAIKNEANRVIPTPMDQNYLSYqaQSETKVFIVAHPKNTTDSVVRTINKAGLRLEVLDIAPLAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
202 UniRef50_C0GE60 Type IV pilus assembly prot... 52 5e-05 1 23.5% 23:141 46:172 ----------------------VSDGIVQEPEVVADALQKLWSKAGIGSKNVVLGMFNQGVIMRLINFPKVPKDKLEQALRLQAGEYFPIPLSqlDFAVVGEVEneVLLVAAKKTHMEPSLEALKKAKLNVDVVDATPLAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
203 UniRef50_C8WRG1 Tfp pilus assembly protein ... 52 5e-05 1 13.6% 33:194 58:226 --------------------------------ALASILSHAFDANRRRKLTVHVALPSRFTVIRQLTLPAVGEKELQSAIELQIQHNIHLPFDEAAYDYveADSVSVLLVAADKSRVNDVIQGFRAVGIRPKTIDIHALALYRLIRRFRPDLPQNFLLLETSEDTVDMHVFHNGLLYLTRQVPVALAPTADVPA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
204 UniRef50_A3ZWV9 Spectrin alpha chain-like p... 51 6e-05 1 19.3% 23:141 585:713 ----------------------ADRRGLIQESVEKLIAHLGE--GGFKDAIVALGQPASELIGRFLKLPPVDQKKLEKTIQYEARNQIPFPLEElhVWDSPPKDeeVAFIATRLLQLQERLAFLKRLGISPHIVQADPIAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
205 UniRef50_Q1IRC1 Putative uncharacterized pr... 51 6e-05 1 17.8% 23:140 50:172 ----------------------LTSQNVSDAGALKSVVADALQASGARTKDVTLIVPDAAVRVALLDFDTLPEKkaDAVVRFRLKKSLPFEVDRAAISYHAQPNgrVLVCVMLNSVLHEYESAVRDAGFLPGVVLPSTLA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
206 UniRef50_A3ZL52 Probable fimbrial assembly ... 51 6e-05 1 16.0% 48:141 70:173 -----------------------------------------------KNDKVAISVPGQAGLARFFKAPPVEAKRIPDIVKYEAKQQIPFPLDEvhVDEGISLETEIGIFAMKRDQVFRSLQPFLDAGIDVDYVQLSPVAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
207 UniRef50_C6CH35 Putative uncharacterized pr... 51 9e-05 1 14.8% 19:227 34:249 ------------------WWQLPLPDGTLRGGSLHHPTELCTVleLPRFVSLRLGFPAPRVLQQRLAMPDRRLREPQryIRKMAVKALPVSGDDLALDYRpqTPNMLLVTAARQTELDVWLHCLRDAGLQPDAVDITPCALRCMAARAGLA--DDRLLLHRFDDHWLWVSPLKAPLAFGTFHPDDMADGATDIQVEPDLIKYVSTCYQKEVPPVAYLSASTPAGLQH----------------------------------------------------------------------------------------------------------------------------------------------------------------
208 UniRef50_C0GNB8 Type IV pilus assembly prot... 51 1e-04 1 11.5% 3:141 28:172 --TVRLARKGREPQLDRVARIVWSAAedFQSKGRRIKEAWGQLGL--KDKSVISSLAGHSVIVKRVFLEKSDSGDLESKINEEAGQYIPFDISDVHLDYheSENQEVILVATKKKVVQDLTQVMDHSGLGLSIVDVDAFAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
209 UniRef50_Q3AED9 Type IV pilus assembly prot... 51 1e-04 1 13.6% 48:224 66:268 -----------------------------------------------GKAKVITTLPGNKIISRIIKVPLMNQKELNAYLDLEAEQYLPVPVKDSVLASveADDGtvLLSAASREIIMDLYDTVVSTGLNLDVIDLPFLAlpEVPVAVVDIGAGNTLlvRSIKWGANAITQMIATNMNLDFVKAEQLKEEKGE--LLAADEQVVDQEKLTIDISIRQAISELIN-------------------------------------------------------------------------------------------------------------------------------------------------------------------
210 UniRef50_B5YJ54 Putative uncharacterized pr... 51 1e-04 1 14.3% 16:141 22:161 ---------------ELVQWEIFepNGVFGSEGIVDSDTLIKTLLKIPPkkVALAISGPTYtvKILQVPYINKDEIALNLPLELDKYIPFSVKEVYYdiLEQSKNrlLVAVANKQIVDEYVNIFERAGITLVAIDIGALAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
211 UniRef50_C1TME3 Putative uncharacterized pr... 50 1e-04 1 15.4% 1:136 19:171 MSNGIYYllLRSdaVNRYEFVSYSHGAVKQDSLVDQEEAVRAIGELSdgFDVALGIPSRDVMIKNVEFPDMDLEMAKDALHWNFDKNFPYDASEALYDagKQDRVHLVVAAVRRFKIQGFLERLRGDGVPLSSMEP-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
212 UniRef50_C0AA00 Fimbrial assembly family pr... 50 1e-04 1 15.8% 3:141 32:163 --ERLAVETFNPDAAQEADW------------PLFFGESLTEIVRRErsGAVTLALPGHHTLSKFVKTPAVDKSKRERIIAFEAQQNIPYPLSEVVWDHVTVSDdeVMLAAAKLDIAESICAAVAEAGLTVEKVTASTTAV------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
213 UniRef50_B9XEZ8 Type IV pilus assembly prot... 50 1e-04 1 19.1% 48:141 68:166 -----------------------------------------------KAKDVNVCAPGFHVFSKFVKLPPVDTSKVTQIIQYEAQQNVPFPLSEVVWDYqaSGELEVLLVAIKSEIVEGLFRVTEKAGLRLQLADVSPAAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
214 UniRef50_C6CY61 Fimbrial assembly family pr... 50 1e-04 1 13.4% 25:381 40:473 ------------------------ADGVILEDQFTNMEELRSSleRLNGTSITLSIPTSQIIIRKLQIGTVNTKELDQLINLEVETALHLPFEDPVYDYIAAGSEevLVYASPQRWLKQCIELLESTGLKVKYAELASTAFARAIQARYIDSLDNTMLIHLDKAnsGSIDGTFTPELIssRINQAIIAGELAGRTQLAAELQQAQPDMRVETVELESPLRKRVrmIPFGLAIREkkARKTKPIPVKLLVAGILWLLCLGAILalQISDYEHTVQVIKDKTALLQQQltQNTEAQADADPQAVVkiNANRQDAVAVLDELTNHLPY--GSRLATIEYN-KPGTLSLTFKSNDLSALSMYLTNLRaaQKVHLQSFADNNGLWV------
215 UniRef50_Q1D9F0 Putative general secretion ... 50 2e-04 1 11.0% 22:357 35:405 ---------------------RRAQEGERADTLRAAVQELLGQLPPGNVDQIVIALPGPALTTHSLSLPFSDARRIEATLPFEVGSQLPFDISDVVYDygKEKASDLLVGVVRKEELAELLALLSELKVDPRIVTHPGLtqGTGEGGAVAVVdeGVQFARTFSGGGKDLSKALATEFQTSLAEAHHWKEQHGAVASAAQGPDAER----AAAAFVRGLQPMLRELRPTLKAFTARTRQQVGAVVLCGGTAKLPGIAEQLSRDlvRVLALPADAKAIPAAEQPVAAQAygNAAGVRAPRFNLRRGEFAFKGDFDYMKDKLGLLASFAATLILLLIAF----GVVRNSVLARREAQVDA------------------------------
216 UniRef50_A5KTJ9 Cell division protein FtsA ... 50 2e-04 1 18.4% 41:143 68:174 ----------------------------------------EKLIGKISSNHAVMSIPTPRTYTRSFTLPLDAEGHLHDAIVLEAEQYIPVPLSQLyiIERSKDKISVLLCAVPQRIVDVCTAAARKVGLRVVMIEPSISAVAR----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
217 UniRef50_A9GDP5 Putative general secretion ... 49 2e-04 1 13.0% 26:356 32:436 -------------------------GEAAVTDGVSEAEAIRAAVGLHRPDAAAIALSGEKSFYRRLDLPAAAQKEVENVLGFELEATVPFEMEDAVFDHrgVETLPVFAAVARADDVRERIAVVKEagFEPErvMPE-LAAPSPASAPIALLDLdrTLSrgLPGTAPALARELRQTLAAwePLAGMYLVGGGATAQGAEMFLSTQLGLTILPLPTPRikTKGFNLRKGALEAERSYPFLREKIPILAGLGTVIALSFGFSI-VAELRTLDAERELLAASLATASHDVLGEETSDPQKARELLEQGPGarVDAFDVMVQLSKAVP--KEITHDVLELDVNRGHVTLQGVVPSVSDAQ-------------------------------
218 UniRef50_C8S440 Putative uncharacterized pr... 49 2e-04 1 14.1% 32:222 38:223 -------------------------------GDALSYLRRSALGLAPHGISTKLVIPNSQILYTEVVAPGPEDSQRRGQIRRALEGLTPYAVDDLVFDWRGNGP-TVQVAVVAKETLTEAEAFATEHRFNPISFVAKPDPAKFSGEPWFGVSGMAAELVPAGEK----VDRDQDAITIVSRDGKSHESAQGAAGKPGAGKPGAGKAESPVAPSVKADDLPPP---------------------------------------------------------------------------------------------------------------------------------------------------------------------
219 UniRef50_C0D961 Putative uncharacterized pr... 49 2e-04 1 14.2% 21:140 30:165 --------------------LEPLPDNYVNRGTIVSMEAMSEFLkrFTDKKCALVLPNSVAFSKRLTMPAMTVEHLKINLPYEFHDFINESRKKYVFDygKPFSMDLMAAAAPKEKLQEYTLMLKHAGFKLTIAAPEIFA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
220 UniRef50_Q6MMP1 Putative type 4 fimbrial bi... 49 2e-04 1 12.6% 30:148 143:267 -----------------------------ADQELEILEYLRDLSSlpAQTRFNFALPQNRVAMRNKFFPFNDRIKISKSLAFELEEDLPFSSDNAIFdiRTVGSgeVLACAAPKIHVQNLIQRAQDSNMDPFIISSEGTSFANVFERW-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
221 UniRef50_Q2RI85 Pilus-associated protein pi... 49 3e-04 1 15.6% 49:157 64:185 ------------------------------------------------GRQAVTAITGERVVVRYLRLPQMAPAELKAGMAYELENYLPTGARDMVVDWTILDDRsvLLAAAPREQVTQLYNIFQGAGLDLVAIDLVPLAlaTISGAVTLLDIGDRW--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
222 UniRef50_C9LRT8 Putative general secretion ... 49 3e-04 1 11.6% 3:365 37:350 --EETLHLPLPPMEAKESLW-----------QEAAGVIQVALAKRVWEKSRIAVCLTEDEVFSYSREFPPLSEREMREAARWDLLASLPDAREEAAYSlrRVGEREVVLAALPREKAQEIHRAFSHEGL----CLASLCFLPTGAG---------RQVPGTFAADGMNLAADDLPQ-----EEDGAAFLAAQELLSREKNHLELLPELMRPADWAFGRLAA---LLAGIFFFCMASIYGWNAWRIHELQGVVQKTAHEMTLLSAERARMEQEAQ---------------EDGRV----AQKERQLISLSKGALplLVHFGT--RTVEGAWIRGLRVVDG-HAVELEGAATSYDALADFVRVLEED----------------------
223 UniRef50_Q04SY3 Actin-like ATPase n=4 Tax=L... 49 3e-04 1 15.6% 47:142 60:159 ----------------------------------------------PGETSIVLNLPLSRLFVREFSIPLTTVKAVREVIPFEVENRIPFPMETVEVtrIDQEKSNVIAYSAHHSELDFITAPFLGSNIVFRGLFVDSVSLA-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
224 UniRef50_Q1NII5 Tfp pilus assembly protein ... 49 3e-04 1 12.7% 8:141 32:168 -------LHLNSPRQQLLAAQQDPATDDQARGrlSEWVRRHQLA----RAPTVLTLAPGEYGMFQVEKPAVNENELRQAVRWRLKDFLDYSPEEAVVDVCQVPPGriYAAAARRGLLQERIAVIRKAGLQLSRIEIPELAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
225 UniRef50_C1ZC69 Type IV pilus assembly prot... 49 3e-04 1 13.6% 54:141 76:173 -----------------------------------------------------ISLPGSKSLLKFIQLPPVEESKVAEIVRYEARQQIPFPLEDVIWDFQPMgdAEVGLFAMKRDDIEHQMYPFNQRKLELELVQIAPLAV------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
226 UniRef50_C8X4Z0 Type IV pilus assembly prot... 49 3e-04 1 12.2% 16:220 14:243 ---------------GRVPWPRQdaTDAKAERLRQLWQALEL-----KDKVVTSSMAGHAVIVKRVRFAKDRIRHLAAEVQKEAKQYIPFDINDVYLDFQDLGphQVLLVASKKKMVHEVQNVLSAAGLGLSVLDVDAFAlgAQQSVFCVCAQGRPLFLREIAFGGHQITERLARTLEITKTEAEKLKVNGPKEEDASNIATVQDVLNKVFADWAQEIQR-----------------------------------------------------------------------------------------------------------------------------------------------------------------------
227 UniRef50_Q7NA51 Similar to unknown protein ... 49 3e-04 1 16.4% 19:237 34:259 ------------------CWQYLLSDAVMPEGRLQRPEILCDIleLPKKISFRLALPVQQTLQKSLILPpiNLKEPEQgiNASAEKQFPFNTRELALDYRIIEQNAY-ISAARQKDLNLWLQCLAQAGIFPDAIDIAPCALRYIAQYAGVP--ADSWLLHRQQSGWLWVSPANAPFAYDLVSANTAVSPQQIIRQLSASSMAEQPVYYSSYQQEALPEGTYSWDMLTahYQPPLPIQ------------------------------------------------------------------------------------------------------------------------------------------------------
228 UniRef50_C6C803 Putative uncharacterized pr... 49 4e-04 1 14.8% 17:198 32:220 ----------------RQWWQLPLPGDTLRGGSLHNPAALCAVleLPHYVSLRLAFPADRVLQQRLSEPDGRLREPEryIEKMAAKKLPVSSDALIFDYrpAVADSVLVTAARKAELALWLDCFRHAGLQLDAVDITPCALRCMAHQAGLASDN--MLVHRFEDRWLWISSLNAPLAFGTVHVDDAADFSALLSYVSA---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
229 UniRef50_D2QZ79 Type IV pilus assembly prot... 48 6e-04 1 19.5% 48:134 68:164 -----------------------------------------------RGDKVAVSVPGESGLARFFKPPPVDVKKIADIVKYEARQQIPFALEDVIWDYQRMPGGqiGLFAMKREQVSKAMQPFLNAGIEVDII-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
230 UniRef50_B2V6U3 Tfp pilus assembly protein ... 48 6e-04 1 18.2% 54:141 82:173 -----------------------------------------------------FSIPVSAVLIKNLKLPKVSEKEMIDAIEWNIKEDIelKAETVyySIIHEDKDFYDIVVvkNKQINRVLEVAENAKIEVDIIEPSAMAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
231 UniRef50_B7RP05 Putative uncharacterized pr... 48 7e-04 1 10.2% 20:215 24:216 -------------------WRVVGELALDVDDLTGELAVLRKTAaePGGVRTKLLIPNDQIKYMTIPTPDLSDAARLDAARKALENATPYAVEDLAFDISS-DGTQTHIAAVARETLAEAEAFAMEHRFHPVSFVAQPSPGLFTGEPFFGPTEAADTIL----DAGDAVDRDAEAVVVLDDLTAVEAAEIRPDPEQPPLADQTHDPVILLPADSA----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
232 UniRef50_UPI00016C4016 hypothetical protein GobsU_... 47 8e-04 1 10.8% 48:205 66:230 -----------------------------------------------APAPVLVSVGRDRVILKELRHPPVPPADEPAVIRFQAVKEMSESPDDVVLDYVPIGDtrAMAVMLRKDVLNAITAMTTAAGLKLAGATPRPYAVAAGLGRAFALGAAPAPEQKTDTVAALTLGPGGGEFTVVRGGEMVLTLAIPAPVMVSEAMLVAQL--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
233 UniRef50_Q3A7K3 MshA biogenesis protein Msh... 47 9e-04 1 10.0% 63:232 80:256 --------------------------------------------------------------LFQVAPPPVPDAELRDAVRWQVKDLIDYPLEEAVVDVFRVGADAryVVAVKQAVVRQQLDLLRHARLKVDAVDIPELCL-RNLAALLPEDPRGVSLLYLGADSGVVIVCRGGRLQLARDIPFGFTALSPegESQPGNIEGLQERLSLLALDIQRSLDFYESSFRQTPVAA-----------------------------------------------------------------------------------------------------------------------------------------------------------
234 UniRef50_A3Q9V9 Conserved hypothetical biog... 47 0.001 1 14.0% 42:141 56:158 -----------------------------------------ALTDKIPAPNLQLVLSEDFYQLLVVDKPMVQPEEMHQALIWSIKDMVSEPVESLHLDypESTNNKVTVVAVNKAMLQALVKAADKHQVTIAGISIEEMAI------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
235 UniRef50_B9Y7Z5 Putative uncharacterized pr... 47 0.001 1 13.5% 25:371 34:415 ------------------------PEGLLINGFIQDEEAFAQWAkgLKGKGVTVIADSTAVIYRQIETPKLKAKALEKNLYFNLARQitENTVDYAILPQAENGSESLTVVVPQSYGDTYSKALKAAGLKPQRMITSTLALIQAGMrwCSDEVCTSVLFNNGRfnVFRFDRNQTPLTVMNERISQLVQFQRI-KNPDSPVELVRIGTTENAESIARELTQ-VLRLPTEIFPAVSGLSASEVSSQVCAVYGLALLARPYDLFKGINHQRYTEAYQQ--RRSLRLILGLFVINALIlnAIKQVEAQLqqQYDDALMLSTQNSLTRQQIED-ALQVLQYSEQTEQFSKTL----FEQIQALrdVAISGLQVQDG----------------
236 UniRef50_B0VJ47 Putative type IV pilus biog... 47 0.001 1 17.4% 46:183 76:219 ---------------------------------------------PKRIQHLVTSIGGDNTSIKQIKTIFLPDEELESALFFEAKKHIPISGTDMILDYqkTNNMNILLAATSKEVLNEHTNVLMTAGLAPNIVDIDSLAVVNSFILNTFVEDGVYILLNLGAHRTNMIIWGPGAKLFARDIP------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
237 UniRef50_Q168Z6 Putative uncharacterized pr... 47 0.001 1 13.1% 7:136 31:158 ------ILLLHRTAAG---WRSIGEADPASESLGEDLAGlrASALISGELLCKLVIPNDQIRYMAIETPGLEDAERRSAADRALEGATPYAVSELIIDV-EADGDTTQIAAVARETLKEAEAFAIEHGFAPVSFVA-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
238 UniRef50_UPI000174561F hypothetical protein VspiD_... 47 0.001 1 11.2% 14:387 11:401 -------------PDSELTWRLWKSTSATTSEQVEAPAECRET-----SKPIVVGLPATACRTVGLILPQVEIALLGSMVEAQLERRGIlpVPNFAWHVLGNQGGQMLVSV--DVLLQPFPAELAVKH--AAKYTAALRLLALPPGELVVVEEQGHLVLAASQSGKLWHcsDMAPVDLARELEIARLslGSLRTELRKHTPIALEHVPTLQPNRTQNLETFPKLLPAAVFQAQASKEKRRRLMSVLMLLALIYAVICAMA--WWYLQQLQQDAATLENQAAVIKQ-----PAADVRSTAQRWRSLEAATDVQRYPMVQLSHITNLMPPSGIVLKRFEAKLTEVELRGEARDAQTASQFLEDLKKHPTLSRYTWSMPTPTmsFRIQGK
239 UniRef50_Q5QWC5 Type II secretory pathway c... 47 0.001 1 10.0% 7:146 23:170 ------VRLLVAKGSANAPELIVNDYEPVQRGSLLKHAD-TLLGKYskHAQVTLVLGTDLYESVQVDRPMLDPEEISESLKYSLSDLVSFAADEieFPEQPSGQDKVVAVAANKSDLMPWVELFGEHDLSLTDIAITELTLPRLAE-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
240 UniRef50_A4F159 Putative uncharacterized pr... 47 0.001 1 10.6% 7:224 14:237 ------IVLLHRAAGG------WRNVGQVPLEAADLPSDLAALKAKgpGGTCKLIIPNDQIRYLSIDTNGASASTCRDMARQALEGATPYPVDELAFD-LSEDGNQTHIAAVALETLTEAESFAVSNGFTPASFVaePFFGPTAAIGTTLVEADGIAVVDIGPAEIPVPAAPATKSADKVDPPKESVNAEKGNASGTAEEAGADEADDLPIAGFSSRRRRPAAD-------------------------------------------------------------------------------------------------------------------------------------------------------------------
241 UniRef50_A5GFB0 Tfp pilus assembly protein ... 47 0.001 1 17.2% 43:135 68:167 ------------------------------------------LRLLTKTKHVSVSLptGRVILLDLETRFKSRDEGADIIRWKLKKSFPFNISDAHLDYqeKDSGelLVSIIARQVVNQYEDLFVEAGLEPNCID------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
242 UniRef50_Q60BY8 Type 4 fimbrial biogenesis ... 47 0.001 1 13.7% 50:144 102:204 -------------------------------------------------RHAVVAVPGSVVITKRIALPalEGDELEAQIELEADQYIPHAREEVSLDFEVLGKndVLLVATRRENVEDRVSVLENAGLGVEIVDVESYAIERA---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
243 UniRef50_B7GH54 Tfp pilus assembly protein,... 47 0.001 1 14.2% 19:159 38:187 ------------------EW--PLPEGIVRDGKIVDEEQLTHIMEqmKHRRIRFLVPDPLVVVRNIPLPkiAHEDIRSYLFMEIGASIPLPFEDAVFDYTVLEKTkvLLFAAPETNVMQYVELFETVKLKPIVADISPLSLYRLFYHFHLANDVDHFLF------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
244 UniRef50_B5YEE0 Fimbrial assembly protein (... 47 0.001 1 15.4% 48:138 63:157 -----------------------------------------------KDKEVILLFESKDISIRTSEYPSMSLKDLEMAILDDLEEFQAFDEssFTFSVITQDKNKVrvATIPKIIIDTWENIFKNLGLTLISLEPSF---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
245 UniRef50_C5S7Y2 Fimbrial assembly family pr... 47 0.001 1 16.4% 19:140 47:191 ------------------RWLVIRPEGRRARVELVMGLETRPLGeqERPPGIELRLPREAVLRRTVSFPSQVRANLPQVIRYELDRLSPFESKDVLFDFVALSGprLDLALCRRDLVEDWITQLEALGTPVDRLTWDGAW-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
246 UniRef50_C0QUJ1 Putative uncharacterized pr... 47 0.001 1 23.3% 52:141 79:172 ---------------------------------------------------VVVSIPISSTLFKTIKLPKMSPKEIEEAVEWNIREDigKTIYDYDIISEDKDMLTVIVVISKIEDIENVQEILGYAGMEADIIDSEGIAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
247 UniRef50_C6E2S2 Tfp pilus assembly protein ... 47 0.002 1 13.8% 43:158 67:189 ------------------------------------------LRLLTRERSVSVSVPDarVVLLDLEARFRNREEGLDVIRWKLKKSLPFDIGTVHLDYQTLEEKelLVSLVSRAVVTQYEELLIQAGLEPKQIDFTSFNLYRLFAPRLDISDDGAFV-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
248 UniRef50_D1Y3M7 Putative uncharacterized pr... 46 0.002 1 13.7% 25:235 49:272 ------------------------PDGLVSHGRLANGAALGalAFRWGKLPFAVGIPSADCLFRLFSLPAADLEEARASMTWCFSDYFPFDFGEALFDLcpPRGGRLNLvaCAKAQILPFLESLRA--PRARVFAAEPQIVASTRAFASVVAEERFLLAadSLHCAFVCEGNGLVFRSVALPAEEFAWSSQiaEINRTLEYVAENFGGAAPPVYIAKDASAPVALPPGDLRAVAR--------------------------------------------------------------------------------------------------------------------------------------------------------
249 UniRef50_Q2B6I7 Putative uncharacterized pr... 46 0.003 1 13.1% 22:143 41:172 ---------------------RYLPNGIIREGKIQDAETLTAILekIKGKEIAFLVPDPVIIIRKLSIpdVSAEEIKGYLYMELGTSIHLPFEDPVFDYTILETgeILLFAAPEEIVHEYVSVFEEARLKP--VLADISCLAL----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
250 UniRef50_Q1PWM9 Putative uncharacterized pr... 46 0.003 1 19.0% 47:104 131:188 ----------------------------------------------SKKTDVVVSVPGQLALSRFSTIPLVSKKQLKSLVSFEAQQQIPFDLKDVVWDYHRLSG-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
251 UniRef50_A7A8R7 Putative uncharacterized pr... 46 0.003 1 14.6% 21:143 34:171 --------------------ALPLPVGAVVDGEVVDAEVVTGLLkkFPRENTILVYSSRRMVFRETDFPYMSLADLRSTLPFQAKGMIPLPIEESELDFVpeQNGKQllVATLRGGLEKTAYTAEEAGFVITSIDAGPFALAR----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
252 UniRef50_A1SFR2 Type IV pilus assembly prot... 46 0.003 1 14.1% 7:141 20:173 ------FVPGRRRPTLRRFAQLPLPSGVVRAGVVADGEALTEALkkFGSRNVALGVANAGVLVRQLDLDWMPPADFRKALRYQVQDVLPFSVDEANLDHHLLEeaRILLVAASRDMVDAFVDSARRARLRIQTVDLLPFAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
253 UniRef50_Q7NZT8 Type 4 fimbrial biogenesis ... 46 0.003 1 15.3% 31:141 65:188 ------------------------------DGNLVDIEGIAEALRRgpIRSVAIAIPTPMAIYKKLLVPASQTEDMDELIESEANQIIPFPLDEvhQVLGPsdDLEVLLCAARKEKVEERVAVVEMAGLRAHVVDVESFAM------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
254 UniRef50_Q21LN6 Putative uncharacterized pr... 46 0.003 1 8.6% 7:168 25:198 ------VVVLGREAGGkiQASTLIAAQGQNSSIASFQSDLSELVEKhkAAKCNLVLAKEDYQLLLVEAPDVPDAEIKEAIRWRVKDLISTPVEQAALDvlPDDGArvYVVVADKARIKEIVDFVAHSQLSLNSIDIVELalALPDE---AAQVRGIALVRIGEGVGSV---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
255 UniRef50_B0K9B9 Tfp pilus assembly protein ... 46 0.003 1 14.0% 22:135 35:154 ---------------------VITNGKIIDINSLADVINETLKRNNIKEKQVCFTISSSNNIIRDLELPLMKEDEVEKALYYEIEQYIL-DTENYVIDYrkNKTIRVLIASSPKDIIEKYVKLAEMLKLKVEAID------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
256 UniRef50_A1SRB1 Type IV pilus assembly prot... 45 0.004 1 14.4% 27:144 48:179 --------------------------GVIVDHRFENIAKLTEIIkpASYQNVAIAVSGADVITKVI---PMNTNLNDQSLEYQVenSIPFPLDEIFLDFenPDLKDVLVSAARKDTVLSQVHCIEEAGLQVKIVDIASHTLARA---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
257 UniRef50_Q1N2F7 Putative uncharacterized pr... 45 0.004 1 12.7% 49:166 48:172 ------------------------------------------------NADCYLVLPPNEYELELIERPQVPDEELLEAVRWRSKGLLSTPAADAVIDVLPLPEDAyyVAAVASEHIRQRVKQIKQIGLDLKIIDIWHMALRNMALYLPEMENGNVALLELHENSG-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
258 UniRef50_Q3A3Y1 Putative uncharacterized pr... 45 0.004 1 13.8% 42:229 67:274 -----------------------------------------LLPIASKERRLALSLPDRCGYVMTMDVatRSRKESREVVAWQLRKLLPG-IADLHFdvLKRTGghLLVVAMEKQALDRYETLFQKAGFILhrLDpdAILLAMNEDGIIVQTYRDSVL---SYYRAGAVGSRISHQLQELHRIVAGCAQDFSPRNRARVFLHADRPVDETTLDALNDCFGRKVLLLTGH--------------------------------------------------------------------------------------------------------------------------------------------------------------
259 UniRef50_A4WRE5 Putative uncharacterized pr... 45 0.005 1 14.8% 9:136 16:142 --------LLRRMPDGWEELGRVPYDAPDLAEALAALRQAAQADAGEAGVTAKVVIPNSQVLYTTLAAPGPDRASRGAQIRAGLEGLTPYEVKDLVYDFEP-QGDEVRVAVVARETLDEAEGFAEEHGFNPVAFVA-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
260 UniRef50_C6Q9T8 Fimbrial assembly family pr... 45 0.005 1 15.9% 32:163 68:204 -------------------------------GSDAIADARRSVIGKRDTNQILLRLAPSQVVRRTLRVPRAAADLLSSVVENKVETIVAWPVENTYFGYRVVADddTEIIATTKTLVDSALQRAQELGLSPRAV--DFAEAPEDASQVEILKLEQDPVTRTAA--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
261 UniRef50_A4BG89 Putative uncharacterized pr... 45 0.005 1 11.4% 2:141 18:163 -SENGLCLFETGPGKDALPYLDIKAT-LSADSPLSAPAAHMRWVRQHAGKRLNILLSNGLYQLLLSDVPDVPEAELRDAIELKAADLINYDLEDALIDVIQLPSDAYriVAMMKTPLQQWLVELAQHGIRVDIIDVEMTQL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
262 UniRef50_Q02D04 Putative uncharacterized pr... 45 0.005 1 15.8% 39:158 67:195 --------------------------------------SLAGSQNARKRKDVALILpsARISVLDFDQFPKDAKEQASLIRFRLKRSVPFDVESAALSyqPGEKGKVDAVVvpLEIVSRYEAPFRTAGMNPGLVTTSSLalAPEAGLSVLAKLTGRVL-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
263 UniRef50_Q0AF41 Type IV pilus assembly prot... 45 0.006 1 9.8% 9:140 52:191 --------RLERYVIEPLPMDALQDGGINQIEQVSDSLQHALKRMGTRQRKIVMALPLTSVITKRINVPAGLReeANQYVPFAMDeqVIGPAPDC------PEEVEVLLAAARKDKVEDRVATAMSAGLKVMVMDIEQFA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
264 UniRef50_B0S8R0 Actin-like ATPase involved ... 45 0.006 1 14.6% 47:169 63:189 ----------------------------------------------PEENRFLINLGIHNLFVRDITVPLVSEKAIQEVLPFEVENLVPYPMEELEVirTGKENSDVITFNVHHSELFRALKPFAKGDLTLSCLSLDSFVLSALITKNYPLLVGDKTILQLDLGGRYSI--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
265 UniRef50_C5BR19 Putative uncharacterized pr... 45 0.006 1 10.7% 30:141 61:181 -----------------------------ASNDAKPALALTQwsQQLKNARCNLVLGQGDYQLLLVEAPDVDAKELRHAIRWRIKDLVNIPLEKAVLDvlPRDGSraYVAVADKSRIEKAIALVRDAGLQLAAIDVSELAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
266 UniRef50_C0QK71 GspL n=1 Tax=Desulfobacteri... 44 0.007 1 14.9% 47:361 64:434 ----------------------------------------------PESALIHLGIPRSLAILKFIELPFAVKENLGTTLKYEMDKHVPIPVDDIDFDYQILEADeqKVLGVerQAFVGLTSELLEIGIVEHGLLTssFPLAEYDGEvgLIESELHSLVEVSRSEKLSvdGDLLKQLGKNDAFDIEIMDWTKAGVFSPDQPSPEAIVALGLALKGLKKLPLQINLL--PFVMRRKPDRAGLYFMAVFAVLAILSCASWGGSFILHQKmmEEMQAQIKTLGVEVLsdTLQKNCRNLEERVDFLNNIKLERVSITDTLKALSVIVP--KETWLQGFTYSEKGMQ--IEGTARSASEMISLLEA--------------------------
267 UniRef50_B6B225 Putative uncharacterized pr... 44 0.008 1 11.7% 14:193 18:203 -------------HQQENGWGRVGDVDIGAADLTGDLAALRARAEALSSGPIelIIPDDQIKYLTVDATGLDKDALQSSVLGALDGATPYPVDDLTFDF-ANEAGQVHIAAVAKETLQEAEAFATEHGFAPMGFVAATTPapSFGVSTLATSMGITALDTDGKPAIVTSDAIPVPVPVASDPEPVIAASEDAP--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
268 UniRef50_A6DJN4 Putative uncharacterized pr... 44 0.008 1 13.1% 2:146 5:151 -NKNIVVLCLAKSGRHLAMKVAKSRSGliKSRILDGdsSLQESLDISANDYFVLCDEGSLSVSVNLALPKLAAKELRNAVSFELGNKIPLPVDAVQWGYY-RDKDSCQLSVISYEAWDEFI--LATHEMAFDFFVSSSSLPELSDD-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
269 UniRef50_Q1QZY8 Type IV pilus assembly prot... 44 0.008 1 12.2% 9:156 36:191 --------RIASYAVRPLHEGAVVERRIRDLDEVANTLTRAVEHARPHSRRAVAAVPASAAITKTLTYPalTDDEIEARIQLESERHIPFPLNEVAFDFQrpDQQDILLVACRLQDVDRLADVLRRAGLEPAAVDVETFAMERAAGELLLGQAASQ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
270 UniRef50_C4XH40 Putative uncharacterized pr... 44 0.010 1 13.0% 49:364 61:448 ------------------------------------------------ARRVALGLDAAKATLRRLPFPFTAPGKIDLVLGPEFEPFLTAPPAETALAWAATALAavLAAALSREALVAQTAALAALGLPPQAACLDLAGLDALLQALTPGSQAVLCVHVADGRADFVCRLDDAPLAWRSLPLPEAADAAqpATSLSALPGWPRLPTGEALPEALALadPKTANFLRGELAPAASRATLRRALLLAGGSALVLA-VCAIGAYFSMLWRLDASLTRTRAETEAVIAAAAPDLAPSLTLPQKLSALRGRLagGVLEILAAIHQGLGPDGAAKARRVALDESRA--TIDAVADDYTTVDAVKRRLAA-----------------------
271 UniRef50_A5WAB6 Tfp pilus assembly protein ... 44 0.010 1 14.8% 23:204 48:238 ----------------------LADDWAEAPGEVVAALQRACRRSGLRQRRVALALPASQVICKLCHLPVEQsaQLEAQLLADAERLFPFPLEDLALDfgASHDqeVMVAACRQSALASLESVVEEAGLQLEAVEVDTIALCRMLPQ---GGLEGAALLRVETRSVTLHDWqyQRCELQTTGPDMNGQWPERLQALLARQSLPA---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
272 UniRef50_D0I1Z6 Putative uncharacterized pr... 44 0.010 1 12.0% 19:361 27:354 ------------------HWYIWPED---------SLDEPTVAPKARRWDKVIGLVPQSVCLFKVfqTDLIPQSQIRQCVANELEQLIDWPEYQSHIWINKIQErqVSVWFWDKSRITFAQ--------PVTHIVpaYQLARVKTSEGILLHIEGQA----PNEQSWAITWQNGKVIEQLHPMQSLLhaNRVRENQYVYTNQTEYPLIQDVTLTDFSCTPSSFVLLEGKCSNQFDFDNPWQYWRQILVLLFFLMIYIAADALLVNFKqiAEQITQLQQEtiQRLRGEAQDTQRVL-----MEIELARFRQypAKLIDALTKNLAQ--DVIIDRLMYKPERLVLQGTIK-DSLGLLETLSAL--------------------------
273 UniRef50_A6TTT4 Type IV pilus assembly prot... 44 0.011 1 14.9% 22:135 45:172 ---------------------ILTPQDCFEDGKIINMLELKEVLKRadIKSTISSIESTQILTREIVLPSVSPEDMKEMINYEIGEYLPIELDKyeFIEEDVTKQKILVAAVPAEIALNHFELIDFLGLNPVALD------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
274 UniRef50_A1B3D0 Putative uncharacterized pr... 44 0.012 1 12.9% 16:209 100:293 ---------------APAAWRHLGSVDFTSSDFQGELARLRAMATGDGTrpVTLIIPDDQILYTTLTVAPGADRE--HAVGRALDGLTPYAIEDLAFDWEG-DGDSVRVAAVARQTLREARDFAGQYGFDGQGYCAVPEAGLYPGEPVFVLEPAPSARPRVDPAQAGVTASGLLIEEELPEEQPALDLDGDQSEAEEEVAAESPVEPVP----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
275 UniRef50_Q0AZI1 Tfp pilus assembly protein ... 44 0.013 1 13.4% 23:141 61:193 ----------------------PTPNGVIEYGKIIAPVELGKAISSlkGQKVISALSNQEIFFDNFILPRMNRRESRKAALYQSSSFLPFPLDEAAFDigQGRKREVFFAAAQSLQVEHLKKVCTLAGLRLTVVEIPALAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
276 UniRef50_Q3A898 Putative uncharacterized pr... 44 0.014 1 16.6% 49:223 73:254 ------------------------------------------------NGRVALSLSDakIVITDLNEPLKRGRDGINLLKWQVREHLLLDPEEIRLDFqpGGKTRVLVAAAAKEVLDQYENLLAAAGAIPALVLFDSLNLMHFYHSKRILTCDHLLVAWTSTTLSLQLIGNGQLQACRFRPAPASEKKLYQEVSCTLAKWEQTWPEAATVPAYLHDLSRTSI--------------------------------------------------------------------------------------------------------------------------------------------------------------------
277 UniRef50_C4Z597 Type IV pilus assembly prot... 44 0.014 1 19.3% 22:135 48:175 ---------------------IPAPEGCYEDGILIDIDTLslVEHRFNSNSVAFSISSPRLATKEVLIPNVKANKIEKIVQANATEYFPVNMDEyhTVLQEIEDqkIMVAAVPSEVVESYYDLAKALGLKVAFVD------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
278 UniRef50_D1B5I8 Tfp pilus assembly protein ... 44 0.014 1 13.2% 51:141 76:174 --------------------------------------------------SAVLGIQSKDVMVKVVQVPRMDERDMKEAFKFEFDKHFPFPSQEAVFDlhPLDSGgfAVAAASRSrvESFLQVCNKAGLMIQSVEPSAVAM------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
279 UniRef50_Q3SLB7 Putative uncharacterized pr... 43 0.014 1 11.9% 150:350 208:424 -----------------------------------------------------------------------------------------------------------------------------------------------------LYMSGQRILPREARLHVLLLDPSGQLDSAQAPLNADPAFSARVIDLATLARALhlRLTPEVAPLAAIASEALPLNLAPVELLQPHVEFLWRRGLR-AAAGIIAFLGAGMTAAYWLHAqqLAKQVQRLEGRYMAIARTFPPDAETPEDLAraLAARLDRRQTEVDTLLATAGAALQSTPGVVPETLSWHDEtgQIRLDIDAA-------------------------------------
280 UniRef50_Q2S971 Putative uncharacterized pr... 43 0.015 1 12.5% 52:227 69:261 ---------------------------------------------------CNLVLPPEMYALHQIERPSVEESELREAVRWKVKDLLDYAIDDAIIDvlRGRPAQVNVVTARKSLLKELIRVINDSGLVLSSIDITELAlpFEEDGKSlmMRENTGLMLLIKNGSVYLSRRLDADMEALADPErwVGQQLALEVQRSFDYFESQMGQAPPRRLMAGSVVNEAELLS----------------------------------------------------------------------------------------------------------------------------------------------------------------
281 UniRef50_Q1CCN3 Type IV pilus biogenesis pr... 43 0.016 1 14.2% 7:175 22:197 ------VIRRRNGWQLRYWWHKILPSGVLREGILHQPDILSEQlqLPRHISLRIALPAQRILQHTIHVPDRRLREPErfIKASASRLFPVNSQALALDYCReaSSELLITAARQSEVQQWQACLEQAGLSSQVIDIAPCALRYMATA--TGLSGPYWLVHRLANEWLWVSSSDMP--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
282 UniRef50_Q7UV57 Probable fimbrial assembly ... 43 0.016 1 18.1% 37:141 55:171 ------------------------------------ADALDQLMQRNDadRVCISVPGQSGLAKFFKPPPVELKKIHDIVKYEAKTQIPFELSDVVWDYQtaLESEVGLFAMKREQAYRQLAPFKDADIEVDMVQLTPIAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
283 UniRef50_D1R6G2 Putative uncharacterized pr... 43 0.018 1 12.7% 46:211 63:231 ---------------------------------------------LSANALVGVALKTDEVLIRPLEVKLKKEQEIASIIDFQSEPLLPFPVENAIVEWTktDGSKLTIIAARKDYVEKELAKWNTFHVEPELLSCAPAALAAFSSQFCDLS-GPQLILHIGSSGTSCVMAEEGRVIAAQSVPRGIEQLVQAFQQDLLQDPLFKERSFASL--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
284 UniRef50_C8W154 Fimbrial assembly family pr... 43 0.020 1 12.7% 27:379 35:456 --------------------------DRTEESELITAEELSMITSRIARCpvVVVSPLAAVIEVAMdlRKMRPYQLKEALRWEAEPYMTVPAAESLVGylETGDGHVWIWvlPEEDYRSLKETFAGGGLKLRRVYPPDVCFPVAAMLavVIDLGQqaLIEDGDITAftLPADLAATRAHLDGLSSSELEPSlaWEIAGRRVILTGPGGLDADIvaAALELRGSGNCTPEFAAVAGAGMRQLhwKKVGivLPMVAVLVIVAIFLSHYFYLKYQLRQFSMEAGDLKVQK-EEGTRLQNSSSEMEKQRSALKQKafQLLLSVTVRCSGLGELSRMNVQYLPDDLVL-LQGEALSPANVNELALTLQKEvhAAIESIGRVEKT--------
285 UniRef50_Q670M8 MshI1 n=2 Tax=Pseudoalterom... 43 0.021 1 15.7% 46:153 36:148 ---------------------------------------------AAPSALVSLILPSQSYQLVQIDKPNLSPEEIQQSLPWTVKDLVTINSADiyIDHPVKQGNqiSVFVTNRSFITPIIDAIKKASAKLELLSCEEIMLTTLVGKHSAANL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
286 UniRef50_B6BAH0 Putative uncharacterized pr... 43 0.022 1 9.3% 42:223 22:195 -----------------------------------------ALRLAPDGVFSKLILPDDQIRYLTIETGETPAEERIAAARTALEGATPYAVDELAFDISA-DGGLTHVAAVALETLDEAETFAVEHGFGPVSFVAAPEDSGFQGEPFF-------GTTRAIRGTEVEPDSDAVEVVGPAKLPAPAAERKAEESAPAPAEDTPEPSADTAAEQPAEQQTPAPA--------------------------------------------------------------------------------------------------------------------------------------------------------------------
287 UniRef50_Q31KD6 Type IV pilus assembly prot... 43 0.022 1 18.8% 25:141 48:181 ------------------------PDGLFQDGRVLDSFSLSDLLRTarTKRVSTAVPGREVITRLLPMPalDDAELRETLIneAALFLPFPREEADIDYLKLdkLHVLLVATRRQVTDVYLDLFAQAGLTPDIVEVGSFAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
288 UniRef50_B8E6H5 Biogenesis protein MshI n=1... 42 0.026 1 10.9% 4:141 28:161 ---DKLWVYAPAQGDSAEQWLPFELKDEHWS------SAFAAVAKSFPNAQLQLILASGLYQLLLTDKPNVDTVELSQALLWSIKDMVTLPVPQIHLDysPIPSNKINVVVVDKAKLVSMVQVIHEQNLQLIGISIEELAM------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
289 UniRef50_A6T3G1 PilM type IV pilus assembly... 42 0.026 1 11.3% 8:140 39:179 -------LRLECFASEPLPRGAVVDGNIENIDQVSDAVLRVWKKSGTRAKFAAMGMPPASVITKKIILPSGLSEeaSQYIPFAL-DEVRLDFDVIGLVENSPDDVEVMLAATRKEKVEDRVAVAEAAGLKPTIMDIESYA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
290 UniRef50_D0LLX1 Cell division protein FtsA ... 42 0.028 1 14.4% 177:364 362:558 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------LAETLGLPVERLSSAHAQALFGDKLAGVGAPVDTACVAasAGGRPHFDLRQGELAYKADLSF-LRERAPALLAAAVILLCFATFNGFAALYKLRRAEASLQTELALETTTLFGEPLDVTATMARIGGAAAGKKstAYDILLEVNNKLPAKGDVTLDVQQLDIRQGKVTFEATARSSPEIDTVEESLQS-----------------------
291 UniRef50_B8FD58 Putative uncharacterized pr... 42 0.036 1 8.3% 51:159 125:242 --------------------------------------------------QVWAAVPSQSVDIRRIFVPKVGRDELPEAVFWTFKKESPFDDAKVVFDFqvRDSGVLKIAVidRGEVNGLRDLFDKAGYPLAGLtpPFFVQNLFRSGWLRAPDDAVAVL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
292 UniRef50_A6FQN6 Putative uncharacterized pr... 42 0.039 1 13.4% 14:229 18:230 -------------HRAEAGWHSVGEVSLDSSNLATKLADLRalALDPSGMTTQLVIPDEQIKFLSFPASDADHDALEQAVRDNLTGATPYALEDLVYDW-TLDAGQVHVAAVARETLAEAEEFVSAHAFNP----VSFGANPRSGQFAGAPWFGKTAQAGQHIPEGETLDPDTAPIHVIGPAPPPPADAAETADPPASDPADSAATPALADTAQSDAKTAPDLNAAQAP--------------------------------------------------------------------------------------------------------------------------------------------------------------
293 UniRef50_Q1IGB2 Putative type IV pili bioge... 42 0.043 1 11.5% 4:263 23:286 ---RMLQLRRQRGHWRVAAWACEPITRPMGHSQLPEALREAHRRCGTPQRRVALALPSSQVICKVCQLPAETARFDAEvlLAQAEQLFPFPLDDLALDfgSPAHIDVLVAACRQSQLDPLEHMFNQAGMQVAAMEVDSFALLRAMG---VEAPADLALLQLEAGEIVLHGWQ-RDLVPLRQHLALDASGRWLESVERLWSLHGAQERVAQVMLAGGAADAERAGQLTDRLAVRCSLACPSPLAGSAVSESLVASMALACGLAL----------------------------------------------------------------------------------------------------------------------------
294 UniRef50_A1WTW4 Fimbrial assembly family pr... 42 0.045 1 11.2% 48:136 108:203 -----------------------------------------------GGSEAVVVLDGTDYQTQQVDAPRVPDEELSGAVRFQLKNLLYIPLEQAMVGAHRQHSDRwlATIASRTRIEGIQELVARAGLKLQAVLP-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
295 UniRef50_A5GWJ6 Putative uncharacterized pr... 42 0.047 1 16.8% 8:215 46:275 -------LQLQSWQQAPLPSGVVEAGVPLLTEALGDLIGDVLLQGGLQAPGARALLPPEAVVLRSLKLPAGRQPD-AEIIPWLMGQelPFPLAEAAVSWQQR-GDHWLLACMPNEQLDRWIDTFAIAGLDLHGLEPSVLalDVRGESWQLLLWRGAVPLRQLSLASASGLDELQAVIAELDGQQPTLWVLADPELTPPLESWSQQLGCRMERIDA----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
296 UniRef50_A4AFF7 Pilus-associated protein pi... 42 0.054 1 14.9% 7:207 30:254 ------ILRFGEVPLPEGA---VRAGEVIDSATVTASIRKLWTQSGIRTRDVVLGVGNSKVLARDIKVPRLPLNQVRESLPFQVQDLLPVPATEALLDFYpeADGEtlVAAIKAPVLVNVNAAIA-AGVNPENVDLSPFALTrgAATTTLVALDGHvfVRLLPSGGADITKGISQRLDISARDAEAIKRSVGVVAARATPEQRPALE------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
297 UniRef50_A3WP70 Type II secretory pathway c... 41 0.059 1 10.6% 48:141 69:167 -----------------------------------------------EHAPVTVVLQPAHYQSTTVERPDVPEQDLAASLRFQLDELTDMSPDEMVTdlNASGQDKITAVVASKTLLSQIVEAVASQSWQLDSITVSEVVL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
298 UniRef50_A3VL32 Putative uncharacterized pr... 41 0.062 1 12.4% 39:223 43:229 --------------------------------------ALRAVAEELGEGTVtlIIPDSQILYTTLEAPGPDDVAREVQIRVALEGRTPYPVSELVFDWRA-EGDVARVAVLAHETMEEAEGFASQFGFNPVSFVARPANGAFsePFFGKTKSAPRILGGNERVTPDATPVPRNPRQIDLPGGMSVPAPTTRPEPVTAQPAPEPTPAEAEQSAPARPMPDPTP--------------------------------------------------------------------------------------------------------------------------------------------------------------------
299 UniRef50_D0CSU5 Putative uncharacterized pr... 41 0.064 1 8.9% 40:263 45:264 ---------------------------------------RKQAFALANDLSCTVVIPAEHVRYLVIPADASDEGDSTARIEAALVAATPYAAEELAFD-SHRRGSDLHVAAIARETLDEARRFTVQYGFVPIRFVAPLQDQTWPGPAEFTFDPSPTL---APPDTAPGPKPTLDAPADHGAVDQADASPAKPEPGPEAD--GAATSTAHPIAEPADPAAFRSFDVQEKPTLIPAQVGSGNRIWRypAIAAAVVFGVVIGALSL----------------------------------------------------------------------------------------------------------------------------
300 UniRef50_A5D349 Tfp pilus assembly protein,... 41 0.065 1 13.2% 6:141 26:175 -----LAVRGRSQDLQAWSSLPVDPG--IMTDPDKNKEGLAKllAGAEGNRVVSALPHGRVITVVVDMPKMPLDELSQAVKWEaeSGRAGEMVLRHVVLDELNNgrVLLALARESFIRAYYSLFSLAGLDLIALELQGLAL------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
301 UniRef50_B5ZIQ8 Fimbrial assembly family pr... 41 0.065 1 18.9% 45:134 65:160 --------------------------------------------ARDRPGATVLLLPPGMMMRRDVTLPAAAEAALDSVLAYEMDRLTPFPADRIVYavLRRDAdqVRLTIVPRASVAPVLGLLDRIGLQPDLL-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
302 UniRef50_B3E8R7 Tfp pilus assembly protein ... 41 0.068 1 16.5% 50:134 76:167 -------------------------------------------------RRIALSLpaGLLLLTRLDEPWKTRDEATGMLRWKLAKRLGMEPELLQLDFhpDGSTDLLVALVHRTVIQQYEDLFQEAGLQPARI-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
303 UniRef50_B9XBV3 Type IV pilus assembly prot... 41 0.074 1 24.3% 34:136 61:179 ---------------------------------LSEHLKAVVQALDAKTKIVTLAIGVNDSIVRHAELPPMPVEDMRMILRNnlQQDLPGHVFDCHVVvvGMQRAKVLVGGAKQQLISDLLQSIKDAGLTADQVIP-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
consensus/100% ...................................................................................................................................................................................................................................................................................................................................................................................................
consensus/90% ...................................................h.h.h.......h.h.h.....t...t.h.h.htt.h....tth.h......t..h.hhhh.tt.h..h.t.h...th....h...........................................................................................................................................................................................................................................................
consensus/80% .................................................h.hhlsstth.hh.hths.h..tphtthl.h.hpp.hs.shpphhhsh...tttth.lhshtpt.htth.t.htthsht..hh..t...h...................................................................................................................................................................................................................................................
consensus/70% .........................................tttthhhhlsspphhhptlphP.httpphtpsl.hthcp.ls.shpphhhsh...ttsphhlssstcphlpthhthhtttulp.thl.st.hhh..............................................................................................................................................................................................................................................
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown